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Introduction n
In many people gallstones are present without symptoms and no treatment is needed. 
Only in the minority of people gallstones become symptomatic requiring treatment. 
Gallstone disease has a high prevalence and a high economic impact in civilized 
Western countries. Prevalence of gallstones in USA varies between 5-22% and depends 
on factors like age, sex, and race.The total estimated number of people with gallstones 
in USA is 20 million (290 million inhabitants). Prevalence data from European countries 
show similar distributions, resulting in a rough prevalence varying between 25-50 million 
people (503 million inhabitants in 32 countries).
In the USA about 600,000 cholecystectomies are performed annually and the annual 
estimated overall cost is more than $5 billion. For Europe no overall data are known, but 
based on the annual cholecystectomy rates between 1.13 per 1000 (Northern Europe) to 
2.17 per 1000 inhabitants (USA) probably between 700,000-1,100,000 cholecystectomies 
are carried out. Gallstones are therefore one of the most common and most costly 
digestive diseases.
Carl Langenbuch performed the first cholecystectomy in humans in Berlin in 1882. 
Removal of both the gallstones and the gallbladder remains the principle of treatment 
today, because it removes the organ that contributes to both the formation of gallstones 
and the complications ensuing from them.
During a century, operative outcomes of traditional open cholecystectomy have consis­
tently improved along with general advances in medicine. For over a century, the open 
cholecystectomy has been the gold standard and appeared to be a safe procedure with 
low complication rates. In uncomplicated procedures a hospital stay of three to five 
days is required and the largest drawbacks are the resulting pain and weeks of disability.
During the 1970s and 1980s alternative therapies aiming for gallstone removal only (like 
dissolution, fragmentation, and extraction) have passed by and are barely applied any- 
more.The disadvantage of therapies that only eliminate the stones is that gallstones recur.
In order to reduce pain and enhance convalescence in traditional open cholecystectomy, 
incisions were shortened. During the 1970s the first small-incision cholecystectomy 
was described, aiming to reduce surgical trauma and quicken recovery. In case of tech­
nical difficulties, the incision is easily extended and converted into a traditional open 
cholecystectomy. During the 1980s more attention was drawn to this minimal invasive 
procedure and several series and alternative techniques were reported. However, further 
evaluation was interfered by another development at the end of the 1980s.
Muhe performed the first laparoscopic cholecystectomy in Germany in September 1985.
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Although a surgical breakthrough, it did not gain much attention initially. Two years 
later a French gynaecologist inspired the French surgeons Dubois and Perissat who 
further developed the procedure. In the United States Reddick and Olsen further con­
tributed to its enormous popularisation. Never before a new surgical technique was 
introduced and accepted as treatment of first choice in such a fast manner. Some declared 
that evaluation of the new laparoscopic technique would be unethical as superiority 
was considered obvious. Drawbacks of, especially initial, higher proportions of bile duct 
injuries were accepted and devoted to a learning curve. Already in 1993, within 5 years 
time,the laparoscopic cholecystectomy was declared to bethegold standard bya presti­
gious consensus conference without considering that a sufficient level of evidence for 
its superiority was not possible to be provided in such a short period of time.
Both the small-incision and the laparoscopic cholecystectomy are minimal invasive pro­
cedures aiming to reduce surgical trauma resulting in a quicker convalescence. Although 
nowadays surgical treatment and cholecystectomy in specific is difficult to conceive 
without laparoscopy, from a scientific point of view the true evidence of superiority of 
any of the three techniques is lacking. An evidence-based evaluation of cholecystec­
tomy may help in the broad discussions on future needs and directions of surgical research 
and laparoscopy in specific.
In this thesis a matrix approach is developed to evaluate clinical intervention research 
on evidence-based pri nciples. The clinical problem of surgical treatment of symptomatic 
cholecystolithiasis may serve as an example of clinical interventions. This thesis 
addresses two issues: the validity of the matrix approach for evidence-based clinical 
intervention research and the true evidence of (non-)superiority of either one of the 
techniques for cholecystectomy.
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ABSTRACT
Background
Clinical evidence continues to expand and is increasingly difficult to overview. We aimed 
at conceptualizing a visual assessment tool, i.e., a matrix for overviewing studies and 
their data in order to assess the clinical evidence at a glance.
Methods
A four-step matrix was constructed using the three dimensions of systematic error, 
random error, and design error. Matrix step I ranks the identified studies according to the 
dimensions of systematic errors and random errors. Matrix step II orders the studies 
according to the design errors. Matrix step III assesses the three dimensions of errors 
in studies. Matrix step IV assesses the size and direction of the intervention effect.
Results
The application of this four-step matrix is illustrated with two examples: peri-opera- 
tive beta-blockade initialized in relation to surgery versus placebo for major non-cardiac 
surgery, and antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial 
fibrillation. When clinical evidence is deemed both internally and externally valid, the 
size of the intervention effect is to be assessed.
Conclusion
The error matrix provides an overview of the validity of the available evidence at a 
glance, and may assist in deciding which interventions to use in clinical practice.
M any consider evidence-based m edicine (EBM) a paradigm  shift in medicine. However, EBM should rather be considered 
a continuation o f  the w ay o f  thinking th at evolved fro m  rationaiistic optim ist philosophers like Thomas Kuhn and  
Karl Popper [5,6] .  They introduced m odern concepts o f  paradigm  sh ift a nd  critica l rationalism  a nd  stressed the  
im portance o f  scientific experim ents o r trials in  order to  challenge 'norm al science’and g a in  reliable knowledge. EBM 
is p a rt o f  this developm ent; which is u nderpinned by the teaching th at clin ica l know ledge based on random ized  
trials and system atic reviews o f  random ized trials represent the m ost reliable evidence [3,4]- accordance, Sehon and  
Stanley [ 7]  state th at EBM should n o t be considered a Kuhnian paradigm  shift [6], bu t should m ore readily be seen in  
the lig h t o f  the 'O uinean doctrine o f  h olism ’ [8]. The 'w eb o f  b e lie f  m etaphor o f  O uine integrates all fu n d am en ta l 
different approaches a nd  underlines the dependency o f  all alternative approaches on each oth er [ 7,8]. EBM rather 
provides categorization o f  results based on m ore o r less controlled observations f itt in g  in  the 'web o f  belief. Analogous  
to  this, o u r presented m a trix  co uld  be considered a helpful to o l in  categorizing evidence a nd  providing graph ical 
visualization. Although we recognize the value o f  alternative approaches in medicine, we considerthat the solid ground, 
which EBM provides, is the approach with which to g o  forw ard. We strongly recom m end against'evidence sh opping’ 
f o r  the evidence one m ay eventually f in d  to support a prejudiced view, ignoring the possible lack o f  evidence at a higher 
level (that is ju m p in g  the fen ce  where it  is lowest). This seem s reasonable both w hen best available evidence is present, 
bu t also w hen best obtainable evidence is w ithin reach with som e extra reasonable efforts.
Table i
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BACKGROUND
Evidence-based medicine (EBM) was first introduced in 1992 [1], and its increased appli­
cation is reflected among others by the growth of The Cochrane Library databases as 
well as implementation of evidence-based guidelines into clinical practice [2]. EBM 
underpins that information provided from randomized trials, and systematic reviews of 
randomized trials represent the most reliable evidence regarding intervention effects 
[3,4].Thanks to the sustained scientific process (Table 1), we now know that the reliability 
of w hat we observe varies due to a whole array of different factors. There are three 
dimensions that particularly influence the reliability of our observations in clinical 
research and they are empirically and theoretically well acceptedithe risk of systematic 
error (‘bias’), the risk of random error (‘play of chance’), and the risk of design error 
(‘wrong design to answer the posed question’) [4,9].
EBM usually follows a four-phase process starting from a clinical question proceeding 
to the implementation of new evidence (Figure 1) [3]. Phase 1 is the formulation of a 
research question and literature search strategy. Phase 2 is the subsequent systematic 
appraisal and synthesis of the available evidence. Phase 3 covers the initiation of new 
research. Alternatively, phase 4 is the implementation of all available evidence when 
statistically and clinically convincing evidence has been obtained.
In daily clinical practice, the question of w hether sufficient evidence is available to 
recommend the im plementation of a specific intervention as a treatm ent arises 
frequently [3]. Depending on the specific clinical question, often an exhaustive list of 
references is retrieved when using a sensitive search strategy in multiple databases [3]. 
After the selection of studies, their data must be interpreted [10-13].
Since results may be contradictory and studies may differ in more than one aspect, to 
draw a clear, practical conclusion from the publications may be problematic [14].
Objective
We aimed at conceptualizing a visual assessment tool, i.e., a matrix for overviewing 
studies and their data in order to assess the clinical evidence.The matrix is constructed 
from the three dimensions of errors: systematic error (‘bias’), random error (‘play of 
chance’),and design error (‘wrong design toansw erthequestion posed’ or'wrong con­
text’). The application of this matrix will be illustrated by two examples: peri-operative 
beta-blockade initialized in relation to surgery versus placebo for major non-cardiac 
surgery, and antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial 
fibrillation.
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METHODS
The three major error dimensions 
The risk o f systematic error (‘bias’)
When evaluating a clinical study, one should always try to assess its risk of systematic 
error [3,4,9-16].There is increasing agreement on how trials and studies can be placed 
in a hierarchy when assessing the risk of systematic error [3,4,9-16], depending on the
Figure i: Overview o f  the fo u r  phases in  the process o f  evidence-based m edicine fro m  question 
to  the initiation o f  new  research o r im plem entation o f  new  evidence.
PI COT: patients, intervention, control, outcom e measure, time.
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type of research (therapeutic, diagnostic, etiologic, or prognostic) [3,10,11,17].The risk of 
systematic error influences the reliability of observed intervention effects [3,10,11,18,19]. 
A significant association between inadequate or unclear bias protection and overesti­
mation of beneficial effects and underreporting of adverse effects has been demon­
strated [16,19-23]. Differences in risk of bias are found both between the different levels 
of evidence and within each level of evidence [4,16,20].
For randomized trials, there is empirical evidence that at least six components are 
associated with systematic error: generation of the allocation sequence [24], allocation 
concealment [25], blinding [26], incomplete outcome measure reporting [4], selective 
outcome measure reporting [4], and other bias mechanisms (e.g., baseline imbalance, 
early stopping, vested interests, etc.) [4,16,20,27-29].The impact of early stopping of 
trials on bias is largely dependent on how the stopping rules were defined and the level 
of statistical significance of the interim analysis [30-32].Trials with one or more syste­
matic error components assessed as inadequate or unclear are considered to be of high 
risk of bias, while trials with all quality components assessed as adequate are consi­
dered to be of low risk of bias [15,27,33].Trials with a low risk of bias are more likely to 
estimate the 'true' effect of the intervention [16,20,27,33].
The systematic error dimension can be measured by an ordinal variable expressed in 
the levels of evidence (Table 2).
The risk of random error (‘play o f chance')
The risk of random error is the risk of drawing a false conclusion based on sparse data. 
There are two types of false conclusions: a false rejection of the null hypothesis (type I 
error; alpha) or a false acceptance of the null hypothesis (type II error; beta). When data 
are sparse, then the so called 'intervention effect’, whether beneficial or harmful, may
Category Studies
Levelia Meta-analysis of randomized trials with low risk of bias
Levelib Randomized trial with low risk of bias
Levelic Meta-analysis of all randomized trials
Level id Randomized trial with high risk of bias
Level 2a Meta-ana lysis of cohort studies
Level 2b Cohort study
Level 3a Meta-ana lysis of case-control studies
Level 3b Case-control study
Level 4 Case-series
Level 5 Expert opinion
Table 2: Categorization o f  systematic error (bias) o f  clinical intervention studies into  levels o f  evidence.
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in fact be caused by randomly skewed variation in prognostic factors between the 
intervention groups due to sampling error.
The question, however, is how we quantify and compare the risk of random error 
between different studies with varying numbers of participants. A p-value reflects the 
risk that the difference in outcome between two interventions has arisen by chance, 
given the data and the null hypothesis are true. Since random low (and random high) 
p-values occur, especially during accum ulation of data and sequential testing, the 
p-value does not sufficiently reflect the true risk of random error.Therefore, the p-values 
of intervention effect estimates certainly are not suitable for comparison of the risk of 
random error between different studies [32,34-37]. We suggest using the standard error 
(SE) for the evaluation of the risk of random error. We used the statistical algorithms 
from the statistical methods group of the Cochrane Collaboration [38].The SE in a study 
may be considered a measure of uncertainty.The SE measures the amount of variabi­
lity in the sample mean; it indicates how closely the population mean is likely to be esti­
mated by the sample mean.The size of the standard error depends both on how much 
variation there is in the population and on the size of the sample. When two indepen­
dent proportions p,= a/n, and p2= c /n2 (with a and c being the numbers of patients with 
events, b and d  being the numbers of patients with no events, and n, and n2 being the 
total numbers of patients in the intervention group and control group, respectively) are 
considered in an individual study or a trial /', then the relative risk ( R R , )  is defined by:
The SE of the log risk ratio for an individual study is calculated by the following formula:
P 2
The Peto odds ratio (O R peto,\) for an individual study or trial /' is defined by:
O R p m ,.i  = exP
where
Y  rcl,-'V(g,+c,HA + 4)
i  A r2  /  \ t  1 \
The SE of the log Peto odds ratio for an individual study is defined by:
or S E  gn(O R
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In a meta-analysis results of studies or trials are meta-analysed into one intervention 
effect estimate. For the Mantel-Haenszel pooled risk ratio [R R m h ) the natural logarithm 
of the R R m h has the standard error given by:
and N, being the total number of patients in a trial.
Forthe pooled Peto OR (O R peto) the natural logarithm of the O R peto has the standard error 
given by:
SE depends on the numbers of events and the sample size.
Due to spurious results, incorrect type I error inferences may be drawn. Recent reports 
indicate that the influence of the‘play of chance’ may be much larger than generally per­
ceived [39]. In randomized trials, random error may be one reason for the early stop­
ping of trials at interim analyses when benefit or harm appear to be significant [32,40]. 
Increased random error may also play a role in the repeated analyses of accumulating 
data in both trials and meta-analyses [36,41-44]. A cumulative meta-analysis subjects 
accumulating data to repeated testing of the data and is bound to eventually lead to a 
false rejection of the null hypothesis (‘false positive’ result) [45,46]. The random error 
phenomenon or ‘multiplicity’ also plays a role in the evaluation of secondary outcome 
measures [40]. For example, when data on the primary research outcome, on which the 
sample size calculation was based, may not show statistical significance, while another 
outcome measure, for which no separate sample size calculation was performed, exhi­
bits statistical significance [47,48].
Random error may be expressed in a continuous variable using the standard error of 
for example the log of Peto odds ratios or the log of relative risks.
The risk of design errors (external validity) the participants included, 
the outcomes measured, the interventions, etc
When there is sufficient internal validity, i.e., low risks of systematic errors and random 
errors, it becomes relevant to consider the risks of design errors (external validity).The
where
• ( a ,+ c , ) - a r c,-JV,
n ;
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design (or context) of any piece of research determines its external validity or genera- 
lisability (Table 3) [4].The external validity becomes questionable when a wrong design 
has been used to answer the question posed. Among the many variables that should be 
considered, the relevance of different outcome measures are of central importance to 
clinical research [13]. We, therefore, focus on them from a patient’s perspective.
Outcome measures can be divided into three categories according to the GRADE clas­
sifications (Figure 2) [13]. Primary outcome measures are central in deciding the use of 
one intervention over another. Large differences in the primary outcome measure between 
groups in a clinical trial may lead to early termination of a trial (following recommen­
dations of a data safety and monitoring committee) [49]. Choice of the primary out­
come should concur with the GRADE category of outcomes/critical for decision-making’ 
[13]. Secondary outcome measures are additional outcome measures. If they are positi­
vely influenced by an intervention, the results may speak for recommending the inter­
vention only if no clinically and statistically significant effects exist on the primary 
outcomes (e.g., a RR=i.oo with 95% confidence limits from 0.98 to 1.02).The secondary 
outcomes should concur with the second and third GRADE categories o f ‘important, 
but not critical outcomes’ [10-13].
GRADE has schematically ordered outcomes according to patients’ perspective on a 
categorical scale from 1 to 9, with the most critical outcome, mortality, being graded 9 
[13]. Depending on the outcomes, this scale should sometimes be considered nominal 
and in other situations be considered functional. Moreover, the severity of each outcome 
may differ as well. A stroke can be minor, while a myocardial infarction may involve a 
substantial worsening of cardiac function. Grading of outcome measures may also vary 
according to the clinical question.Therefore, outcomes within a category (i.e., critical, 
important, or not important) may be interchangeable. However, one can hardly argue 
that outcomes between categories (i.e., critical, important, or not important) are inter­
changeable (e.g., mortality is always more important than length of stay in hospital).
1 Outcome measures
2 Participants
3 Experimental intervention
4 Control intervention
5 Clinical centres or settings including patients
6 Goal - explanatory or pragmatic
7 Trial structure - parallel group,crossover,etc
8 Objective - superiority,equivalence, non-inferiority
9 Unit of analysis
Table 3: Types o f  variables to consider when evaluating the risk o f  design errors ('context errors') 
and hence external validity o f  evidence.
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Eventually, the design error dimension can be expressed by the priority of outcome 
measures as an ordinal variable according to GRADE [13].
Conceptualization of the error matrix
A four-step matrix can be constructed, building upon the three dimensions: systematic 
error, random error, and design error. Matrix step I ranks the identified studies accor­
ding to the dimensions of systematic errors and random errors. Matrix step II orders 
the studies according to the design errors.Matrix step III assesses the three dimensions 
of errors in studies. Here, a ‘Manhattan-like’ error matrix is constructed where the best 
evidence is represented by the largest skyscrapers located on the ‘upper-west side’. 
Matrix step IV assesses the size and direction of the intervention effect, e.g., by calculating 
the number-needed-to-treat to obtain benefit or to harm one patient.
The principle of the matrix approach can be used in different situations.The overall ef­
fort in research should be to minimize all three risks of errors before the size and the di­
rection of the intervention effect can be assessed reliably.The'algorithm’ of the matrix
Importance of outcomes
all-cause mortality
cardiovascular mortality
non-fatal myocardial infarction
non-fatal stroke
hypotension
bradycardia
9
8
7
6
5
4
3
2
1
Figure 2: Hierarchy o f  outcomes according to importance to non-cardiac surgery patients undergoing  
preventive beta-blocker intervention [13].
Some outcom e measures m ay be correlated (e.g. cardiovascular m ortality is included in  all-cause m ortality).
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Figure y. M atrix step I, ordering o f  evidence according to systematic error (in levels o f  evidence) 
and random error (measured by standard error) considering all-cause m ortality in peri-operative 
beta-blockade versus placebo f o r  m ajor non-cardiac surgery (example i).
Level of evidence Standard error
All-cause
mortality
Cardiovascular
mortality
Non-fatal
myocardial
infarction
Non-fatal
stroke
Bangalore [50] ia 0.12 0.16 0.10 0.28
Poise [51] ib 0.13 0.17 0.10 0.33
MaVS [52] ib 1.07 Z N 0.66
Dipom [53] ib 0.34 0.48 o.gi Z
Mangano [54] ib 0.85 1.22 1.22 1.11
Bangalore [50] 1C 0.11 0.15 0.09 0.28
Wetterslev [55] 1C 0.24 N 0.23 N
Poldermans [56] id 0.76 0.76 Z N
Lindenauer [57] 2b 0.02 N N N
AHA Guidelines [58] 5 N N N N
Table 4: Ordering o f  evidence according to levels o f  evidence (systematic error), standard erro r (random error), and outcome 
measures (design error) in  peri-operative beta-blockade versus placebo f o r  m a jor non-cardiac surgery (exam ple 1).
Z: outcom e with zero-events in one o r both treatm ent arm s which m akes SE incalculable; N: n o  data. 
Some outcom e m easures m ay be correlated (e.g. cardiovascular m ortality is included in all-cause m ortality). 
In this exam ple the fo rm ula s f o r  SE o f  InRR ifor individual studies and SE o f  Ih RRmh f o r  meta-analysis w ere used.
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approach is generally applicable to all kinds of interventions, although details may dif­
fer according to the specific clinical question. Or, the character of the three dimensions 
remains the same, while according to the specific question details may differ, like: the 
preferred hierarchy for levels of evidence, the chosen formula for standard error (RR, O R peto, 
or any other association metric), and the types of outcomes.
all-cause 
Level o f ■  m° r,“M,y
card io-vaseu tar 
mortality
Hotì-fatal H  brady- I  llypo- 
stroko ■  card in I  tension
Bangalore 2008 
(SO)
Bangalore 2008 
(50)
Bangalore 2008 
(50)
Bangalore 2008 
(50)
Mangano 1996 
<54); Dipom 2005 
(53); MaV$ 2006 
(52); Poise 2008
(51)
Mangano 1996 
(54); Dipom 2005 
(53); MaVS 2006 
(52); Poise 2008 
(51)
Mangano 1996 
(54); Dipom 2005 
(53); Poise 2008 
(51)
Mangano 1996 
(54); Dipom 2005 
(53); MaVS 2006 
(52); Poise 2008 
(51)
Bangalore 2008 
(50); Wetterslev 
2006(55)
Bangalore 2008 
(50)
Bangalore 2008 
(50); Wetterslev 
2006 (55)
Bangalore 2008 
(50)
Poldermans 1999 
(56)
Poldermans 1999 
(56)
Poldermans 1999 
(56)
Lindenauer 2005 
(57)
AHA Guideline 
2007 (58)
AHA Guideline 
2007 (58)
AHA Guideline 
2007 (58)
AHA Guideline 
2007 (58)
Figure 4 : M atrix step it, ordering o f  evidence on peri-operative beta-blockade versus placebo f o r  m ajor non-cardiac surgery  
according to importance o f  outcome measures (design error) and levels o f  evidence (systematic error) (example 1).
The outcom e m easures have been adapted to the beta-blockade question.
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M anhattan-like three-dimensional m atrix building upon the risks o f  systematic error, random error, and design error.
The evidence with the lowest systematic, random, and design error is represented by the tallest skyscrapers, 
located on 'the upper west side’.
A 'quick g u id e ' to the perception o f  the f ig u re  :
I f  y o u  w ant to know  w hat the evidence is f o r  peri-operative beta-blockade to influence m yocardial infarction: g o  to  the 
yello w  bars and read i) Level o f  evidence (the risk o f  system atic error) and 2) standard error (the risk o f  random  error).
Data with risk o f  system atic error > level 2 b and  random error SE > 1.0 were om itted fro m  the figu re. The guidelines, which  
advocate the use o f  peri-operative beta-blockade, were n o t included in this f ig u re  since the system atic error is level 5 and the 
random  erro r cannot be calculated (not based on data) [58]. The SE o f  outcom es with zero events cannot be calculated either.
From  these 'benefit’ and 'harm ’ M anhattan figures, one can see at a glance that beta-blockers m a y provide benefit to  patients 
in term s o f  nonfataI m yocardial infarction (yellow  bars). However, one can also see th at beta-blockers m ay cause harm  to  
patients in term s o f  all-cause m ortality  (red bars), cardiovascular m ortality (blue bars), and nonfata! stroke (green bars). 
Reading the dim ension o f  system atic error it  is im m ediately clear that there is level 7 a evidence available f o r  all these f o u r  
outcom e measures. Reading the dim ension o f  random  error on this system atic error level o f  evidence shows th at there is 
a sm all risk o f  random  error considering all-cause m ortality (0,12), cardiovascular m ortality (0,16), a nd  nonfata I m yocardial 
infarction (o,w ), and a m oderate risk o f  random  erro r considering nonfata I stroke (0,28). It is clear at a glance that the best 
available evidence does n o t support peri-operative beta-blockade f o r  m a jo r non-cardiac surgery.
o  to  o ,io  = ignorable risk o f  random  error 
o ,io  to  0,20 = sm all risk o f  random  error 
0,20 to  0,30 = m oderate risk o f  random  error 
0,30 to  0,50 = substantial risk o f  random  error 
> 0,50 = high risk o f  random  error
A clean version f o r  creating a M anhattan f ig u re  can be obtained at the Copenhagen Trial U nit’s hom epage (www.ctu.rh.dk).
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RESULTS
The application of this four-step matrix is illustrated with two examples: peri-operative 
beta-blockade initialized in relation to surgery versus placebo for major non-cardiac 
surgery and antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial 
fibrillation.
Example i: Initiating peri-operative beta-blockade for major non-cardiac surgery
A clinical question in PICOT structure illustrates this model. Is initiating peri-operative 
beta-blockade effective in patients undergoing major non-cardiac surgery?
Patients: patients undergoing major non-cardiac surgery; Intervention: initiating peri­
operative beta blockade; Control: placebo; Outcome measure: mortality myocardial in­
farction, and stroke; Time: follow-up of at least 30 days.
We searched in CENTRAL in The Cochrane Library, PubMed, EMBASE, and personal files 
for all article types up to October 2009, in all languages. Specific searches using the 
terms ‘beta-blockade’, ‘peri-operative’, ‘placebo’, ’mortality’, ‘randomised’, and ‘non-car- 
diac surgery’ were undertaken.The search resulted in multiple publications relevant to 
our question. References were selected from journals on the basis of importance and 
relevance [50-58]. We included the publications in our matrix evaluation by extracting 
information on all-cause mortality, cardiovascular mortality, non-fatal myocardial infarc­
tion, and non-fatal stroke. However, the matrix may easily be extended to other outcomes.
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In step I, we assessed the systematic error and the random error for the chosen outcomes 
of each study (Figure 3, Table 4). In step II, we evaluated the design error (Figure 4). In step 
III, we constructed the three-dimensional matrix (Figure 5). We did not elaborate on the 
matrix step IV in this example.
From Figure 5 it can be concluded at a glance that peri-operative beta blockade does 
not reduce mortality in patients undergoing major non-cardiac surgery. Peri-operative 
beta-blockade in these patients seems to increase all-cause mortality. However, peri­
operative beta-blockade does reduce non-fatal myocardial infarction on the expense of 
an increased cardiovascular mortality and an increased rate of non-fatal stroke.
Example 2: Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial 
fibrillation [59].
The conclusion of this Cochrane review focuses on the significant increased mortality 
associated with use of class ia antiarrhythmics (odds ratio 2.39; 95% confidence interval 
(Cl) 1.03 to 5.59) [59].The data of this outcome in class ia antiarrhythmics in this review 
[59] as well as in the included randomised trials [60-67] were analysed using the matrix 
error approach.
In step I, we assessed the risk of systematic error and the risk of random error for the 
chosen outcome of each study (Figure 6, Table 5). In step II, the design errorshould be 
evaluated by assessing multiple outcome measures. However, in this example we only 
consider the outcom e‘all-cause mortality’, since other outcomes were found to be not 
statistically significantly different [59]. Therefore, no figure of step II is shown. In step III,
Level of evidence Standard error
All cause mortality
Byrne-Ouinn [60] id 2.02
Hillestad [61] id 2.00
Karlson [62] id 1.42
Lloyd [63] id 1-55
PA FAC [64] ib 0.78
Sodermark [65] id 0-73
SO PAT [66] ib 1.51
Steinbeck [67] id Z
Lafuente-Lafuente [59] 1C 0.43
Table 5: Ordering o f  evidence according to levels o f  evidence (systematic error), standard error (random error), and outcome 
measures (design error) in antiarrhythm ics f o r  m aintaining sinus rhythm after cardioversion o f  a tria l f ib rilla tio n  (exam ple 2).
1: outcom e with zero-events in both treatm ent arm s which m akes SE incalculable;
In this exam ple the fo rm ula s f o r  SE o f  InORpetoj f o r  individual studies and SE o f  I nORpetofor meta-analysis were used.
28 C hapter 2
we constructed the three-dimensional matrix (Figure 7). We did not elaborate on the 
matrix step IV in this example, since the available studies are not internally valid (high 
risks of both systematic and random error).
From Figure 7 it can be concluded at a glance that there is both substantial risk of sys­
tematic and random error involved in the evidence available so far considering mortality 
associated with class ia antiarrhythmics.The best available level of evidence ic study 
shows substantial risk of random error (0.43) and the best available level of evidence ib 
study shows high risk of random error (0.78). So, the conclusion in the Cochrane review 
of a significant increased mortality is based on data with high risks for both systematic 
and random errors, and should therefore be considered unreliable.
Level 1 a~
64
o66Level 1 b-
Level 1 c-
59
O
o 65
62 63 60
Level 1 d"
61
Level 2 s r
Level 2b"
Level 3a~
Level 3b~
Level 5 '
Random error measured by standard error (in 0.01)
Figure 6: M atrix step I, ordering o f  evidence according to systematic error (in levels o f  evidence) and random error 
(measured by standard error) considering all-cause m ortality in antiarrhythm icsfor m aintaining sinus rhythm after 
cardioversion o f  atrial fibrilla tion  (example 2).
Com pare this f ig u re  with Figure 3: the studies in this f ig u re  are located on the righ t side o f  the f ig u re  (all SE > 0.40), 
in contrast with Figure 3 w here the studies are concentrated on the u pper left side o f  the f ig u re  (six studies with SE < 0.4
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M anhattan-like three-dimensional m atrix building upon the risks o f  systematic error, random error, and design error.
The evidence with the lowest systematic, random, and design error is represented by the tallest skyscrapers, 
located o n *the upper west side ’.
A "quick g u id e ' to the perception o f  the fig u re :
I f  y o u  w ant to know  w hat the evidence is f o r  antiarrhythm ics f o r  m aintain ing sinus rhythm  after cardioversion o f  atrial 
fib rilla tio n  to influence all-cause m ortality: g o  to  the red bars and read i) Level o f  evidence (the risk o f  system atic error) 
and 2) standard erro r (the risk o f  random  error).
O nly the Cochrane review  and the trials included in this system atic review  were considered in  this example. Data with risk 
o f  random  error SE >7.0 w ere om itted fro m  the figu re. The SE o f  outcom es with zero events cannot be calculated.
From  these 'benefit’ and 'harm 'M anhattan figures, one can see at a glance th at there is n o  benefit a t all and th at 'the upper 
w est side’ is empty. Class 7 a antiarrhythm ics m ig h t increase m ortality; however, since high risks f o r  both system atic error and  
random  error are present there is insujficien t evidence f o r  reliable conclusions.
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DISCUSSION
The aim of our matrix is to facilitate the overview of evidence in clinical intervention 
research. The matrix can serve as a tool to provide visual assessment of reliability of 
observations with respect to systematic error, random error (internal validity), and 
design error (external validity).
The matrix should not replace the thorough process of systematically reviewing evi­
dence and profound evaluations of data, but could be integrated within these research 
activities as a tool for overviewing the results. Also, this matrix is notan absolute measure 
of the risks of errors. The position of studies in relation to each other is relative rather 
than absolute.
There is a lack of awareness of the importance of th e ‘play of chance’ for the reliability 
of study findings. Ordering the standard errors of the studies might be a tool for ran­
king studies according to the level of random error. We have used natural logarithm (In) 
transformations for calculating standard errors, although the logarithm with the base 
10 may be used without producing different conclusions.
As an alternative, the Bayes factor can be considered [37,68].The Bayes factor is a likeli­
hood ratio comparing one hypothesis versus another, and, therefore, varies with the 
definition of the possible alternative hypotheses. The Bayes factor is a sum mary
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measure that provides an alternative to the p-value for the ranking or the flagging of 
associations as ‘significant’ [69].The Bayes factor:
Probability (Data, given the null hypothesis)
Bayes factor = ---------------------------------------------------------------------
Probability (Data, given the alternative hypothesis)
or simple approximations can be very difficult or even impossible to implement for the 
clinician, since a search for the maximum of the multidimensional posterior may be 
required for each association [69].This also includes the asymptotic Bayes factor intro­
duced by Wakefield [69]. In contrast to the Bayes factor, it is possible to calculate the 
standard error and when available it provides a tool for comparison of the risk of random 
error between studies of the same intervention.
The aim of minimising error risks according to the three dimensions actually combines 
the methodological efforts of falsifying any alternative hypothesis in the evaluation of 
an intervention. Thereby, the matrix concept visualises how far the scientific process 
has evolved to fulfil Poppers falsification criterion stating that researchers should pri­
marily engage trying to falsify any relevant alternative hypothesis and not only the null 
hypothesis [5].The minimisation of systematic errors and random errors, by providing 
ample room for the null hypothesis, as well as measuring important outcomes is the 
most audacious attack on any realistic alternative hypothesis. If an array of progressively 
qualified attacks fails to support the null hypothesis then we can reliably trust the 
intervention to be either beneficial or harmful.
The conclusion based on an assessment ofthe evidence usingthe matrix approach may 
be implemented into clinical practice or serve as an incentive for new research. The 
matrix facilitates the identification of lacunae in our knowledge and is likely to benefit 
the process of developing evidence-based guidelines.
Preference for the highest evidence
One has to be aware ofthe multiple forms of bias, potentially present in evidence below 
level 1 (Table 2). Several examples illustrate that large, apparently beneficial intervention 
effects from lower level evidence, even from randomized trials [54,56,70], may eventually 
be reversed to harmful effects when new high-quality evidence appears [50,71].This is 
where the three dimensions of error are of central importance in providing a tool for 
reliability assessment.
Limitations
Apart from the three error dimensions influencing the reliability of data, other factors
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play a role in ¡ncomparability and uncertainty of inferences. Many reports of studies 
appear incomplete, and the lack of details raises questions. Incomplete reporting limits 
interpretation, but more importantly, this reporting factor should be distinguished from 
the methodological quality of the trial [72].
Statements like CONSORT [73], PRISMA [74], and MOOSE [75] aim to improve and to 
maximize the amount and correctness of information to be retrieved from publications. 
These guidelines also create awareness among researchers about the most important 
issues to report so that the quality of future research may increase. By following reporting 
guidelines theyield of the research question is likely to be increased (phase 1 in Figure 1).
Standard error does not consider testing of multiple outcomes and multiple testing on 
accumulating data, which may also induce risks of random error due to multiplicity as 
well as correlations.
The division of all outcomes into ‘primary’ and ‘secondary’ outcome measures can be 
helpful as this division sets the standards for the evaluation of interventions. However, 
this division is artificial, and outcome measures, situated on the border of primary and 
secondary outcomes, exist. For example, one can argue that quality of life is a primary 
outcome rather than a secondary outcome. Further, there is also a quantitative aspect 
in the artificial division into primary and secondary outcomes. Small significant dif­
ferences in primary outcome measures (e.g., bile duct injuries in patients undergoing 
cholecystectomy) may be found favouring one intervention, while large differences in 
secondary outcome measures (e.g., costs) may favour the comparator. Eventually, one 
may prefer the larger advantages in secondary outcomes to the smaller disadvantages 
in a primary outcome measure.
Another limitation in the outcome measure dimension is that often outcome measures 
are correlated and mostly this correlation is ignored. For example when mortality is an 
outcome measure and complications is another, which again counts deaths as compli­
cations, then there is a correlation between the two outcome measures. Authors usually 
carryout multiple univariate analyses ignoring correlations between outcome measures.
Step IV of the matrix includes the assessment of the size of the intervention effect, e.g., 
expressed in numbers-needed-to-treat to obtain benefit or to harm one patient with the 
intervention. This step is the last one since it is irrelevant to consider effect sizes and 
their directions if a study does not appear to be internally and externally valid.
Another aspect to consider is heterogeneity [76,77]. Statistical heterogeneity reflects 
the between trial variance of meta-analytic intervention effect estimates rather than
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the play of chance [76]. Clinical heterogeneity however, represents differences in 
populations, procedures, or interventions in daily practice. All these factors of clinical 
heterogeneity, together with concordance of in- and exclusion criteria should be 
considered whenever we want to implement results of available evidence. Assessment 
and consideration of heterogeneity or diversity, therefore, forms thefinal step before new 
evidence is implemented. Assessment of heterogeneity is not included in our matrix.
CONCLUSIONS
Assessment of risks of systematic error, random error, and design error are essential 
factors in evaluating evidence and drawing conclusions. We used the standard error in 
our matrix to rank studies according to their risk of random error. The risks of these 
error types were incorporated into a three dimensional matrix to create a schematic 
overview of the internal and external validity of the evidence, seen at a glance.
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ABSTRACT
Background
Cholecystectomy is one of the most frequently performed operations. Open cholecys­
tectomy has been the gold standard for over 100years. Small-incision cholecystectomy 
is a less frequently used alternative.
Objectives
To compare the beneficial and harmful effects of small-incision versus open cholecys­
tectomy for patients with symptomatic cholecystolithiasis.
Search strategy
We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (6 April 2004), 
The Cochrane Library (Issue 1,2004), MEDLINE (1966 to January 2004), EMBASE (1980 to 
January 2004), Web of Science (1988 to January 2004), and CINAHL (1982 to January 
2004) for randomised trials.
Selection criteria
All published and unpublished randomised trials in patients with symptomatic chole­
cystolithiasis comparing any kind of small-incision or other kind of minimal incision 
cholecystectomy versus any kind of open cholecystectomy. No language limitations 
were applied.
Data collection and analysis
Two authors independently performed selection of trials and data extraction.The metho­
dological quality of the generation of the allocation sequence, allocation concealment, 
blinding, and follow-up was evaluated to assess bias risk. Analyses were based on the 
intention-to-treat principle. Authors were requested additional information in case of 
missing data. Sensitivity and subgroup analyses were performed if appropriate.
M ain results
Seven trials randomised 571 patients. Bias risk was high in the included trials. No mor­
tality was reported.The total complication proportions are respectively 9.9% and 9.3% 
in the small-incision and open group, which is not significantly different (risk difference 
all trials, random-effects 0.00,95% confidence interval (Cl) -0.06 to 0.07).There are also 
no significant differences considering severe complications and bile duct injuries. How­
ever, small-incision cholecystectomy has a shorter hospital stay (weighted mean diffe­
rence, random-effects -2.8 days (95% Cl -4.9 to -0.6)) compared to open cholecystectomy.
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Authors’ conclusions
Small-indsion and open cholecystectomy seem to be equivalent regarding risks of com­
plications, but the latter method is associated with a significantly longer hospital stay 
The quicker recovery of small-incision cholecystectomy compared with open cholecys­
tectomy confirms the existing preference of this technique over open cholecystectomy
Only the abstract rather than the f u ll  text o f  the Cochrane systematic review is printed  
here due to space lim itations. The f u ll  text may be accessed at the Cochrane Library 
(http://0nlinelibrary.w iley.c0m /0/c0chrane/clsysrev/articles/CD 004788/fram e.htm l). 
Instead, the sister publication in Alimentary, Pharmacology & Therapeutics sum m arizing  
the results o f  chapters 3,4, and 5 is printed hereafter.
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Systematic review: 
open, small-incision or 
laparoscopic cholecystectomy 
for symptomatic cholecystolithiasis
F. Keus, H. G. Gooszen, C. J. H. M. van Laarhoven 
A lim ent Pharmacol Ther 200g;2g(4):3sg~3j8  
(Chapters 3,4, and 5 summarised)
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ABSTRACT
Background
Laparoscopic cholecystectomy has become the method of choice for gallbladder removal, 
although evidence of superiority over open and small-incision cholecystectomy is lacking.
Aim
To compare the effects of open, small-incision, and laparoscopic cholecystectomy tech­
niques for patients with symptomatic cholecystolithiasis.
Methods
We conducted updated searches until January 2007 in multiple databases. We assessed 
bias risk.
Results
Fifty-nine trials randomized 5556 patients. No significant differences in primary outcomes 
(mortality and complications) were found among all three techniques. Both minimal 
invasive techniques show advantages over open cholecystectomy in terms of convale­
scence. Small-incision cholecystectomy showed shorter operative time compared with 
laparoscopic cholecystectomy (random-effects, weighted mean difference, 16.4 min; 
95% confidence interval, 8.9-23.8), but the two techniques did not differ regarding hos­
pital stay and conversions.
Conclusions
No significant differences in mortality and complications were found among all three 
techniques. Laparoscopic cholecystectomy and small-incision cholecystectomy are 
preferred over open cholecystectomy for quicker convalescence. Laparoscopic chole­
cystectomy and small-incision cholecystectomy show no clear differences on patient 
outcomes.
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INTRODUCTION
Gallstones are one of the major causes of morbidity in western society It is estimated 
that the incidence of symptomatic cholecystolithiasis is up to 2.2 perthousand inhabi­
tants [1,2] with an annual performance rate of cholecystectomies of more than 500 000 
in the US [3-5]. Open cholecystectomy (OC) has been the gold standard for treatment 
of symptomatic gallstones since the 1880s [6]. Since the early 1970s, incisions were 
shortened, resulting in small-incision cholecystectomy (SIC). Morbidity and complications 
seemed to decline and patients recovered faster [7,8]. The first laparoscopic cholecys­
tectomy (LC) was introduced in 1985 [9]. LC rapidly became the method of choice for 
removal of the gallbladder [4], although evidence of superiority over SIC and OC was 
lacking. This rising popularity was based on many arguments, including assumed 
advantages such as fewer complications and quicker post-operative recovery. LC seemed 
superior based on nonrandomized observations [5,10-13], but these comparisons may 
not provide an adequate assessment of intervention effects. However, conflicting data 
on clinical outcomes arose from randomized trials.
Despite several randomized trials assessing OC, SIC and LC, no systematic review with 
meta-analysis of these trials has been conducted.The objectives of our review were to 
evaluate the beneficial and harmful effects of the three different types of cholecystec­
tomy for patients with symptomatic cholecystolithiasis.
METHODS
We conducted the review according to our peer-reviewed, published protocol [14] 
follow ingthe recommendations in the'Cochrane Handbook for Systematic Reviews of 
Interventions’ [15].
Criteria for considering trials
Only randomized trials were included comparing SIC vs. OC, LC vs. OC, or LC vs. SIC. 
Trials were included irrespectively of numbers of patients randomized, blinding, and 
language of the article. Ouasi-randomized studies were excluded.
Participants in the trials were patients with one or more stones in the gallbladder con­
firmed by ultrasonography or other imaging technique and symptoms attributable to 
them, scheduled forcholecystectomy.Trials that included a small proportion of patients 
with acute cholecystitis in addition to patients with symptomatic cholecystolithiasis 
were included.Trials that only included patients with acute cholecystitis were excluded.
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Sm all-indsion cholecystectomy was defined by an incision length of 8 cm or less, 
either vertical or transverse.The length of incision up to 8 cm was chosen arbitrarily as, 
in literature, most authors used this cut-off point between SIC and (conversion to) OC 
[16-19]. Any other open procedure with an incision length exceeding 8 cm was consi­
dered an OC.
Laparoscopic cholecystectomy included those procedures that started as a laparoscopic 
procedure. Any kind of LC was considered with creation of a pneumoperitoneum (by 
Veress needle or open introduction) or mechanical abdominal wall lift, irrespective of the 
number of trocars used.
The primary outcome measures were mortality, complication proportions, and relief of 
symptoms (pain relief). Secondary outcome measures were conversions, operative time, 
hospital stay, convalescence time, pulmonary function, pain scores, analgesic use, and 
health-related quality-of-life according to availability.
Search strategy
We updated the search of our published reviews up to January 2007. We searched The 
Cochrane Hepato-Biliary Group Controlled Trials Register (8 February 2007), CENTRAL 
on The Cochrane Library (Issue 1, 2007), The National Library of Medicine (MEDLINE) 
(1966 - January 2007),The Intelligent Gateway to Biomedical & Pharmacological Infor­
mation (EMBASE) (1980 - January 2007), ISI Web of Knowledge (Web of Science) (1988 - 
January 2007), and ClNAHL (1982 - January 2007) for randomized trials (Table 1). Additional 
relevant trials were looked for by cross reference checking of identified randomized trials. 
All trial authors were requested for additional information lacking from their reports.
Methodological quality
Methodological quality, study design, and reporting quality have been recognized as 
criteria which can restrict bias in the comparisons of interventions. Inadequate metho­
dological quality in randomized clinical trials carries the risk of overestimating inter­
vention effects [20-22]. We assessed methodological quality of included trials usingthe 
following components: generation of the allocation sequence, allocation concealment, 
blinding, and follow-up.These four methodological components were scored adequate, 
unclear or inadequate /n o t performed according to Cochrane definitions [14,15]. Low- 
bias risk trials were defined by trials that scored adequate in three or more of the four 
above-mentioned methodological quality criteria. Pooled results including all trials were 
compared to pooled results from low-bias risk trials to assess the effect of methodolo­
gical quality on the estimated intervention effect.
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Database Time span 
of search
Search of strategy Hits Titels
selected
The Cochrane Hepato- 
Biliary Group Controlled 
Trials Register
8 February 
2007
(cholecystectomy OR incision*) AND 
(gallstone* OR cholelithiasis OR 
(stones AND gallbladder))
911 68
Cochrane Database of 
Systematic Reviews in 
The Cochrane Library
Issue 1,2007 cholecystectomy 73 0
Database of Abstracts of 
Reviews of Effects in 
The Cochrane Library
Issue 1,2007 cholecystectomy 29 5
Cochrane Central Register 
of Controlled Trials in 
The Cochrane Library
Issue 1,2007 cholecystectomy 1485 156
Health Technology 
Assessment Database in 
The Cochrane Library
Issue 1,2007 cholecystectomy 14 4
NHS Economic Evaluation
Database in
The Cochrane Library
Issue 1,2007 cholecystectomy 77 8
MEDLINE 1950 to (((GaIlbladder[Tiab] AND (Surgery[Tiab] OR 9246 371
January 2007 Endoscopy[Tiab] OR SurgicaI[Tiab] OR
Laparoscopy[Tiab])) OR Cholecystectomy[Tiab])
OR ((("Gallbladder"[MeSH] OR "Gallbladder 
Diseases"[MeSH]) AND ("Surgery"[MeSH] OR 
Msurgery"[Subheading] OR "Endoscopy, 
Gastrointestinal"[MeSH] OR "Surgical 
Procedures, Operative"[MeSH] OR "Surgical 
Procedures,Minor"[MeSH] OR "Laparoscopy" 
[MeSH])) OR "Cholecystectomy"[MeSH])) AND 
(randomized controlled trial[PTYP] OR 
randomized controlled trials OR controlled 
clinical tria I [PTYP] OR clinical trial[PTYP] OR 
clinical trials OR (clinical AND trial) OR random 
allocation OR random* OR double blind method 
OR single blind method OR (singl* OR doubl* OR 
trebl* ORtripl*) OR blind* OR mask* OR placebo* 
OR placebos OR research design OR comparative 
study OR evaluation studies OR follow up studies 
OR prospective studies OR control OR controlled 
OR prospectiv* OR volunteer*)
EMBASE 1966 to 
January 2007
cholecystectomy 768 137
Web of Science 1988 to 
January 2007
TS=(cholecystectomy AND random*) 1546 157
CINAHL 1982 to 
January 2007
cholecystectomy 957 9
Total 15106 915 (620)
Table i: Databases, used search strategies, and results o f  laparoscopic versus small-incision cholecystectomy.
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Extraction of data
Inclusion and exclusion criteria used in each trial were considered. We extracted: number 
of randomized patients, number (and reasons) of patients not randomized, number of 
patients excluded after randomization, number of drop-outs, information on intention- 
to-treat analysis, sample size calculation, single- or multi-centre design, primary and 
secondary outcome measures, antibiotic prophylaxis, surgical experience, and intra­
operative cholangiography.
General descriptive data (like gender, age, body mass index (BMI), and American Society 
of Anaesthesiologists (ASA) classification) are supposed to be equally divided due to 
randomization [23]. Trials were assessed for imbalance in general descriptive data. 
Outcome data were extracted according to availability.
For reasons of the wide range of the types of complications described, all complications 
were categorized into four subcategories: intra-operative, minor, severe, or bile duct 
injury. Furthermore, total complication proportions were calculated. As bile duct injuries 
are considered the most important complication in cholecystectomy, these were regis­
tered separately from all the other complications and hence not counted as severe or 
minor adverse event. Intra-operative complications may reflect immediate differences 
in techniques; therefore, the intra-operative complications (excluding all bile duct inju­
ries) were categorized separately from other complications. All other complications were 
categorized into minor and severe complications. Complications which were possibly 
life-threatening (e.g. cardiac, pulmonary, and bleeding) and complications with a major 
impact on postoperative quality of life or recovery time (e.g. re-operations) were cate­
gorized as severe complications. All other complications with mild consequences were 
categorized as minor complications.
Statistical analysis
Exploration of the data showed that for many binary data, the outcome was rare or zero 
in one or both arms. In Review Manager (http://www.cochrane.org), odds ratios and 
relative risks (RRs) are not estimable in trials with zero events in both arms; therefore, 
risk differences have been used in our Cochrane review. However, alternative software 
allows for calculating RRs including the zero event trials by using continuity corrections. 
For reasons of consistency of effect, ease of interpretation, and mathematical properties, 
binary outcomes were expressed in RRs using Trial Sequential Analysis software (Copen­
hagen Trial Unit, Center for Clinical Intervention Research, Copenhagen, Denmark) [24-27].
Continuous data were presented in weighted mean differences (WMD). Forthe analysis, 
mean values with their corresponding standard deviations are needed to calculate WMD 
with 95% confidence intervals (Cl).
System atic review : open, sm all-in cisio n  or laparoscopic cholecystectom y for sym ptom atic... 4 9
Funnel plots were used for visual assessm ent of the presence of publication bias and 
whether treatment estimates were associated with study size.
Depending on the presence of heterogeneity the results of the random- [28] or fixed- 
effect model [29] were presented. Heterogeneity was calculated by the Cochran’s 0 test 
and quantified by measuring I2 [15]. Arbitrarily an I2 of 2 5 %  distinguished between using 
a fixed- or random-effects model.
Figure i: OUOROM statement flow  diagram summarizing the numbers of trials in each phase of the review and 
meta-analysis evaluating techniques of cholecystectomy for symptomatic cholecystolithiasis.
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Subgroup and sensitivity analysis
Two types of subgroup analyses were performed. First, subgroup analyses according to 
each of the quality criteria dom ains were performed to compare the effects of the 
interventions according to the methodological quality of the trials (adequate compared 
to unclear/inadeq uate). Second, high- and low-bias risk trial subgroup analyses were 
conducted according to classification of the trials (defined by three or more adequate 
quality domains). Sensitivity analyses were performed for continuous outcomes imputing 
data for m issing values.
RESULTS
Altogether, the search resulted in 15 106 hits. In each step of selection, we included the 
publication in case of any doubt. After selections by titles (915) and correction for dupli­
cates, 620 publications remained.The abstracts of these 620 publications were reviewed 
independently by two authors and differences were discussed. A total of 451 publications 
could be rejected based on their abstract. Eventually, 169 publications were selected for 
further evaluation from which a total of 79 were excluded (Figure 1). A total of 59 trials 
were described in 90 publications [30-32].
Two trials were only described in short [33,34]. As no language restriction was used, four 
publications were translated [35-38]. Double publications of trial results by the same 
research group were considered one trial [39-44]. After contacting individual trialists, 
additional data and information were obtained from 10 out of 59 trials.
Patient characteristics and trial designs
All included trials used sim ilar inclusion criteria.The extensiveness in which exclusion 
criteria were described varied, but nearly all trials excluded patients with acute chole­
cystitis. We did not find any im balance in baseline data on age, gender, BMI and ASA 
classification.
One trial used a three-arm design [17]. Another trial used a five-arm  design comparing 
LC in one arm versus OC in four arms with variable application of medication treatment 
to reduce post-operative paralytic ileus. We sum m arized all OC patients in one group, 
resulting in a ratio of one to four of included patients in both groups [45]. The trial by 
Lausten included two groups: patients with postnecrotic liver cirrhosis and patients 
with chronic hepatitis (both groups ASA classifications III and IV). Both groups were ran­
domized separately. For data managem ent reasons, we listed both groups as separate 
trials [46,47]. All other trials used a two-arm  parallel-group design.
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Trial Setting Number Methodological quality
of centres Generation Allocation Blinding Follow-
of allocation concealment up
sequence
Sm all-incision (SIC) versus open cholecystectomy (OC)
Assalia 1993 56 Israel 1 U U N U
Coelho 1992a 36 Brasil 1 A U N U
Coelho 1993 * 17 Brasil 1 U U N U
O'Dwyer 1992a 57 UK and Ireland 2 U A N U
Schmitz 1997a 58 Germany 1 U A N A
Seenu 19 9 4 59 India 1 U U N U
W ani 2002 6o'61 India 1 U U N U
Total
Laparoscopic (LC) versus open cholecystectomy (OC)
Agnifili 1993 62‘65 Italy 1
Bellon 1998 66167 Spain 1
Berggren 19 9 4 68 Sweden 1
Bianc-Louvry 2 0 0 0 69 France 1
Bukan 20 0 4 70 Tu rkey 1
Charlo 1995 38 Spain 1
Chaudhary 19 9 9 71 India 1
C h u m illa s i9 9 8 72 Spain 1
Coelho 1993 * 17 Brasil 1
Coskun 2 0 0 0 73 Tu rkey 1
Dauleh 199574 United Kingdom 1
Demirer 2 0 0 0 75 Tu rkey 1
Dionigi 19 9 4 76-77 Italy 1
Engin 19 98 78 Tu rkey 1
Essen 19 9579 Sweden 1
Gal 19 9 780 Hungary 1
Galizia 2 0 0 181 Italy 1
García-Caballero 199345 Spain 1
Hasukic 2 0 0 2 82 Bosnia Herzegovina 1
Hendolin 2000 83 Finland 1
H u a n g i9 9 684 Taiwan 1
Jan 1993 37 China 1
Ji 2005 85 China 1
Karayiannakis 19 9 786187 Greece 1
Kjaersgaard 19 9 4 88 Norway 1
Koprulu 19 9 6 89 Tu rkey 1
La u sten 19 9 9 -146-47 Egypt 1
La u sten 1999-2 46-47 Egypt 1
Lujan 1998 90 Spain 1
Luo 2003 91>92 China 1
Milheiro 19 9 4 93 Portugal 1
Mimica 2000 94 Croatia 1
Ortega 1996 9$ United States 1
Prisco 2000 96 Italy 1
Putensen-H im m eri99297 Austria 1
Rovina 1996 98 Greece 1
U U N U
U U N U
U A N U
A U N U
U U N U
A U N U
A U A A
U A N U
U U N U
U U N U
U U N U
U U N A
U U N U
U A N U
U A N U
U U N U
U A N U
U U A A
U U N U
U A N U
U U N U
A N N A
U A N U
U A N A
U U N A
U U N U
U U N U
U U N U
U U N U
U U N U
U A N U
U A N U
A U A U
U U N U
U U N U
U U N U
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Randomized Patients Patients included Intra- Antibiotic Surgical
excluded Intervention Control operative prophylaxis expertise
cholangio-
graphy
SIC OC
50 0 24 26 No Y S
50 0 25 25 Y U U
BO* 0 15 15 U U U
30 0 16 14 Y U R
130 0 65 65 U U U
181 0 97 84 U U R
100 0 50 50 U U U
571 0 292 279
LC OC
50 0 29 21 Y U U
28 0 14 14 No U U
30 3 15 12 No No SS
41 0 25 l6 Y U S
30 0 15 15 U U U
200 0 100 100 U U U
43 0 21 22 U Y U
40 0 20 20 No Uo U
30* 0 15 15 U U U
70 0 35 35 U U u
78 0 40 38 U No s
100 0 50 50 No No SS
57 0 30 27 No U SS
32 0 16 l6 U U SS
12 0 6 6 Y U u
42 0 21 21 U Y u
33 18 10 5 U U u
100 4 20 76 U U s
60 2 30 28 U U SS
49 2 25 22 No U s
29 2 15 12 U U u
101 0 50 51 U U u
80 0 38 42 U U u
96 9 45 42 U U SS
72 2 35 35 U U u
40 0 20 20 U U u
16 2 7 7 No U SS
14 0 7 7 No U SS
285 21 133 131 Y Y u
26 0 14 12 U U u
40 0 20 20 No U u
100 0 50 50 U U u
20 0 10 10 No U u
25 5 10 10 Y U u
20 0 10 10 U U u
51 0 26 25 U U SS
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Trial Setting Number
of centres Generation 
of allocation 
sequence
Methodological quality 
Allocation Blinding 
concealment
Follow-
up
Trondsen 1993 99 Norway 1 U U N U
Volpino 19 9 8 100 Italy 1 U U N U
Zajac 19 9 8 101 Poland 1 U U N U
ZuIfikaroglu 2002 34 Tu rkey 1 U U N U
Total
Laparoscopic (LC) versus sm all-incision cholecystectomy (SIC)
Barkun 19 9 2102 Canada 5 A U N A
Bruce 19 9 9 103 United Kingdom 1 A A N U
Coelho 1993*17 Brasil 1 U U N U
Grande 20 0 2104 Italy 1 U A N U
Harju 2 0 0 6 105 Finland 1 U A N U
Keus 2 0 0 7 49 Netherlands 1 A A A A
Kunz 19 9 2106 Germany 1 U U N U
Majeed 19 9 6 16 United Kingdom 1 U A A A
McGinn 19 9518 United Kingdom 1 U A N A
McMahon 19 9 4 41 United Kingdom 5 U A N A
Ros 2 0 0 119 Sweden 5 U A A A
Secco 2 0 0 2 35 Italy 1 U U N A
Srivastava 2 0 0 150 India 1 U A N A
Tate 1993 33 Hong Kong 1 U U A U
Vagenas 2 0 0 6 107 Greece 1 A U N U
Total
Table 2: Details on setting, methodological quality, numbers of included patients, and interventions in the included randomized 
trials in the three comparisons evaluating techniques of cholecystectomy for symptomatic cholecystolithiasis.
Surgical interventions
An incision length of 8 centimetres was taken as cut-off between SIC and OC [16-19]. 
Some trials using the SIC technique did not mention the size of the incision. We classi­
fied these trials based on how the author labelled the operation.Two trials performed 
SIC by a 5-cm vertical (midline) incision [35,48], the others by a transverse incision in 
the right hypochondrium, some with muscle splitting [49], others by transsection of 
the rectus oroblique muscles [16,50]. OC included all procedures with an incision length 
exceeding 8 cm, either by vertical or transverse incision.
Usually, LC was not further specified. Some trials stated that a four trocar technique 
was used, creating a pneum operitoneum by using carbon dioxide insufflations with a 
m axim um  intraperitoneal pressure of 12-15 m L mercury.
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Randomized Patients
excluded
Patients included 
Intervention Control
Intra­
operative
cholangio­
graphy
Antibiotic
prophylaxis
Surgical
expertise
72 2 35 35 U U U
120 2 58 60 U U U
110 0 58 52 U u u
50 0 25 25 U u u
2492 74 1203 1215
LC SIC
70 8 37 25 No Y SS
22 0 11 11 U Y SS
30* 0 15 15 U U U
40 0 18 22 No Y U
157 0 72 85 No U R
264 7 120 137 No Y R
100 0 50 50 U U U
203 3 100 100 Y U SS
310 0 155 155 No U R
302 3 151 148 No Y R
726 2 362 362 Y U R
181 9 86 86 No Y S
100 1 59 40 No U SS
22 0 11 11 U U SS
88 0 44 44 U U SS
2615 33 1291 1291
* Three-armed trial. A = adequate; U = unknown; N = not performed; Y = 
5 = one surgeon; 55 = several surgeons; R = also registrars.
yes;
Data on the use of antibiotic prophylaxis, surgical experience (one or a few highly expe­
rienced surgeons performing all operations or also involving registrars), and intra-operative 
cholangiography (attempted in all or only in selected patients) were recorded as well (Table 2).
Sm all-incision vs. open cholecystectomy
We included eight publications describing seven trials random izing 571 patients 
between SIC (292) and OC (279) [30].
We assessed adequate m ethodological quality as follows: generation of allocation 
sequence one trial (14.3%), allocation concealment two trials (28.6%), blinding no trials 
(0%), and follow -up one trial (14.3%). All trials were h igh-b ias risk trials, as no trial 
scored adequate in three or more methodology criteria.
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Sm all-incision (SIC) 
versus open 
cholecystectomy (OC)
Laparoscopic (LC) 
versus open 
cholecystectomy (OC)
Laparoscopic (LC) 
versus sm all-incision 
cholecystectomy (SIC)
SIC
(n=292)
o c
(n=279)
LC
(n=i203)
OC
(n=i2i 5)
LC
(n=i29i)
SIC
(n=i2gi)
INTRA-OPERATIVE (0) (0) ( 10 /0 .8 % ) (1 /  0.1) (15 3/11.9 % ) (88 /  6.8%)
♦ gallbladder perforation 7 1 112 62
♦ bleeding 2 23 19
♦ stone in common bile duct 1
♦ stone left in abdomen 10
♦ vascular injury (hepatic artery) 1
♦ bowel injury 5
♦ hepatic injury 1 1
♦ cardiac 1 1
♦ cerebrovascular 1
♦ other (not specified) 1
POSTOPERATIVE-MINOR (25 /  8.6%) (19 /  6.8%) (27 /  2.2%) (40 /  3-3% ) (9 8 /7 .6 % ) (114 /  8.8%)
♦ retained bile duct stone (ERCP) 1 2 4 1
♦ subcutaneous emphysema 1
♦ wound infection 12 15 4 19 36 55
♦ wound haematoma 12 4 3 6
♦ urinary retention 1 8 18
♦ urinary tract infection 8 9 5 14
♦ phlebitis 3 4 3
♦ dyspeptic syndrome 11 12
♦ readmission (abdominal pain) 2
♦ other (not specified) 6 6 24 14
POSTOPERATIVE-SEVERE ( 4 /1 .4 % ) ( 7 /2 .5 % ) (31 /  2.6%) (91 /  7.5%) (4 8 / 3.7% ) (50 /  3.9%)
♦ bleeding: drainage /
blood transfusion 4 1 11 4
♦ bleeding: re-operation 2 6 3
♦ stone left in cystic duct
(re-operation) 1
• biliary fistula
(unspecified /  conservative) 1 1
♦ ileus (re-operation) 1 2
♦ ileus (conservative) 4 9 1
♦ platzbauch 3
♦ pancreatitis 3 6
♦ abscess (drainage /  unspecified 1 2 2 5
♦ abscess (re-operation) 1 1
♦ pneumonia 1 5 7 22 14 20
♦ atelectasis 1 6 35
♦ septic shock 1 2
♦ septic shock (re-operation) 1
♦ cardiovascular 1 5 2 6
♦ cerebrovascular accident 1 1 1
♦ encephalopathy 1 2
♦ upper Gl bleeding
(endoscopy /  conservative) 2 1 3
Table 3: Detailed overview of the type of complications including all randomized trials in the three comparisons 
evaluating techniques of cholecystectomy for symptomatic cholecystolithiasis.
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Sm all-incision (SIC) Laparoscopic (LC) Laparoscopic (LC)
versus open versus open versus sm all- incision
cholecystectomy (OC) cholecystectomy (OC) cholecystectomy (SIC)
SIC OC LC OC LC SIC
(n=292) (n=279) (n=i203) (n=i2i5) (n=i2gi) (n=i2gi)
♦ hernia cicatricalis 3 1
♦ epididym itis (re-operation) 1
♦ other (not specified) 4 6
BILE DUCT INJURY (0) (0) (2 /  0 .2%) (2 /  0.2%) ( 15 /1 .2 % ) ( 2 2 /1 .7 % )
♦ cystic duct leakage:
drainage /  ERCP 1 3 1
♦ cystic duct leakage:
re-operation 3
♦ accessory duct leakage
(re-operation) 1
• minorcom mon bile duct
injury (intra-operative) 5 3
• major common bile duct
injury: re-operation 3 2
♦ hepatic duct injury
(intra-operative) 1
♦ bile leakage (origin
unknown): conservative 2 1 2 8
♦ bile leakage (origin
unknown): re-operation 2 3
TOTAL COMPLICATIONS 29 (9-9%) 26 (9.3%) 70 (5.8%) 134 (11.0%) 314 (24.3%) 274 (21.2%)
♦ Re-operations
(all complications) 2 (0.7%) 0 3 {0.2%) 3 (0.2%) 20 (1.5%) l8 (1.4%)
Primary outcome measures
7. Mortality
None of the trials reported clearly on mortality.
2. Complications
In all seven trials, including 571 patients, complications were explicitly reported (Table 3). 
We found no significant differences in all complication categories (Table 4).
20. intra-operative complications
Zero intra-operative complications were reported.
2b. Minor complications
The minor complication proportions were 8 .6 %  in the sm all-incision group vs. 6 .8 %  in 
the open group.
2C . Severe complications
The severe complication proportions were 1.4 %  in the sm all-incision group vs. 2 .5%  in the 
open group.
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Sm
all-incision 
(SIC) versus 
open 
Laparoscopic 
(LC) versus 
open 
Laparoscopic 
(LC) versus 
sm
all-incision 
cholecystectom
y 
(SIC) 
cholecystectom
y 
(OC) 
cholecystectom
y 
(O
C)
2d. Bile duct injuries
Zero bile duct injuries were reported.
2e. Total complications
The total complication proportions were 9 .9 %  in the sm all-incision group vs. 9 .3 %  in 
the open group.
3. Symptom relief
No trial reported relief of symptoms.
Secondary outcome measures
4. Operative time
Three trials including 210 patients reported operative tim e. No significant difference 
was found between the sm all-incision and open techniques. In a sensitivity analysis 
im puting m issing data, there was no significant difference either (data not shown).
5. Hospital stay
Two trials including 180 patients reported hospital stay.There was a significantly shorter 
hospital stay favouring the sm all-incision technique. However, this concerns the data of 
only two trials. A sensitivity analysis with im puting m issing data supports the finding 
of a significant shorter hospital stay in the sm all-incision group (data not shown).
6. Other secondary outcome measures
Insufficient data were available considering other outcomes.
Laparoscopic vs. open cholecystectomy
We included 47 publications describing 39 trials random izing 2418 patients between 
LC (1203) and OC (1215) [31].
We assessed adequate m ethodological quality as follows: generation of allocation 
sequence five trials (12.8%), allocation concealment 10 trials (25.6%), blinding three trials 
(7.7%), and follow-up six trials (15.4%). No comparison of high vs. low-bias risk trials was 
performed as only one trial scored adequate in three or more methodology criteria.
Primary outcome meaures
7. Mortality
M ortality was explicitly mentioned in 13 trials including 987 patients. There was one 
death in the OC group out of 485 patients compared with o deaths out of 502 patients 
in the laparoscopic group.
2. Complications
Com plications were explicitly reported in 30 trials, including 1965 patients.
20. Intra-operative complications
Intra-operative complications were 0 .8 %  and 0 .1%  in the laparoscopic and open group, 
respectively, w ithout significant difference.
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2 b. M inor complications
The m inor com plication proportions in the laparoscopic and open groups (2.2%  and 
3.3%  respectively) were not significantly different.
2C . Severe complications
The severe complication proportions were 2 .6 %  and 7.5% in the laparoscopic and open 
group respectively M eta-analysis of all trials showed a significant difference favouring 
the laparoscopic technique, while m eta-analysis in subgroups according to adequate 
methodological quality showed no significant difference.
Study
or sub-category
laparoscopie (LC) 
nW
open (OC) 
n/N
RR (random) 
95% CI
weight
%
RR (random) 
95% CI
01 High-quality trials
Jan 1993 S/SO 1/51 3.82 S.10 IO .62, 42.121
Berggren 1994 1/1S 0/12 -  1.37 2.44 IO .11, 54.97]
Milhero 1994 1/20 2/20 3.28 0.S0 10.05, 5. OS]
Charlo 1995 13/100 16/100 1324 0.81 10.41, 1.60]
Essen 1995 0/6 0/C Hoc estim able
Ortega 1996 0/10 0/10 Hot estim able
Karaylannakis 1997 0/45 0/42 Hot estim able
Chumillas 1998 0/20 1/20 1.94 0.33 10.01, 7.72]
Engln 1998 0/16 0/16 Hot- estim able
Chaudhary 1999 0/21 2/22 2.14 0 .21 10.01, 4.11]
Demirer 2000 0/50 0/50 Hot estim able
Hendclrn 2000 1/2S 2/22 3.25 0-44 0 .0 4 , 4.53]
Mimica 2000 2/50 0/50 -- ► 2.10 5.00 10.25, 101.58)
Galizia 2001 2/10 1/5 3.72 1.00 10.12, 8. 56]
JI2005 7/38 15/42 12.10 0.52 10.24, 1.13]
Subtotal (95% O) 476 463 4 47-56 0-75 10.48, 1.17]
Total events: 32 (laparoscopic (LC)), 40 (open (OC))
Test for heterogeneity: Chi = 7.62, df = 9 (P = 057). F = 0%
Test for overal effect; Z ■1 28 (P » 0.20)
02 Low-qualiy trials
Agnifili 1993 1/29 4/21 3.80 0.18 (0 .02, 1.-51]
Coetw 1993 0/1S 1/1-5 1.96 0.33 10.01, 7.53]
Dionigi 1994 0/30 1/27 1.92 0.30 10.01, 7.09]
Dauieh 1995 0/40 0/38 Hot estim able
Huang 1996 0/15 3/12 4— 2.28 0.12 10.01, 2.05]
Gal 1997 0/21 0/21 Hot estim able
Bellon 1998 0/14 0/14 Hot estim able
Lujan 1998 18/133 31/131 —■- 14.89 0.S7 10.34, 0.97]
Volpino 1S98 2/58 5/60 5.77 0.41 10.08, 2.05]
Zajac 19S8 0/58 14/52 4— 2.39 0.03 10.00, 0.51]
Lausten 1999 (2) 0/7 0/7 Hot estim able
Coskun 2000 0/35 10/35 4— 2.38 0.05 10.00, 0.78]
Lausten 1999(1) 1/7 0/7 — 2.05 3.00 10.14, 63.151
Prisco 2000 0/10 0/10 Hot estim able
Hasukic 2002 0/30 6/28 2-34 0.07 10-00, 1.22]
Subtotal (96% Cl) S37 513 52-44 0.35 |0 .15, 0-82]
Total events: 36 (laparoscopic (LC)), 83 (open (OC))
Test for heterogeneity: Chi - 25.17, df = 10 (P = 0.005), P = 60.3%
Test for overal effect: Z * 2 41 (P ■ 0.02)
Total (95% Q) 1013 981 ♦ 100.00 0.60 10.38, 0.95]
TcM events; 66 (laparoscopic (LC)), 123 (open (OC»
Test for heterogeneity: Chi » 31.49, df = 20 (P = 0.05), I* = 36.5%
Test for overal effect: Z =2.18 (P = 0.03)
0.01 0.1 10 100
Favours LC Favours OC
Figure 2: Forrest plot showing individual data and pooled results of total complications including all trials 
on laparoscopic versus open cholecystectomy.
Forrest plot was constructed using RevMan (www.cochrane.org), while calculations were performed using Trial Sequential 
Analysis software as RevMan does not allow using continuity corrections. Therefore, pooled estimates and confidence 
intervals differ slightly from results in Tables while the overall significant and nonsignificant findings concur.
The squares indicate individual trial results in the form of estimated relative risks; the horizontal lines through them represent 95% 
confidence intervals for each trial. The sizes of the squares indicate the weight that each study contributes to the pooled estimate 
of the meta-analysis. The diamond at the bottom of the plot represents the pooled relative risk and the 9 5 %  confidence interval.
60 Chapter 3,4 , 5
2d. Bile duct injuries
Bile duct injuries were 0 .2 %  in each group w ithout significant difference.
2e. Total complications
The total complication proportions were 5 .8 %  in the laparoscopic group and 11.0 %  in 
the open group. M eta-an a lysis of all trials showed a significant difference favouring 
the laparoscopic technique, w hile m eta-analysis in subgroups according to adequate 
methodological quality dom ains showed no significant difference (Figure 2).
In a funnel plot using data on total complications, there was some suspicion of bias 
considering the absence of sm all trials favouring the open technique (Figure 3).
3. Symptom relief
Insufficient data on relief of symptoms were available.
Secondary outcome measures
4. Operative time
Operative tim e was reported in 23 trials, including 1134 patients.There were no signifi­
cant differences between LC and OC. In a sensitivity analysis im puting m issing data, 
there was no significant difference either (data not shown).
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Figure 3: Funnel plots using data of total complications including 9 5 %  confidence interval lines.
Laparoscopic versus open cholecystectomy.
There is some suspicion of bias considering the absence (in the lower right part) of small trials favoring the open technique.
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5- Hospital stay
Hospital stay was reported in 20 trials including 1111 patients. There was a significantly 
shorter hospital stay favouring the laparoscopic technique (Figure 4).
6. Convalescence
Three trials including 328 patients reported convalescence considering work leave.The 
laparoscopic technique showed a significantly quicker convalescence.
7. Other secondary outcome measures
Insufficient data were available considering other outcomes.
Laparoscopic vs. sm all-incision cholecystectomy
We included 37 publications describing 15 trials random izing 2582 patients with 1291 
patients in each group [32].
We assessed adequate m ethodological quality as follows: generation of allocation 
sequence four trials (26.7%), allocation concealment nine trials (60.0%), blinding four 
trials (26.7%), and follow-up eight trials (53.3%).There were three low-bias risk trials. Pooled 
results including all trials were compared to pooled results including low-bias risktrials.
Primary outcome measures
7. Mortality
Study Laparoscopic (LC) Open (OC) VMD (random) Weight WMD (random)
or sus-category N Mean (SD) h Mean (SO) 9S%0 % SS%CI
01 Hk^ i-qualïy trials
Jan 1993 SO 4.50(1.401 SI 5.60(1.30» ♦ 4.94 -1.10 -1.63, -0.571
Berggren 1994 15 1.60(0.561 12 2.83(0.84) -m- 4.93 -1.03 -1.SÖ, -0.43)
Kjaersgaard 1394 35 2.50(1.51) 35 4.90(4.25) —■— 4.30 -2.40 -3.91, -0.691
Charta 1995 100 3.00(1.01) 100 7.00(2.63) 4.93 -4.00 -4.55, -3.4SI
Éssen 1995 e 1.30(0.50) 6 2.50(0.60) * 4.90 -1.20 -1.02, -0.531
oriega 1996 10 1.20(0. 20) 10 1.10(0.10) 1 5.04 0.10 -0.04, 0.241
Karayiannakis1997 45 2.00(0. 60) 42 5.60(1.10) •* 6.00 -3.60 -3.98, -3.2ZI
Chjnilias 1998 zo 3.25(0.71) 20 1Q.57(4.67> -- ■-- 3,00 -7.32 - 9 .39, -5.25)
Engh1998 16 1.68(0.60) 16 3.06(0.77) -* 4. 96 -1.38 -1.86, -0.901
Hanc-Louvry 2000 zs 2.50(1.00) 16 4.60(1.20) -m- 4. 36 -Z.10 -2.81, -1.391
Oafizia 2001 10 1.00(0.01) 5 5.20(2.20) -- --- 3. 93 -4. 20 -6.13, -2.2?)
SuHotal (95% Cl) 332 313 ♦ 51. £2 -2.43 -3.£6, -1.301
Test tor h eterogenei1/: On - 579.09,01 m 10 (P OjOOOOI), I1- 98.3%
Test lor overal effect 1 =4.21 (P« 0.0001 )
02Low-qualitytrietö
Agnrt*1993 29 3.20(1.20) 21 7.30(3.20) —■— 4.36 -4.10 -5.54, -2.6SI
Dionigi 1994 30 3.10(0.50) 27 7.10(1.60) -*■ 4.90 -4.00 -4.63, -3.371
Huang1996 15 3.93(1.711 12 7.92(0.79) —t - 4.71 -3.99 -4.96, -3.OZI
Volpine 199Ö S3 4.60(2.90) 60 7.77(3.10) —•— 4. 63 -3.17 -4.ZS, -Z.09]
Zajac 1998 SS 1.00(0.01) SZ 9.10(2.80) 4. 84 -8.10 -8.86, -7.34]
Lausten 1999 (2) 7 2.70(0. 30) 7 4.60(0.20} • 5. 02 -1.90 -2.17, -1.63]
Lausten 1999(1) 7 2.90(0.30) 7 5.30(0.30} • 5.01 -2.40 -2.71, -2.091
Prisco 2000 IO 2.00(0.01) 10 5.60(0.52} « 5. 01 -3.60 -3.92, -3.28)
Luo 2003 14 3.20(1.12) 12 5.70(0.69) -m- 4.36 -3.60 -4.20, -2.SOI
Buien 2004 15 2.00(0.20) 15 5.00(0.40) ■ 5.03 -3.00 -3.23, -2.77)
SuMotal (95% CI) 243 223 ♦ 48.38 -3.74 -4.52, -2.9SI
Test ter hetwogef>e*y; Ch = 282.75, c* = 9 (P 0.00001), I5 = 966%
Test tor overal eilet* 1 ■9,37 (P «0.00001)
TctM (95% Cl) S7S 536 ♦ 100-00 -3.07 -3.89, - z .zs)
Test lor heterogenety: Ch = 1532.66, df = 20 (P < 0.00001 ), F = 98.7%
Test tor overal ettect: 1 =7.40 (P <0 00001)
-10 ^  0 S 10
Favours LC Favours OC
Figure 4: Forrest plot showing individual data and pooled results of hospital stay including all trials 
on laparoscopic versus open cholecystectomy.
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M ortality was explicitly mentioned in seven trials including 1952 patients. There was 
one death in each intervention group.
2. Complications
Com plications were explicitly reported in 14 trials including 2560 patients.
20. Intra-operative complications
Intra-operative complications in the laparoscopic and sm all-incision groups were 11.9 %  
and 6 .8 % respectively. A majority of the events were accounted for by the trial of Ros and 
consisted of gallbladder perforations [19]. Intra-operative complication proportions were 
significantly lower in the SIC group.
2b. Minor complications
The minor complication proportions were 7.6 %  and 8.8% respectively in the LC and SIC 
group w ithout significant difference.
2C . Severe complications
Severe complications were 3.7%  and 3 .9 %  in the LC and SIC group respectively w ithout 
significant difference.
2d. Bile duct injuries
Bile duct injuries were 1.2 %  and 1.7%  in the LC and SIC group respectively w ithout sig­
nificant difference.The difference in bile duct injuries was m ainly caused by eight cases 
of bile leakage with unknown origin and conservative treatment in the SIC group (five 
cases from one trial).
Study
or sub-category
Laparoscopic (LC) Small-incision (SIC) 
n;N n/N
RR (random) 
95% Cl
Weight
%
RR (random) 
95% Cl
01 Hi^ i-quality trials
Majeed 1996 13/100
ROS 2001 211/362
Keus 2006 2 1/12 0
Subtotal (95% C!) 582
Total events: 245 (Laparoscopic (LC)), 189 (Small-incision (SIC))
Test for heterogeneity; Chi’ =1.14. df = 2 (P = 0.56), P = 0%
Test for overal effect: Z = 3:90 (P « 0.0001)
14/100
159/362
16/137
599
■*
♦
12.01
20.00
13.50
45.52
0.93
1.33
1.50
1.32
10.46, 
11-15, 
10.82, 
11.15,
1.871
1.53]
2.74)
1.51)
02 Lcw-quaHy trials 
Barkun1992 1/37 2/25 4-------■------------- 2.29 0.34 |0.03, 3.53)
1 36 0.33
0.78
7* £81
McMahon 1994 27/1S1 34/148 15.91
to 01 
to .so. 1 .2 2 ]
Bruce 1999 0/11 
Srivastava 2001 1/59 
Grande 2002 o/ie  
Secco 2002 20/86 
Harju 2006 1/72 
Vagenas 2006 3/44
Subtotal (9S% CO 698
Total events: 89 (Laparoscopic (LC)), 65 (Small-incision (SIC)) 
Test for heterogeneity: Chi» = 2219. df = 8 (P = 0.005), I* = B3.9% 
Test for overal effect: Z = 0 90 (P = 0.37)
0/11
17/40
0/22
15/86
7/85
3/44
681
3. 09
13.55 
2.85 
4.62 
54.48
Hot. estim able 
0.04 |0.01# 0.29] 
Hot estim able
1.33 10.73, 2.431 
0.17 [0 .02, 1.341 
1.00 10.21, 4.69) 
0.73 10.36, 1.461
Total (95% Cl) 1280 
Total events: 314 (Laparoscopic (LC)), 274 (Small-hcislon (SIC)) 
Test for heterogeneity: Chi* = 28.43, df = 11 (P = 0.003), I* = 61.3% 
Test for overal effect: 2 = 0.03 (P = 0.97)
1290 100.00 1.01 10.69, 1.47)
0.1 0.2 05
Favours LC
2 5 
FovoLfs SIC
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Figure 5: Forrest plot showing individual data and pooled results of total complications including all trials 
on laparoscopic versus small-incision cholecystectomy.
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2e. Total complications
The total com plication proportions including all trials were 24 .3 %  and 2 1.2 %  in the 
laparoscopic and sm all-incision groups respectively, without significant difference.Total 
complication proportions in low-bias risk trials [16,19,49] were higher (42.1% and 31.6% 
respectively) compared with total com plications including all randomized trials and 
significantly lower in the SIC group (Figure 5).
Excluding gallbladder perforations in sensitivity analyses resulted in total complication 
proportions decreasing to 15.6% and 16 .4 %  respectively In recalculations including low- 
bias risk trials, significance disappears both in intra-operative com plications (fixed 
effect: RR: 1.66; 9 5 %  Cl: 0.96-2.88) and in total complications (fixed effect: RR: 1.07; 9 5 %  
Cl: 0.83-1.37).
A funnel plot raises some suspicion for publication bias considering the absence of 
sm all trials favouring the sm all-incision technique (Figure 6).
3. Symptom relief
Insufficient data on relief of symptoms were available.
Secondary outcome measures
4. Conversions to OC
Conversions were reported in nine trials including 1952 patients. Conversion proporti-
Figure 6: Funnel plots using data of total complications including 95% confidence interval lines.
Laparoscopic versus small-incision cholecystectomy.
There is some suspicion of bias considering the absence (in the lower right part) of small trials favouring the small-incision technique.
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ons were 12 .9 %  and 15.1% in the LC and SIC group respectively. M eta-an a lysis of conver­
sions including all trials shows no significant difference, while m eta-analysis including 
low-bias risk trials shows a significant difference favouring the LC technique.
5. Operative time
Operative tim e was reported in 11 trials, including 2198 patients. M eta-analyses of all 
trials and low-bias risk trials consistently showed that SIC was significantly faster (on 
average 16 min) to perform than LC (Figure 7).
6. Hospital stay
Hospital stay was reported in nine trials, including 1702 patients. M eta-analysis of hos­
pital stay including all trials shows a significant difference favouring LC (on average 0.8 
day), while m eta-analysis including low-bias risk trials shows no significant difference.
7. Convalescence
Limited data areavailableon convalescence.Three trials (all low-bias risk) including 1181 
patients reported convalescence considering work leave. M eta-analysis showed no 
significant difference between LC and SIC considering convalescence in terms of work- 
leave.
Five trials including 1246 patients reported convalescence considering normal activity. 
M eta-analysis including all trials shows a significantly quicker convalescence conside­
ring normal activity favouring the LC technique, w hile low-bias risk trials do not show 
a significant difference.
8. Other secondary outcome measures
Insufficient data were available considering other outcomes.
Study Laparoscopic (LC) Small-incision (SIC) WMD (raradom) Weight WhD (random)
or sub-category N Mean (SD) N Mean (SD) 95%  a % 95% Cl
01 Ktf-i-quality triste
1996 100 63.20 < Z4.60) 100 45.40113.801 -* 3.63 23.80 117.61. 23.93]
Ros 2001 362 108.00(45.00) 362 34.00145.001 9.61 14.00 17.44, 20.561
Keus 2006 1ZO 71.85(25.S3) 137 50.41(18.29) 9. 82 11. 44 15.90, 16.98]
Subtotal (95% Cl) 582 sss ♦ 29.19 16.36 18.88, 23.83)
Test Jar heterogenely: Ch = 9.05, df = 2 (P =001)^ = 77.9%
Test lor overall eifect 1  =4.29 (P< 0.0001)
02 Low-quality trials
Barkiii 1992 37 85.30(32.00) 25 73.10t24.SOi --- 7 . S i 12.80 1-1.23, 26.63]
Kuii1992 $0 102.00(35.00} 50 102. 00 0 2 . 00) 7.82 0.00 1-13.14, 13.14]
McMahon 1994 151 71.00(20.OOJ 148 57.00(24.00) ■» 9. 92 14.00 18.99, 19.01]
Srh/astava 2001 59 54.20(20.93) 40 57. 20 (17 . 85) 9. 35 -3. 00 1-10.69, 4.69]
Grande 2002 IS 42.96(24.00) 22 32.00(8.00) — S. 23 10. 95 1-0.63, 22.53]
Secco 2002 86 3S.70(11.20) 86 37.60(5.70) 10.25 -1.90 1-4.S6, 0.76)
HarjJ 2006 72 79.00 <27.00) 85 SS.00U9 .S0 l -m. 9.40 24.00 (16.S I ,  31.49]
Vageres 2006 44 101.30(33.10) 44 64.32(20.76) —* — 8. 29 36.98 125.44, 48.52]
Subtotal (95% Cl) 517 S00 ♦ 70.87 11.48 12.07, 20.901
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Figure ~j: Forrest plot showing individual data and pooled results of operative time including all randomized trials 
on laparoscopic versus small-incision cholecystectomy.
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DISCUSSION
A total of 59 randomized trials with varying methodological quality studied the clinical 
outcomes of OC, SIC, and LC. Overall, no differences were found in primary outcomes 
am ong the three techniques. Although some differences in complications were found, 
subgroup analyses showed no differences according to adequate methodological qua­
lity domains. Secondary outcomes show differences am ong the three techniques. Both 
m inim al invasive techniques have advantages over OC in terms of convalescence. SIC 
and LC are comparable apart from a shorter operative tim e using the sm all-incision 
technique. Uncertainty remains considering conversion proportions and hospital stay.
The total numbers of patients with complications are high.Total complication propor­
tions in the LC vs. SIC comparison are 24 .3 %  and 21.2%  respectively including intra-ope- 
rative gallbladder perforations, w hich are generally not considered a com plication. 
Excluding gallbladder perforations decreases total complication proportions to 15.6 %  
and 16 .4 %  respectively.These percentages are still higher than figures (up to 5%) known 
from other reviews including non-random ized series. Such studies represent lower 
levels of evidence [10,11,51,52]. One has to assum e that especially interested and skilled 
surgeons conducted the trials and carried out the interventions. Everyday clinical prac­
tice and complication rates ought to be followed through clinical databases and com­
pared with benchmark values. The situation in the real world may therefore even be 
worse.The complication proportions in the other two comparisons (SIC vs. OC and LC vs. 
OC) are substantially lower compared with the proportions in the LC vs. SIC comparison. 
Probably differences in methodological quality of the trials play a role. As results from 
low-bias risk trials are considered more reliable [20-22], we believe that the proportions 
in the LC vs. SIC comparison are closer to the truth.
Three low-bias risk trials were identified in the LC vs. SIC comparison and only one in the 
other two comparisons. Accordingly bias risk was relatively low in the LC vs. SIC com­
parison, but high in the other two comparisons. H igh-quality trials are more likely to 
estimate the ‘true’ effects of the interventions [20-22,53,54]. In this review, trials with 
unclear or inadequate methodological quality tended to show more often a positive or 
neutral effect of laparoscopic surgery whereas high-quality trials were more likely to 
show a neutral or negative effect of laparoscopic surgery.The first example concerns 
operative time. In detailed subgroup analyses (according to the four methodological 
quality criteria), the high-quality trial subgroups showed significant differences favou­
ring the SIC technique, w hile the low -quality trial subgroups do not show this diffe­
rence [32]. Hospital stay is a second example. Low-quality trial subgroups as well as all 
trials together do show a significant difference favouring the LC technique, w hile high- 
quality trial subgroups show no significant difference between the two operations [32]. 
Differences in methodological quality or a loss of power may explain the differences.
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However, these observations are in concordance with other studies show ing linkage 
between un cle ar/in ad e q u ate  methodological quality and significant overestimation 
of beneficial effects and underreporting of adverse effects. The sm all trials favouring 
laparoscopic surgery may be regarded as an example of either low methodological qua­
lity or publication bias.
Conversion proportions including all randomized trials show no significant differences. 
Subgroup analysis including low-bias risk trials shows more conversions using the sm all- 
incision approach. Higher methodological quality may reflect a real difference, but it 
may as well represent a random effect because of a loss of power. Uncertainty remains 
and more randomized patients are needed to reach strong conclusions.
The question however, is whether these secondary outcomes are that important.The dif­
ference in operative time is only 16 minutes for each cholecystectomy. Regarding hospi­
tal stay, we have to remember that it is no more than a surrogate marker for convalescence 
and because of numerous factors influencing its length, it does not necessarily reflect 
objective differences between two operative procedures. Moreover, differences in hos­
pital stay in open studies may represent bias, unless the type of surgery is blinded.
The issue in applicability is the question whether selection for randomized trials intro­
duces bias so that participation is associated with greater risks and that outcomes are 
worse than expected in daily life practice. In this issue, different outcomes caused by a 
different (better or worse) treatment have to be distinguished from a better recording 
of outcomes.There is empirical evidence that participation in randomized trials does not 
lead to worse outcomes and that results are applicable to usual practice [55]. However, 
one could argue that through a more careful follow-up, outcomes are better recorded 
leading to more objective results.
Another issue in applicability relates to generalisability. Although several bias introdu­
cing factors can be identified, populations from the individual trials are representative 
of the general surgical population; trials used general and comparable inclusion criteria. 
Moreover, the m ethodological quality of the included randomized trials is relatively 
high m aking results even more reliable. We therefore believe that the results of this 
analysis may apply to the general surgical practice.
There are lim ited data on additional secondary outcom es in the included trials and 
several questions like pulm onary and cardiovascular consequences after surgery and 
more detailed questions on convalescence remain unanswered. Differences between 
LC and SIC in ASA III and IV patients, especially considering pulm onary and cardiovas­
cular influences might appear substantial. Most importantly, details on costs are lacking,
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which potentially may provide arguments to preferences for one of both techniques.
CONCLUSIONS
Both SIC and LC are preferred over OC based on a quicker convalescence. Both m inim al 
invasive techniques are associated with high proportions of complications.There seems 
to be no significant difference in complications, although some uncertainty remains. 
No differences are detected in convalescence, w hile SIC has a shorter operative time. 
Uncertainty remains regarding differences in hospital stay and conversion proportions. 
Research should focus on costs to afford additional arguments for choosing the most 
valuable form of cholecystectomy.
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ABSTRACT
Background
Cholecystectomy is one of the most frequently performed operations. Open cholecys­
tectomy has been the gold standard for over 100 years. Laparoscopic cholecystectomy 
was introduced in the 1980s.
Objectives
To compare the beneficial and harm ful effects of laparoscopic versus open cholecys­
tectomy for patients with sym ptom atic cholecystolithiasis.
Search strategy
We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (April 2004), 
The Cochrane Library (Issue 1,2004), MEDLINE (1966 to January 2004), EMBASE (1980 to 
January 2004), Web of Science (1988 to January 2004), and CINAHL (1982 to January 
2004) for randomised trials.
Selection criteria
All published and unpublished randomised trials in patients with symptomatic cholecys­
tolithiasis comparing any kind of laparoscopic cholecystectomy versus any kind of open 
cholecystectomy. No language lim itations were applied.
Data collection and analysis
Two authors independently performed selection of trials and data extraction. The 
methodological quality of the generation of the allocation sequence, allocation conceal­
ment, blinding, and follow-up was evaluated to assess bias risk. Analyses were based on 
the intention-to-treat principle. Authors were requested additional information in case 
of m issing data. Sensitivity and subgroup analyses were performed when appropriate.
Main results
Thirty-eight trials randomised 2338 patients.M ost of the trials had high bias risk.There 
was no significant difference regarding mortality (risk difference 0 .0 0 ,9 5 %  confidence 
interval (Cl) -0.01 to 0.01). M eta-analysis of all trials suggests less overall complications 
in the laparoscopic group, but the h igh-quality trials show no significant difference 
(’allocation concealment’ high-quality trials risk difference, random-effects -0 .0 1,9 5 %  Cl 
-0.05 to 0.02). Laparoscopic cholecystectom y patients have a shorter hospital stay 
(weighted mean difference (WMD), random -effects -3 days, 9 5 %  Cl -3.9 to -2.3) and 
convalescence (WMD, random-effects -22.5 days, 9 5 %  Cl -36.9 to -8.1) compared to open 
cholecystectomy.
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Authors’ conclusions
No significant differences were observed in mortality, complications, and operative time 
between laparoscopic and open cholecystectom y Laparoscopic cholecystectom y is 
associated with a significantly shorter hospital stay and a quicker convalescence com­
pared with the classical open cholecystectom y These results confirm the existing 
preference for the laparoscopic cholecystectomy over open cholecystectomy
Only the abstract rather than the fu ll text of the Cochrane systematic review is printed 
here due to space limitations. The fu ll text may be accessed at the Cochrane Library 
(http://0nlinelibrary.wiley.c0m/0/c0chrane/clsysrev/articles/CD0062s1/frame.html). 
Instead, the sister publication in Alimentary, Pharmacology & Therapeutics summarizing 
the results of chapters 3,4, and 5 is printed on page 44.
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ABSTRACT
Background
Cholecystectomy is one of the most frequently performed operations. Open cholecystec­
tomy has been the gold standard for over 100 years. Small-incision cholecystectomy is a 
less frequently used alternative. Laparoscopic cholecystectomy was introduced in the 1980s.
Objectives
To compare the beneficial and harm ful effects of laparoscopic versus sm all-incision 
cholecystectomy for patients with sym ptom atic cholecystolithiasis.
Search strategy
We searched The Cochrane Hepato-Biliary Group Controlled Trials Register (6 April 2004), 
The Cochrane Library (Issue 1,2004), MEDLINE (1966 to January 2004), EMBASE (1980 to 
January 2004), Web of Science (1988 to January 2004), and CINAHL (1982 to January 
2004) for randomised trials.
Selection criteria
All published and unpublished randomised trials in patients with sym ptomatic chole­
cystolithiasis comparing any kind of laparoscopic cholecystectomy versus sm all-incision 
or other kind of m inim al incision open cholecystectomy. No language lim itations were 
applied.
Data collection and analysis
Two authors independently performed selection of trials and data extraction. The 
methodological quality of the generation of the allocation sequence, allocation conceal­
ment, blinding, and follow-up was evaluated to assess bias risk. Analyses were based on 
the intention-to-treat principle. Authors were requested additional information in case 
of m issing data. Sensitivity and subgroup analyses were performed if appropriate.
Main results
Thirteen trials randomised 2337 patients. M ethodological quality was relatively high 
considering the four quality criteria. Total complications of laparoscopic and sm all-in - 
cision cholecystectom y are high: 26 .6 %  versus 22.9 % . Total com plications (risk diffe­
rence, random-effects -0.01, 9 5 %  confidence interval (Cl) -0.07 to 0.05), hospital stay 
(weighted mean difference (WMD), random-effects -0.72 days,9 5 %  Cl -1.48 to 0.04),and 
convalescence were not significantly  different. H ig h-q uality  trials show a quicker 
operative tim e for sm all-incision cholecystectomy (WMD, high-quality trials ’blinding’, 
random -effects 16.4 m inutes, 9 5 %  Cl 8.9 to 23.8) w hile low -quality trials show no 
significant difference.
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Authors’ conclusions
Laparoscopic and sm all-incision cholecystectomy seem to be equivalent. No differences 
could be observed in m ortality, com plications, and postoperative recovery. Sm all- 
incision cholecystectomy has a significantly shorter operative time. Com plications in 
elective cholecystectomy are prevalent.
Only the abstract rather than the fu ll text of the Cochrane systematic review is printed 
here due to space limitations. The fu ll text may be accessed at the Cochrane Library 
(http://0nlinelibrary.wiley.c0m/0/c0chrane/clsysrev/articles/CD00622g/frame.html). 
Instead, the sister publication in Alimentary, Pharmacology & Therapeutics summarizing 
the results of chapters 3,4, and 5 is printed on page 44.
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ABSTRACT
Objectives
M eta-analysis of randomized trials with binary data can use a variety of statistical 
methods. Zero-event trials may create analytic problems. We explored how different 
methods may im pact inferences from meta-analyses containing zero-event trials.
Methods
Five levels of statistical methods are identified for m eta-analysis with zero-event trials, 
leading to numerous data analyses. We used the binary outcomes from our Cochrane 
review of random ized trials of laparoscopic vs. sm all-in cision cholecystectom y for 
patients with sym ptom atic cholecystolithiasis to illustrate the influence of statistical 
method on inference.
Results
In seven m eta-analyses of seven outcomes from 15 trials, there were zero-event trials in 
o to 71.4 %  of the trials. We found inconsistency in significance in one of seven outcomes 
(14%; 9 5 %  confidence lim it o .4 %-57.g %). There was also considerable variability in the 
confidence limits, the intervention-effect estimates, and heterogeneity for all outcomes.
Conclusions
The statistical method may influence the inference drawn from a m eta-analysis that 
includes zero-event trials. Robustness assessments are needed to reduce bias in m eta­
analyses that include zero-event trials.
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INTRODUCTION
Randomized trials seldom detect intervention differences when binary outcomes are 
rare or absent. M eta-analyses are conducted to obtain more precise estimates and to 
increase power to detect small, but clinically important, intervention effects.The num ­
ber of system atic reviews with meta-analyses is increasing [i; www.cochrane.org].The 
applied statistical methods may impact inferences. M eta-analyzing trials is problematic 
when no events occur in one or more trial arms [2]. Adding continuity corrections may 
help, but it introduces fake events and may bias inferences.
In our recently published Cochrane reviews on cholecystectom y [3-5], we included 
trials with rare events as well as zero events.The Cochrane Review M anager [RevMan 
Analyses 4.2.10; http://w w w .cochrane.org] ignores data from zero-event trials when 
calculating odds ratios and relative risks [6]. Although alternative ways of dealing with 
zero-event data exist, we chose risk differences as a sum m ary statistic [2-7]. We now 
assess w hether the inferences from one of the reviews [5] would change if other 
statistical methods were applied.
METHODS
The effect estimate and the confidence lim its of a m eta-analysis are influenced by the 
sum m ary statistic [8], the statistical method of pooling data [7], the type of continuity 
correction [2], the value of continuity correction [2,9], and the fixed- or random-effects 
model [10-12] chosen. Inconsistency of results has been noted when these variables 
were examined individually [2,7-12]. We could not identify studies that quantified the 
effect of the different choices on intervention-effect estimates, confidence lim its, 
heterogeneity (inconsistency factor, I2) [13], statistical significance, and inference from a 
meta-analysis. We hypothesized that the different combinations may lead to differences 
in variables. Furthermore, the initiation of future trials should be based on m eta-ana- 
lysis of previous trials on the intervention [1,14,15]. Therefore, a precise intervention- 
effect estimate is im portant to provide valid relative risk reductions (RRRs) for use in 
sam ple-size calculation.
Choice levels
Five “choice levels”for inclusion of zero-event trials in a binary m eta-analysis exist.The 
first is the sum m ary statistic: relative risk (RR), odds ratio (OR), or risk difference (RD).The 
second refers to zero-event trials: excluded or included.The third, when included, is the 
type of continuity correction. The fourth is the value of continuity correction. The fifth 
is the method of m eta-analyzing data, which must be selected from a variety of fixed-
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and random-effects models [1,16,17]. The m ultiple options lead to hundreds of com bi­
nations. The type of data (e.g., sm all or large trials, group-size im balance, number of 
events) may influence the choice. Not all combinations are suitable.The large variety of 
statistical choices increases the risk of a spurious but statistically significant o r“desired” 
result. If a m eta-analysis is w ithout zero-event trials, the first- and fifth-level choices 
become relevant.
First level: summary statistic. The sum m ary statistic RR, OR, or RD should be chosen. 
Arguments influencing the selection are consistency of effect, mathem atical properties, 
and ease of interpretation [8]. We examined all three, as there is no absolute preference 
and no single statistic uniform ly performs best.
Second level: exclude or include zero-event trials. Zero-event trials are frequently omitted 
from analyses, causing potential information loss and overestimated intervention effect 
[18]. Such trials may contribute significantly to the estimates of event proportions pending 
population risk. Om ission of data may bias the results. Ethically, patients in these trials 
deserve inclusion.
W hen RR or OR is chosen, RevMan [6] autom atically includes trials with zero events in 
one arm by adding 0.5 to each arm, but trials with zero events in both arms are omitted. 
Other types of software allow  the inclusion of all trials, using different types and 
values of continuity corrections.To assess the influence of om itting zero-event trials on 
RR and OR, we used RevMan.To include zero-event trials, we used the Trial Sequential 
Analysis (TSA) program (Copenhagen Trial Unit, Centre for Clinical Intervention Research, 
Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) [14].
Third level: type of continuity correction. Continuity corrections are used to include zero- 
event trials in the calculation of RR and OR. Sweeting et al. introduced “reciprocal” and 
“em pirical” continuity corrections as alternative methods to the addition of 0.5 and 
showed that the last performed worse in all situations [2]. We tested all three types.
Fourth level: size of continuity correction. Conventionally, a value of 0.5 is added to each 
group in a 2 x 2 table; thus, one participant is added to each intervention arm. Agresti 
found that sm aller continuity corrections improved the estim ates of the most likely 
ORs [9]. We tested four continuity values (1.0, 0.1, 0.01, and 0.001), half of which were 
added to each intervention arm. We report only the results with 1.0 and 0.01, unless 
otherwise stated.
Fifth level: the statistical meta-analyzing model (fixed- or random-effects model). Ra n d o m -
effects models may result in more cautious estim ates compared with fixed-effect
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models [19], as ¡ntertria I variance is added to the sam pling error of the individual trials, 
g iving wider confidence lim its.The random-effects model may be chosen when consi­
derable heterogeneity is present, to a Now for larger uncertainty. There is no strict guide 
as to which model to use. Because we consider the fixed-effect model a special case of 
the random-effects model in the absence of heterogeneity, and because the random- 
effects model is less susceptible to random error, we present only the results from this 
model, specifically the DerSimonian and Laird model [10].
Application of the statistical tests to real data
We used the data of m eta-analyses on binary outcome measures from our Cochrane 
review on laparoscopic cholecystectomy vs. sm all-incision cholecystectomy for patients 
with symptomatic cholecystolithiasis [5]. As complications varied, we analyzed four sub­
categories (intraoperative, minor, severe, and bile duct injury) and total complications. 
Because we had the number of complications, and not the number of patients with 
complications, double counts were possible [5].This may be a problem, but we estimate 
that less than 5 %  of the complications were double counts.
The effect of statistical method of analysis was evaluated by m easuring the interven- 
tion-effect estimate, 9 5 %  confidence limits, heterogeneity, and statistical significance. 
Heterogeneity was calculated by the Cochran 0 test and quantified by the I2 [13].
Trials were defined as low-bias risk trials when at least three of the four risk domains 
(generation of the allocation sequence, allocation concealment, blinding, and follow-up) 
were adequately performed [20-22]. We repeated all calculations including only the 
low-bias risk trials in sensitivity analyses [20-22].
RESULTS
The m eta-analyses included 15 randomized trials [20-34] with 2,582 participants: 1,291 
laparoscopic cholecystectomy patients and 1,291 sm all-incision cholecystectomy patients 
[5] (Table 1). Only 4 6 .6 %  to 93.3% of 15 trials reported outcomes (Table 1). Am ong trials 
reporting outcomes, 0 %  to 71.4 %  were zero-event trials.
Inconsistency of significance and heterogeneity
The m eta-analysis on intraoperative complications included 10 zero-event trials, 2 trials 
with zero events in one intervention group, and 2 trials with events in both intervention 
groups (Figure ia). We found inconsistency in significance. The RR and OR analyses 
showed significant effects favoring sm all-incision over laparoscopic cholecystectomy 
(P < 0.0001) w ithout heterogeneity. The RD pooled intervention effect was 0.01 with
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| Intra-operative complications |
Summary
statistic
Random-
effects
Exclude or 
include zero 
event trials
I CC type
Include
(TSA)
| Reciprocal | | Empirical |
I 1.0 | | 0.01 | | 1.0 | | 0.01 |
I gD I
Exclude Include
(RevMan) (RevMan)
EE 1.71 1-75 1.74 1-75 1.74 0.01
9 5 % lower CL 1.37 1.40 1.40 1.40 1.39 -0.02
to to to to to to to
9 5 % upper CL 2.12 2.18 2.16 2.18 2.17 0.05
I ' M 0.0 0.0 0.0 0.0 0.0 93-7
Sign (P) <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.47
Mortality
Summary
statistic
Random-
effects
Exclude or 
include zero 
event trials
I CC type
Include
(TSA)
| Reciprocal | | Empirical |
I 1.0 | | 0.01 | | 1-0 | | 0.01 |
Exclude Include
(RevMan) (RevMan)
EE 1.00 0.99 0.94 0.95 0.99 0.00
9 5 % lower CL 0.25 0.00 0.23 0.00 0.10 0.00
to to to to to to to
9 5 % upper CL 3.98 480,520 3-75 477,301 9.46 0.00
I’ M 0.0 0.0 0.0 0.0 0.0 0.0
Sign (P) 1.00 1.00 0.93 0.99 0.99 0.99
Figure i: Effect estimate, confidence limits, heterogeneity, and significance calculated using different statistical methods 
including data on intra-operative complications (a) and mortality (b) of all randomised trials on laparoscopic versus
small-incision cholecystectomy.
Legenda: RR: relative risk; RD: risk difference; TSA: trial sequential analysis program (including zero-event trials; developed by 
the Copenhagen Trial Unit; Copenhagen, Denmark); RevMan: Review Manager, software for Cochrane Reviews (excluding 
zero-event trials; www.cochrane.org); CC type: type of continuity correction; CC size: size of continuity correction; Random 
-effects: Random-effects model (DerSimonian and Laird); EE: pooled intervention effect estimate; CL: confidence limits;
I2: inconsistency factor, quantification of heterogeneity; Sign (P): significance expressed in P-value. Results of OR 
analyses were comparable to RR analyses and were therefore not presented. Since constant continuity corrections perform 
worse in all situations (2) only reciprocal and empirical continuity corrections were presented. Additionally, for reasons of 
simplicity o.i continuity corrections were not presented.
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Number of Number of Total Number of Number of Number of
outcomes in outcomes in number of trials with participants zero-event
laparoscopic small-incision of outcomes data* trials (proportion
cholecystectomy cholecystectomy (proportion) of trials
(proportion) (proportion) reporting data)
• Mortality 1 (0.1%) 1 (0.1%) 2 (0.1%) 7 1952 5 (71.4°/")
• Intra-operative
complications 153 (11.9%) 88 (6.8%) 241 (9.3%) 14 2560 10 (71.4%)
• Minor complications 98 (7.6%) 114(8.8%) 212 (8.2%) 14 2560 3 (21.4%)
• Severe complications 48 (3.7%) 50 (3.9%) 98 (3.8%) 14 2560 4 (28.6%)
• Bile duct injuries 15(1.2%) 22 (1.7%) 37 (1.4%) 14 2560 5 (35.7%)
• Total complications 314 (24.3%) 274 (21.2%) 588 (22.8%) 14 2560 2 (14.8%)
• Conversions to open
cholecystectomy 148 (12.9%) 172 (15.1%) 320 (14.0%) 9 1952 0 (0%)
Table i: Event proportion of binary outcome measures in a systematic review with meta-analyses of 15 trials 
on laparoscopic versus small-incision cholecystectomy in patients with symptomatic cholecystolithiasis.
* Eight trials did not report on mortality, one trial did not report on complications, and six trials did not report 
on conversions to open cholecystectomy.
Level of ch o ice  of m eth od
Statistical pooling method DL RE
Summary statistic RR RD OR
Exclude or include zero event trials Include
(CC)
Exclude
(RM)
Include
(RM)
nclude
(CC)
Exclude
(RM)
Type of continuity correction Rec Emp Rec Emp
Value of continuity correction 1.0 0.01 1.0 0.01 1.0 0.01 1.0 0.01
Ou tcom e  m easures
Mortality 1.00 0.99 0.94 0.95 0.99 0.00 1.00 0.99 0.94 0.95 1.00
Intra-operative complications * 1.71' 1-75' 1-74* 1-75 * 1.7 4 * 0.01 2.11 * 2.25 * 2,22 * 2.26* 2.21 *
Minorcomplications 0.97 1.04 0-97 1.04 0.91 -0.02 0 93 1.04 0-95 1.04 O.87
Severe complications 1.12 0-74 1.07 0.74 i-34 0.01 1.15 O.74 1.09 0.74 1.36
Bile duct injuries 0.74 O.67 0.70 0.67 0.71 0.00 0.74 0.66 0.70 0.66 0.70
Total complications 1.03 1.O4 1.03 1.04 1.01 -0.01 0.98 i.OO 0.98 1.00 0.96
Conversions 1.02 1.02 1.01 1.02 1.01 0.00 1.03 1.03 1.02 1.04 1.02
Table 2: Pooled effect estimates of meta-analysis of mortality, complications, and conversions using different statistical methods.
DL RE: DerSimonian and Laird random-effects model; RR: relative risk; RD: risk difference; OR: odds ratio; CC: Continuity 
correction (methodology that includes zero-event trials by adding partially event fractions); RM: RevMan (Review Manager 
software used in Cochrane reviews that excludes zero event trials in RR and OR); Rec: reciprocal continuity correction;
Em p.- empirical continuity correction; *significant difference favoring small-incision cholecystectomy; ^ inconsistency 
in significance. Pooled intervention effect estimate < 1 favors laparoscopic cholecystectomy; Pooled intervention effect 
estimate > 1 favors small-incision cholecystectomy.
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narrow 9 5 %  confidence lim its (-0.02 to 0.05) and showed no significant difference 
(P = 0.47).The RD analysis showed heterogeneity of 9 4 % .
Regarding all other outcomes, all analyses concurred that no significant difference was 
present.
Inconsistency of confidence limits
In all outcome measures, we found variations in the width of the confidence lim its. For 
instance, in m ortality with a control event rate of 0.1%, the 9 5 %  confidence lim its in RR 
changed from a narrow interval (0.23-3.75), using a 1.0 em pirical continuity correction, 
to a broad interval (0.00-9.132E17), using a 0.001 em pirical continuity correction (Figure 
ib).The range of the 9 5 %  confidence lim its increased to infinity with decreasing conti­
nuity corrections, in both RR and OR. In contrast, RD confidence lim its were narrow 
(0.00-0.00).
For all other outcomes, the variations in the width of the confidence lim its were less 
substantial.
Inconsistency of m eta-analyzed intervention-effect estimates
For all outcomes, we found variations in the m agnitude of the m eta-analyzed inter- 
vention-effect estim ates, both in RR and in OR (Table 2). For instance, a substantial 
variation was found in the analysis of severe complications, with RR varying from 0.74 
to 1.34, corresponding to RRR varying from -2 6 %  to + 34 % .
W hen the continuity correction was varied, both the direction and the m agnitude of 
the intervention-effect estimates in the random-effects RRand OR calculations changed 
with respect to m inor and severe com plications. For severe complications, the inter- 
vention-effect estimates shifted from favoring sm all-incision cholecystectomy (RRn.07) 
to favoring laparoscopic cholecystectom y (RR: 0.74) when the em pirical continuity 
correction changed from 1.0 to 0.01.
The meta-analyzed intervention-effect estimates did not vary substantially for the other 
outcomes.
Sensitivity analysis
We repeated all calculations including only the low-bias risk trials w ithout noticeable 
effect on our results. The inconsistency of significance in intraoperative complications 
persisted.
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DISCUSSION
We found inconsistency in significance, confidence limits, intervention-effect estimates, 
and heterogeneity depending on the analysis conducted. We discovered clin ically  
important disagreement in the interpretation of the significance in one of seven outcome 
measures (14%; 9 5 %  confidence lim its o .4 % -57 .9 %).T h e  RD analysis showed no statis­
tically significant difference, whereas all the other analyses resulted in significantly 
more intraoperative complications in the laparoscopic group than in the sm all-incision 
cholecystectomy group. We observed considerable variability in the confidence lim its 
with the size of the continuity corrections. Different m eta-analytical methods resulted 
in varied intervention effect estimates for all examined outcomes. The differences in 
the confidence lim its and intervention estimates may have an im pact on conduct of 
further trials. Sam ple-size calculation is dependent on the control event rate and effect 
estimate, which are influenced by inclusion or exclusion of zero-event trials.
The RD is an analysis of real data. In RD, the w eighting of the individual trial is based on 
the num ber of participants in the trial, independent of the event numbers. Conse­
quently, trials that contribute the m ajority of events may be given relatively low 
weighting, w hile zero-event trials may be given relatively heavy weighting. Zero-event 
trials could reflect the “truth”, but they could also underreport events caused by bias, 
random error, or short follow-up. In the RR analysis including zero-event trials, data are 
added artificially, which may influence reliability. In RR analyses, the weighting is related 
to the proportion of events by inverse variance w eighting. In the relative sum m ary 
statistics, trials with the m ajority of events are weighted more heavily than zero-event 
trials, w hich RevMan analyses exclude, or given low w eighting when a continuity 
correction is used.
We found inconsistency in conclusions on significance in one out of seven outcomes 
with varying control event rates and numbers of zero-event trials. Choice of statistical 
analysis was made at five levels. Each choice may contribute to the varying conclusions. 
Consequently, the inconsistency may be due to the com bination of the model, 
sum m ary statistic, and continuity corrections used for zero-event data. However, the 
variation in distribution of events and participants might have a greater influence on 
conclusions depending on the method of w eighting the data in the m eta-analysis 
compared with the influence of how zero events were handled. Some outcomes without 
inconsistency in conclusions (e.g., mortality and bile duct injuries) showed less variation 
in event proportions compared with other outcomes (e.g., intraoperative and severe 
complications), while all outcomes included a substantial number of zero-event trials. 
Therefore, zero-event trials may not influence significance as much as hypothesized.
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In mortality, the 9 5 %  confidence lim its using a continuity correction of 0.01 (0.00- 
477.301) are wide, whereas those using a continuity correction of 1.0 (0.23-3.75) are 
unrealistically narrow considering the paucity of inform ation.The 1.0 continuity correc­
tion adds 12 “artificia l” deaths to the two deaths actually observed, risking unreliable 
estimates. W ith decreasing continuity corrections, the range of the confidence limits 
increased to infinity. In contrast, confidence limits in RD were suspiciously narrow (0.00- 
o.oo).This is misleading, given that only one patient died in each intervention group. Our 
analyses illustrate that meta-analysis including zero-event trials on outcomes with rare 
events may produce highly unreliable confidence limits.
We found variation in the intervention-effect estimates, and some of it was substantial. 
Obviously, the event proportion in the background population and the intervention- 
effect estimate may greatly influence trial sam ple-size calculation [14,15].The RR inter­
vention-effect estimates with the outcome of severe complications varied from 0.74 to 
1.34. Considering such an im portant outcom e measure with an event proportion 
approaching 5 % , an intervention effect of 2 6 %  RRR would certainly be an incentive for 
a new randomized trial. In contrast, a 2 .0 %  RRR would not be. Thus, the choice of the 
statistical analysis influences the estimated intervention effect and hence the impetus 
to initiate a new trial [14,15].
A composite outcome measure of all serious events may be the most appropriate, as it 
includes all outcomes and yields a higher event proportion (approximately 10 %). In our 
m eta-analysis, the trial carried out by Ros et al. [22] dominates the intraoperative com­
plications in the RR and OR m eta-analyses, w hile in the RD model alm ost equal 
w eighting is applied to all trials. A real difference in intraoperative complications across 
trials may be caused by heterogeneity in the populations at risk, heterogeneity in the 
surgeons’ skills, or bias, e.g., systematic difference in registration of complications. Many 
of the trials did not focus on complications, which therefore may have been overlooked. 
Differences in the bias risk of trials might add to the differences in their reporting. Low-bias 
risk trials - e.g., the Ros et al. trial [22] - produce more reliable estimates. Remarkably, all 
the zero-event trials were high-bias risk trials [5].Therefore, the “truth” may lie in low-bias 
risk trials with higher proportions of com plications.The statistical heterogeneity in the 
RD model (94%) may therefore reflect the system atic errors related to the reporting of 
com plications.This example illustrates the intim ate linkage of statistical analysis to the 
clinical perspective. Thorough knowledge of the clinical setting is needed in order to 
draw overall statistical inference from meta-analyses.
Consideringthe issues arisingfrom  the zero-event data [18] and the recommendations 
originating from simulation studies [2,7], RevMan does not seem optim ally equipped for 
handling zero-event trials. Moreover, RevMan is not equipped for robust assessm ent of
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m e ta -a n a ly s e s  in c lu d in g  ze ro -e ve n t tr ia ls .
Several trials did not report certain outcomes. Such lack of reporting may represent out­
come measure reporting bias, which may lead to biased overestimation of intervention 
effects [35]. We did not consider this bias risk.
The choice of statistical method may im pact the conclusions of m eta-analyses of 
binary data when zero-event trials are included. RevMan does not handle zero-event 
trials appropriately and may produce erroneous results.The choice of statistical method 
leads to varied estimates of confidence lim its and m eta-analyzed intervention-effect 
estimates. A priori selection of statistical methods for meta-analyses should be included 
in the protocol for a system atic review [16] in order to avoid w ish-biased, post hoc 
selection of “desirable” results. Differences in estim ates of intervention effects may 
im pact the design of future trials [1,14,15]. Conducting m ultiple assessments of robust­
ness may prevent spurious conclusions, reducing statistical method bias.
REFERENCES
7 Sutton AJ, Higgins JPT. Recent developments in meta-analysis. Stat Med 2007;27:625-650.
2 Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity 
corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-1375.
3 Keus F, de Jong JAF, Gooszen HG, et al. Small-incision versus open cholecystectomy for patients 
with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; Issue 4:CDoo4j88.
4 Keus F, de Jong JAF, Gooszen HG, et al. Laparoscopic versus open cholecystectomy for patients 
with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; Issue 4:CDoo623i.
5 Keus F, de Jong JAF, Gooszen HG, et al. Laparoscopic versus small-incision cholecystectomy for 
patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev 2006; Issue 
4:CDoo622g.
6 Review Manager (RevMan). Version 4.2 for Windows. The Nordic Cochrane Centre, The Cochrane 
Collaboration: Copenhagen, 2003.
7 Brad burn MJ, Deeks JJ, Berlin JA, et al. Much ado about nothing: a comparison of the perfor­
mance of meta-analytical methods with rare events. Stat Med 200j;26:53~jj.
8 Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with 
binary outcomes. Stat Med 2002;21:1575-1600.
g Agresti A. An Introduction to Categorical Data Analysis. Wiley and Sons: New York, igg6.
10 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials ig8 6 ;j:ijj-i8 8 . 
n Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of 
disease.J Natl Cancer Inst igsg;22:jig-j48.
12 Greenland S, Robins JM. Estimation of a common effect parameter from sparsefollow-up data. 
Biometrics ig8s;4i:55~68.
Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials 95
13
14
15
16
17
18
19
2 0
21
22
23
24
25
26
27
28
29
30
31
96
Higgins JP, Thompson SC. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;2i: 
1539-1558.
WetterslevJ, Thorlund K, BrokJ, et al. Trial sequential analysis may establish when firm evidence 
is reached in cumulative meta-analysis. J Clin Epidemiol 2008;6 i:64-js- 
BrokJ, Thorlund K, Cluud C, et al. Trial sequential analysis reveals insufficient information size 
and potentially false positive results in many meta-analyses.J Clin Epidemiol 2008;6i:j63~j6g. 
Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane 
Collaboration, 2008 <http://www.cochrane.org>.
Sidik K, Jonkman JN. A comparison of heterogeneity variance estimators in combining results 
of studies. Stat Med 200j;26:ig64~ig8i.
Friedrich JO, Adhikari NK, Beyene J. Inclusion of zero total event trials in meta-analyses main­
tains analytic consistency and incorporates all available data. BMC Med Res Methodol 2007,7:5. 
Poole C, Greenland S. Random-effects meta-analyses are not always conservative. Am J Epidemiol 
1999;150:469-475.
Keus F, Werner JEM, Gooszen HG, et al. Randomized clinical trial on small-incision and laparos­
copic cholecystectomy in patients with symptomatic cholecystolithiasis: primary and clinical 
outcome. Arch Surg 2008;i43:3ji~3jj.
MajeedAW, Troy G, NichollJP, et al. Randomised, prospective, single-blind comparison of lapa­
roscopic versus small-incision cholecystectomy. Lancet igg6;34j:g8g-gg4.
Ros A, Gustafsson L, Krook H, et al. Laparoscopic cholecystectomy versus mini-laparotomy 
cholecystectomy: a prospective, randomized, single-blind study. Ann Surg 200i;234:j4i-j4g. 
BarkunJS, BarkunAN, SampalisJS, et al. Randomised controlled trial of laparoscopic versus mini 
cholecystectomy. The McGill Gallstone Treatment Group. Lancet igg2;340:m6-mg.
Bruce DM, Smith M, Walker CB, et al. Minimal access surgery for cholelithiasis induces an 
attenuated acute phase response. Am J Surg iggg;ij8:232-234.
CoelhoJC, de Araujo RP, Marchesini JB, et al. Pulmonary function after cholecystectomy perfor­
med through Kocher’s incision, a mini-incision, and laparoscopy. World J Surg igg3;T/:S44~546. 
Grande M, Tucci GF,Adorisio O, et al. Systemic acute-phase response after laparoscopic and open 
cholecystectomy. Surg Endosc 2002;16:313-316.
HarjuJ,Juvonen P, Eskelinen M, et al. Minilaparotomy cholecystectomy versus laparoscopic cho­
lecystectomy. A randomized study with special reference to obesity. Surg Endosc 2006;20:583-586. 
Kunz R, Orth K, Vogel J, et al. [Laparoscopic cholecystectomy versus mini-lapcholecystectomy. 
Results of a prospective, randomized study] (article in German). Laparoskopische Cholecystek- 
tomie versus Mini-Lap-Cholecystektomie. Ergebnisse einer prospektiven, randomisierten Studie. 
Chirurg igg2;63:2gi-2gs-
McGinn FP, Miles AJ, Uglow M, et al. Randomized trial of laparoscopic cholecystectomy and 
mini-cholecystectomy. BrJSurg iggs;82:i3j4~i3jj.
McMahon AJ, Russell IT, Baxter JN, et al. Laparoscopic versus minilaparotomy cholecystectomy: 
a randomised trial. Lancet igg4;343:i3s~i38.
Secco GB, CatalettiM, Bonfante P,etal.[Laparoscopic versus mini-cholecystectomy: analysis of 
hospital costs and social costs in a prospective randomized study] (article in Italian). Video- 
colecistectomia versus mini-colecistectomia: analisi dei costi ospedalieri e dei costi sociali in 
uno studio prospettico randomizzato. Chir Ital 2002;s4:68s~6g2.
Chapter 6
j2  Srivastava A, Srinivas C, Misra MC, et al. Cost-effectiveness analysis of laparoscopic versus 
minilaparotomy cholecystectomy for gallstone disease. A randomized trial. IntJTechnol Assess 
Health Care 200i;ij:4gj-502.
33 Tate JJ, Lau WY, Leung KL, et al. Laparoscopic versus mini-incision cholecystectomy. Lancet 
1993;341:1214-1215.
34 Vagenas K, Spyrakopoulos P, Karanikolas M, et al. Mini-laparotomy cholecystectomy versus lapa­
roscopic cholecystectomy: which way to go? Surg Laparosc Endosc Percutan Tech 2006;16:321-324.
35 Furukawa TA, Watanabe N, Omori IM, et al. Association between unreported outcomes and 
effect size estimates in Cochrane meta-analyses. JAMA 200j;2gj:468~4j0.
Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials 97
Chapter 7
Trial sequential analyses of 
meta-analyses of complications 
in laparoscopic vs. small-incision 
cholecystectomy: more 
randomized patients are needed
F. Keus, J.Wetterslev, C. Gluud, H. G. Gooszen, C. J. H. M. van Laarhoven
J Clin Epidemiol 2010;63:246-256
Trial sequential analyses of m eta-analyses of complications in laparoscopic vs. small-incision... 99
ABSTRACT
Objective
Conclusions based on m eta-analyses of randomized trials carry a status of “tru th”. 
M ethodological components may identify trials with system atic errors (“bias”). Trial 
sequential analysis (TSA) evaluates random errors in m eta-analysis. We analyzed meta­
analyses on laparoscopic vs. sm all-incision cholecystectomy regarding different outcome 
measures for the occurrence of type I errors.
Study Design and Setting
Using TSA, we calculated the required inform ation size (IS) and the trial sequential 
m onitoring boundaries regarding com plications in our Cochrane review with m eta­
analyses of cholecystectomy. For each outcome, we calculated a low risk of bias hetero- 
geneity-adjusted IS. As a sensitivity analysis, we calculated an a priori heterogeneity- 
adjusted IS.
Results
According to the trial sequential analyses based on a low risk of bias heterogeneity- 
adjusted IS definitive evidence may be reached by conducting one more randomized 
trial. Information may be required on 582 and 119 additional randomized patients to 
evaluate the effect on severe complications and serious adverse events (SAEs), respectively.
Conclusion
Our results provide incentives to conduct a new trial with a low risk of bias focusing on 
a new composite outcome measure of SAEs to obtain conclusive evidence on which 
operative method to recommend.
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INTRODUCTION
The number of Cochrane reviews and the availability of The Cochrane Library w orld­
wide have increased during the last decade [i].The development and application of 
evidence-based guidelines, usually based on the highest level of evidence, that is, 
system atic reviews of randomized trials with low risk of bias, have also increased [2].
The conclusions based on such reviews with meta-analyses may carry a status o f“truth”, 
and scepticism tends to be sparse. However, there is a high probability that differences 
between treatments are found because of random errors (“the play of chance”) [3,4], 
systematic errors (“bias”) [5-8],and design errors (“wrong design toansw erthequestion 
posed” o r“wrong context”, e.g., lack of sufficient education in one of the interventions) 
[9]. Potentially spurious results may arise because of random errors (type I and II errors), 
when a limited number of trials and patients are included and with frequent updating 
of the cum ulative m eta-analysis [3,4].
In the planning of a randomized trial, the sam ple-size calculation provides an insight 
into the ability to detect an intervention effect with sufficient power. The sample size 
is calculated to detect a prespecified intervention effect with a risk of type I (a) and 
type II (p) error [10]. It is inappropriate to make conclusions based on sm all differences 
between treatments from a randomized trial with only few patients included. Likewise, 
it may be inappropriate to draw conclusions from a m eta-analysis when information is 
sparse [4]. W ithout evaluating how much inform ation is needed and how much we 
have at hand, we may not be able to reliably assess the results. Consequently, we might 
well draw inappropriate conclusions because of random errors in a cum ulative m eta­
analysis with too little information.
We have conducted trial sequential analysis (TSA), based on the calculation of the 
heterogeneity-adjusted required information size (IS) and the analysis of the cumulative 
z-curve [4,11-15]. In a cum ulative m eta-analysis, the pooled intervention effect estimate 
is updated whenever a new trial is added according to the chronological sequence of 
pub lish ing .The cum ulated z-values can be calculated and plotted against the new 
cumulated IS obtained [4,11-15]. Further, trial sequential monitoring boundaries (TSMBs) 
can be constructed and the relation of the z-curves to the boundaries may determine 
w hetherfirm  evidence is established or not in the m eta-analysis [4,11-15].
We conducted a Cochrane Hepato-Biliary Group review with meta-analyses comparing 
laparoscopic vs. sm all-incision cholecystectomy for patients with sym ptom atic chole- 
cystolithiasis [16]. This review is in the process of being updated, and 15 trials with a 
total of 2,582 randomized patients were included [17]. The question is w hether the
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required IS has been reached to detect or reject a w orthw hile and realistic intervention 
effect or whether possible differences reflect spurious P < 0.05 values (type I error).
Aim
The aim of this study was to calculate the required IS and the TSMB for the m eta-ana- 
lyses of our Cochrane review on laparoscopic and sm all-incision cholecystectomy for 
patients with symptom atic cholecystolithiasis.
METHODS 
Data
There are many kinds of complications in cholecystectomy; they were categorized into 
four subcategories in our Cochrane review [16]: intraoperative, minor, severe, and bile 
duct injury. Further, total complication proportions were calculated. Bile duct injuries 
were registered separately from the other com plications and hence not counted as 
intraoperative, severe, or minor adverse event. Likewise, the intraoperative complications, 
excluding bile duct injuries, were categorized separately from the m inorand the severe 
complications. As the number of complications was reported and not the number of 
patients with complications, patients may occasionally have been double counted [16].
Intraoperative, minor, severe, and bile duct injury complications have been considered 
to be independent outcome m easures.The total complication category, however, sum ­
marizes all complications and is thus not independent of the other outcome categories. 
We considered total complications the most important outcome measure in our syste­
matic review. However, total complications also include complications, which can hardly 
be considered critical for decision m aking according to the Grade categorization of out­
comes [9,18-20].Therefore, it seems more sensible to compile all serious adverse events, 
considered critical for decision m aking, into a single composite outcome measure 
called “serious adverse events” (SAE). SAE includes mortality, bile duct injuries, severe 
complications, and clinically im portant intraoperative complications.
From a statistical point of view, analyses of m ultiple outcome measures require P-value 
adjustment, which is difficult when outcomes are not strictly independent. So despite 
the fact that all the outcomes defined may be of interest, we chose to analyze only the 
most im portant ones to reduce inflation of type I error by m ultip lic ity of testing. 
Therefore, we analyzed mortality, the four com plication subcategories, and total 
complications. Additionally, a composite outcome measure of SAE was generated and 
evaluated post hoc as a hypothesis-generating analysis.
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Zero-event trials
Several trials included in our review had zero events in one or both groups of surgical 
intervention. In a previous study, we evaluated the im pact of different m eta-analytical 
statistical methods on the conclusions of our review depending on the handling of the 
zero-event problem [21]. Based on this study and recommendations from the literature, 
we decided to use an em pirical continuity correction of 0.01 in zero-event trials for the 
present analyses [16,21-24].
Bias protection
As randomized clinical trials with a high risk of bias may overestimate intervention effects 
[5,8,25], results of randomized clinical trials with a low risk of bias are considered more 
valid. Therefore, the risk of bias should be assessed based on the adequacy of the 
generation of the allocation sequence, allocation concealment, blinding, and follow- 
up [26]. In our Cochrane review, trials that were considered adequate regarding at least 
three of the four above-mentioned bias protection criteria were considered as low risk 
of bias [16].
Trial sequential analysis
Repeated testingon accum ulating data may cause random errors [27]. Also, sm all trials 
may indicate significant findings which are in fact because of random errors. Such 
results are often overruled when results from adequately powered trials emerge [28,29]. 
TSA uses TSMB in a m eta-analysis adopted from discrete sequential boundaries in a 
single trial to evaluate the am ount of evidence actually reached [4,11-14]. TSA prevents 
premature declaration of superiority of an intervention that is misled by a random low 
P-value because of repeated testing in a cum ulative m eta-analysis. Apart from assess­
ment of the presence of random error, TSA offers additional advantages such as reesti­
mation of sample size, provides incentives for the conduct of new high-quality trials, and 
may stop trials if the intervention benefits are remote or nonexistent, either when the 
IS has been reached or when the intervention effect is dram atic and no more trials are 
needed [4,11-15].The required IS may be calculated like the sample size of an adequately 
powered trial to detect a prespecified intervention effect with a risk of a type I (a) and 
a type II (3) error [4,11-15].The desired IS in a m eta-analysis may then be this sample size 
adjusted for the heterogeneity am ong the included trials in the m eta-analysis [4,11-15].
For the calculation of the required IS, four components have to be specified: the risk of 
a type I error (a), the risk of a type II error (3), a control event rate (CER), and a relative 
risk reduction (RRR). Usually, a  is set at 0.05, and the power (1 - 3) is set at 0.80.
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IS calculation based on a priori and low-bias intervention effects
The clinical im portance of an a priori selected RRR will depend on the specific research 
question. Randomized trials w ith a high risk of bias may overestim ate intervention 
effects compared with trials with a low riskof bias [5-8].Therefore, it may be more valid 
to base the required IS calculation on the intervention effect estimated by the trials 
with a low risk of bias [4,11-15].
However, estimated intervention effects of trials with a low risk of bias may be sm aller 
or larger than what is considered relevant from a clinical point of view. It is also possible 
that, by chance, a very large effect is measured in trials, despite a low risk of bias which 
may lead to an early false rejection of the null hypothesis. Evidence of a possible smaller 
effect may still be present legitim izing the conduct of new larger trials. Therefore, 
it seems useful to calculate the required IS based on both an a priori anticipated inter­
vention effect and an intervention effect based on the estimate from the trials with a 
low risk of bias [4,11-15].
Heterogeneity
It is assumed in m eta-analyses that participants involved in the different trials show 
sim ilar intervention effects. However, heterogeneity may be present. As heterogeneity 
may influence the choice of a fixed-effect ora random-effects model in a meta-analysis, 
heterogeneity may influence the calculated required IS [4].Therefore, heterogeneity 
ought to adjust IS in TSA calculations [4,11-15]. An increase in heterogeneity consequently 
results in a larger required IS before firm evidence can be obtained. Both the a priori 
and the low risk of bias IS should be heterogeneity-adjusted.
Statistical analysis
TSA calculations were performed considering the outcome measure ofall complication 
categories. Relations between the cum ulated z-curve determ ined by the random - 
effects model, the traditional criterion z = 1.96, the TSMB, and the required IS were 
analyzed.Two types of required IS calculations were used.
The a priori heterogeneity-adjusted IS (APHIS) calculation uses imputed values of CER 
and RRR based on clinical considerations. Before the analyses, consensus was reached 
am ong the authors that incidences in the sm all-incision group were taken as CER in all 
APHIS analyses and an arbitrary RRR of 2 0 %  was considered clinically relevant.
The low -bias risk heterogeneity-adjusted IS (LBHIS) uses values of CER and RRR 
estimated from the trials with a low risk of bias [4,11-14].
The findings of the well-conducted trials with a low riskof bias may be considered more
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realistic compared with an a priori anticipated intervention effect.Therefore, the LBHIS 
calculations were conducted as prim ary analysis, and the APHIS calculations were 
conducted as sensitivity analysis.
“Firm evidence” is defined by a cum ulative z-curve crossing the calculated IS needed 
or alternatively crossing the TSMB before the calculated IS needed has been reached. 
“Spurious results” are defined by a cum ulative z-curve crossing the traditional z = -1.96 
or z = 1.96 boundary but not the TSMB. Such results may represent random error as a 
result of repetitive testing on accum ulating data (nominal type I error).
The analyses were performed using the TSA program (developed by The Copenhagen 
Trial Unit, Center for Clinical Intervention Research, Denm ark).The results of using this 
program have been described in a number of m eta-analyses [4,11-15].
RESULTS
A total of 15 randomized trials were included. A total of 2,582 patients were randomized 
to laparoscopic vs. sm all-incision cholecystectomy, with 1,291 in each group [16]. The 
event proportions in the laparoscopic group, the sm all-incision group, and the total 
group of patients, the number of participants, the number of trials with data, and the 
number of zero-event trials are listed in Table 1. Detailed data of each trial are listed in 
Table 2.
LC SIC Total 
(LC +  SIC)
Number of 
participants
Number of trials 
with data
Number of 
zero-event trials
Mortality 1 (0.1%) 1 (0.1%) 2 (0.1%) 1952 7 5
Intra-operative complications 153 (12.0% ) 88 (6.9% ) 241 (9.4% ) 2560 14 10
Minor complications 93 (7.7% ) 114 (8.9%) 212 (8.3% ) 2560 14 3
Severe complications 48 (3.8% ) 50 (3.9% ) 98 (3.8% ) 2560 14 4
Bile duct Injuries 15 (1.2% ) 22 (1.7% ) 37 (1.4% ) 2560 14 5
Total complications 314 (24.5% ) 274 (21.4% ) 588 (23.0% ) 2560 14 2
Composite outcome measure: 
'serious adverse events' 95 (7.4% ) 100 (7.8% ) 195 (7.6% ) 2560 14 3
Table v. Number of events, event rate (in brackets), total number of participants, number of trials with data, and the number of 
trials with zero events of evaluated binary outcome measures in laparoscopic (LC) and small-incision cholecystectomy (SIC).
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Mortality
We found no statistically significant difference in mortality between laparoscopic and 
sm all-incision cholecystectom y The LBHIS required reaches infinity and is incalculable 
(Table 3).
In a sensitivity analysis the APHIS required for detecting a significant difference in mor­
tality is at least 86,000 patients (based on a 2 0 %  RRR and 0 .0 8 %  CER).
Intraoperative complications
We found strong evidence for a statistically significant difference in intraoperative com­
plications favoring sm all-incision cholecystectom y The LBHIS required is 229 patients. 
The z-curve in the LBHIS calculation in itially  does not cross any boundary. However, the 
z- curve unexpectedly crosses the TSMB and the traditional z = -1.96 (P = 0.05) after 
having passed the LBHIS required. It is especially one trial that forces the z-curve to 
cross theTSM B [30].This trial included gallbladder perforations as complications [30].
Bias risk Number of 
participants
Complications
intra-operative minor severe bile duct injuries total
LC SIC LC SIC LC SIC LC SIC LC SIC LC SIC
Barkun1992 High 37 25 0 0 0 1 1 0 0 1 1 2
Kunz1992 High SO SO 0 O 0 0 2 1 0 1 2 2
Coelhoi993 High IS is 0 0 0 1 O 0 0 0 0 1
Tate 1993 High 11 11 na na na na na na na na na Na
McMahon 1994 High 151 148 0 0 19 19 4 12 4 3 27 34
McGinn 1995 High 155 155 0 0 5 2 8 O 1 2 14 4
Majeed 1996 Low 100 100 1 0 S 12 3 2 1 0 '3 14
Bruce 1999 High 11 11 0 0 0 O 0 O 0 0 0 0
Rg s 2001 Low 362 362 148 ®5 39 36 18 31 6 7 211 159
Srivastava 2001 High 59 40 0 1 0 11 0 O 1 5 1 17
Grande 2002 High 18 22 0 0 0 O 0 O 0 0 0 0
Setco 2002 High 86 86 0 0 16 14 4 1 0 0 20 IS
Harju 2006 High 72 85 0 0 0 6 O 1 1 0 1 7
Keus2006 Low 120 ’37 4 2 10 10 6 1 1 3 21 16
Vagenas 2006 High 44 44 O 0 1 2 2 1 0 0 3 3
Total 1291 1291 153 88 98 114 48 50 15 22 314 274
Table 2: Overview of the bias risk; the numbers of participants, and the numbers of complications of the included randomized 
trials in the Cochrane review with meta-analysis on laparoscopic (LC) versus small-incision cholecystectomy (SIC).
na: not available. High risk of bias = the trial is considered unclear or inadequate regarding two or more of the following four 
design components: generation of the allocation sequence, allocation concealment; blinding,follow-up. Low risk of bias = the 
trial is considered unclear or inadequate regarding one or none of the following four design components: generation of the 
allocation sequence, allocation concealment; blinding,follow-up.
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In sensitivity analysis excluding Intraoperatlve gallbladder perforations, there Is a lack 
of evidence fora statistically significant difference In Intraoperatlve complications (data 
not shown). The outlying result of this one trial explains the boundary crossing after 
having passed the LBHIS required.
In a sensitivity analysis, the APHIS required Is 9,602 patients (based on a 2 0 %  RRR and 
6 .9 %  CER).The z-curve In the APHIS calculation crosses the TSMB curve after only 18 %  
of the required IS (Figure 1).
Minor complications
We found no statistically significant difference In m inor com plications between the 
two operation methods. The z-curve fluctuates around zero not even approaching 
z = -1.96 (P = o.o5).The LBHIS cannot be calculated.The m eta-analysis Is underpowered 
to detect or reject an Intervention effect suggested by the trials with a low risk of bias.
APHIS or LBHIS 
based 
calculation
relative
risk
reduction
(RRR)
control 
event rate 
(CER)
calculated 
IS needed
cumulative 
IS reached 
so far (%) *
cumulative z-curve 
crosses:
spurious
significant
difference
maybe
present
firm
evidence
reached
how many 
additional 
participants 
may be 
needed
traditional
boundaries
(p=0 .05)
ca Iculated 
TSMB
Mortality APHIS 20% 0.08% 86000 2% No No No No 84048
LBHIS Infinity No No No No Infinity
Intra-operative 
complications
APHIS 20% 6.9% 9602 27% Yes Yes No Yes o s
LBHIS ■75% 23% 229 1118% No No No No 0
Minor com pi ¡cations APHIS 20% 8,9% 7302 35% No No No No 4742
LBHIS -0.8% 9-9% Infinity No No No No Infinity
Severe complications APHIS 20% 3.9% 17478 15% Yes No Yes No 14918
LBHIS ■37% 8.0% 3142 81% Yes No Yes No 582
Bile duct injuries APHIS 20% 1.7% 40918 6% No No No No 38358
LBHIS 26% 2.0% 19964 13% No No No No 17404
Total complications APHIS 20% 21% 5354 48% No No No No 2794
LBHIS -32% 39% 1016 252% No No No Yes 0
Composite outcome 
measure;
'serious adverse events'
APHIS 20% 7.8% 11764 22% No No No No 9204
LBHIS -32% 16% 2679 96% No No No No 119
Table 3: Trial sequential analysis of a priori heterogeneity adjusted information size (APHIS) and low risk of bias based 
heterogeneity adjusted information size (LBHIS) on different binary outcome measures in laparoscopic (LC) and small-incision
cholecystectomy (SIC).
APHIS: a priori heterogeneity adjusted information size; LBHIS: low risk of bias based heterogeneity adjusted information size;
IS: information size; RRR: relative risk reduction used for the IS calculation; CER: control event rate; TSMB: trial sequential 
monitoring boundary. * A total of y randomised trials including ig$2 patients report mortality. A total of 74 randomised trials 
including 2560 patients report complications.$ Although the calculated IS needed (g6o2 participants) has not been reached 
yet (2560 participants so far), no more additional participants are needed since the cumulative z-curve crosses the TSMB.
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In a sensitivity analysis, the APHIS required is 7,302 patients and concurs with the LBHIS 
analysis.
Severe complications
We found a lack of firm  evidence for a statistically  significant difference in severe 
complications between the two operation methods. However, the z-curve crosses the 
traditional z = -1.96 boundary in the LBHIS analyses, whereas the z-curve does not cross 
theTSM B lbhis (Figure 2).The LBHIS required is 3,142 patients (based on a 36 .7%  RRR and 
8 .0 %  CER).The conclusion is that the proportion of severe complications m ayor may not 
be different between the two operation methods.The meta-analysis is underpowered to 
detect or reject an intervention effect suggested by the trials with a low risk of bias.
In a sensitivity analysis, APHIS calculations are similar. The z-curve crosses the traditional 
z = -1.96 boundary, whereas the z-curve does not cross theTSMBLBHis.The APHIS required 
is 17,478 patients (based on a 2 0 %  RRR and 3 .9 %  CER).
Figure i: Trial sequential analysis of a priori set heterogeneity adjusted information size (APHIS) on difference 
in intra-operative complications between laparoscopic and small-incision cholecystectomy.
The z-vafue is plotted vertically. The numbers of patients are plotted horizontally. The vertical red line represents the 
calculated information size needed. The horizontal lines at z=-i.g6 and z=i.g6 indicate the traditional two-sided p = 0.05. 
The symmetrical red curves represent the calculated trial sequential monitoring boundaries. The blue line represents the 
cumulative z-value, with each consecutive trial marked by a file d  circle. Firm evidence has been reached when the cumulative 
z-curve crosses the calculated boundaries before the calculated information size. Spurious significant differences between 
treatments are found when the cumulative z-curve crosses the traditional z=-i.g6 or z=i.g6, but not the calculated trial 
sequential monitoring boundaries. APHIS = g,6o2 patients; meta-anaiysis has reached only 27%  of this figure; relative risk 
reduction 20%; control event rate 6.g%. The Ros trial dominates the course of the z-curve [30].
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Bile duct injuries
We found no statistically significant difference in bile duct injuries between the two 
operation methods.The z-curve does not even approach the traditional boundary.The 
LBHIS required is 19,964 patients.The meta-analysis is underpowered to detect or reject 
an intervention effect suggested by the trials with a low risk of bias.
In the APHIS, sensitivity analysis findings concur and 40,918 patients are required 
(suggested by a prespecified 20% RRR and a CER of 1.7%).
Total complications
We found no statistically significant difference in total complications between the two 
operation methods. In the LBHIS calculation,only 1,016 patients are required. According 
to the LBHIS, the meta-analysis appears to be overpowered and is able to reject an inter­
vention effect of 31.7% RRR with a CER of 39.1% suggested by the trials with a low risk of 
bias. In the LBHIS analysis, the z-curve does not cross the traditional boundary of P = 0.05.
In a sensitivity analysis, the APHIS required is 5,354 patients (based on a 20% RRR and 
21.4% CER), which suggests that the meta-analysis is underpowered to detect or reject 
an intervention effect (Figure 3).
Figure 2: Trial sequential analysis o f  lo w  risk o f  bias based heterogeneity adjusted inform ation size (LBHIS) on 
difference in severe complications between laparoscopic and small-incision cholecystectomy.
LBHIS = 3142 patients; meta-analysis at 8 7 % ; relative risk reduction  -36.7%; control event rate y.g6%.
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Composite outcome measure: SAE
All serious complications (including mortality, bile duct injuries, severe complications, 
and severe intraoperative complications) were added into a composite outcome measure 
of SAE. We found no significant difference in SAE between the two operation methods 
(Figure 4).The z-curve does not cross the traditional boundary, but it fluctuates around 
zero.The LBHIS required is 2,679 patients.Only 119 more patients are needed to reject 
or detect an intervention effect of 31.5% RRR (with a CER of 15.7%) as suggested by the 
trials with a low risk of bias.
In a sensitivity analysis, the APHIS required is 11,764 patients (based on a 20% RRR and 7.8% 
CER), the z-curve does not cross z = -1.96, and the meta-analysis is underpowered to reject 
or detect an intervention effect of this magnitude.The APHIS analysis suggests that many 
more patients are needed to detect or reject the 20% RRR compared with the LBHIS analysis.
DISCUSSION
We have reanalyzed our meta-analysis data on complications associated with laparos­
copic and small-incision cholecystectomy for patients with symptomatic cholecystoli- 
thiasis and calculated the required IS using the TSA program [16,17]. We find that firm 
evidence has been reached considering intraoperative complications and total compli­
cations by the LBHIS TSA analyses, favoring small-incision over laparoscopic cholecys­
tectomy. However, the results are dominated by data from one of the trials [30], 
and analyses excluding intraoperative gallbladder perforations show no significant 
differences between the two operation techniques. Sensitivity APHIS TSA analyses show 
that definitive evidence has not been reached. Furthermore, we observe that there is no 
sufficient information as yet to reliably reject or accept potential differences in other 
complications between the two operative interventions.
Potentially spurious (random error) results favoring the laparoscopic technique were 
obtained while evaluating severe complications (Figure 2) [16]. Meta-analyses of severe 
complications and the composite outcome measure SAE are still underpowered to de­
tector reject a statistically significant intervention effect - but firm evidence may be ob­
tainable by adding a new trial for both outcome measures according to the LBHIS TSA.
The LBHIS analysis on total complications shows that a clinically meaningful difference 
can be rejected, whereas the sensitivity APHIS analysis shows that the meta-analysis is 
still underpowered to detect or reject an intervention effect. With regard to all other 
types of complications, the meta-analyses are underpowered to detect or reject a signi­
ficant intervention effect.
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Figure 3: Trial sequential analysis o f  a p rio ri set heterogeneity adjusted inform ation size (APHIS) and ignoring the Bruce 
trial [31] as it provides non-detectable inform ation on difference in total complications between laparoscopic and
small-incision cholecystectomy.
APHIS = S354 patients; meta-analysis a t 48%; relative risk reduction 20%; control event rate 21.4%.
Figure 4: Trial sequential analysis o f  lo w  risk o f  bias based heterogeneity adjusted inform ation size (LBHIS) on difference 
in a composite outcome m easure4serious adverse events' between laparoscopic and small-incision cholecystectomy.
LBHIS = 267g patients; meta-analysis at g6%; relative risk reduction -31.5%; control event rate 75.7%.
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Results of APHIS and LBHIS analyses may differ. APHIS results may originate from clinical 
a priori guesses of the magnitudes of CERs and RRR, using experiences from related 
clinical research areas. LBHIS results are based on the specific estimates of these para­
meters in randomized trials with a low risk of bias performed in the specific research 
area so far. Large differences between these APHIS and LBHIS results reveal a discre­
pancy between what may be generally clinically accepted and what is found based on 
reliable evidence. Both calculations may be wrong:The clinical anticipation of an inter­
vention effect (worthwhile or at hand) may obviously be wrong, although there may 
also very well be random error in the trials already conducted especially if they have 
been small. We rely more on the findings of the well-conducted trials with a low risk of 
bias because clinical “guesstimates” or perceptions represent a lower level of evidence 
and may very well underestimate true complication rates. However, in the case of only 
few and small trials with a low risk of bias, we have to consider the IS calculation with 
realistic anticipations of the intervention effects, as well as, the APHIS TSA.
After mortality, many surgeons usually consider bile duct injuries the second most 
serious event in cholecystectomy. However, as the event rate is rare, 20,000 randomized 
patients are needed to reach the required IS for strong evidence regarding this out­
come. Therefore, the preference for one of the surgical methods may probably never be 
answered on the basis of bile duct injuries alone. Likewise, which method has the lowest 
mortality is a question likely to be impossible to answer in a randomized clinical trial as 
more than 90,000 patients are needed. Accordingly, it may be more clinically relevant 
to focus on other“ primary” outcome measures.
TSA calculations on severe complications show that the required IS may be within reach. 
LBHIS TSA show that inclusion of about 582 patients in a new trial with a low risk of 
bias may be an informative supplement, which may establish definitive evidence in a 
subsequent meta-analysis. APHIS analysis, however, does not agree that an IS on severe 
complications is within reach. The difference in both calculations is caused by the 
differences in both RRR and CER. Although the APHIS conditions (RRR of 20% and CER 
of 3.9%) seem realistic, trials with a low risk of bias are known for more valid results [5-8]. 
The question is whetherthere is a methodological problem in the trials with a low risk 
of bias or that we are underestimating the CER in the APHIS calculations. Another issue 
may be that the outcome measure of severe complications ignores mortality, bile duct 
injuries, and severe intraoperative complications. Although each one of these separately 
is a rare event, the cumulative total or composite outcome measure of SAE may be a 
common event. As the two most important outcome measures (i.e., mortality and bile 
duct injury) could never form a realistic primary research question for a randomized 
trial, a composite outcome measure is probably the most sensible alternative. We 
therefore conducted a post hoc analysis, adding all serious complications (mortality,
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bile duct injuries, severe complications, and severe intraoperative complications) into 
one composite SAE outcome measure.This composite outcome measure was compiled 
retrospectively and can therefore only be considered to be hypothesis generating. Our 
analysis shows a CER of 15.7%, which is large enough to examine a potential clinically 
relevant difference. The LBHIS required is 2,679 patients based on an RRR of 31.5%, 
resulting in an additional 119 patients needed.This IS is obtainable with a new trial.
Conducting meta-analyses involves learning from errors in the past related to both 
systematic errors and random errors.This process of learning should lead to improved 
methodology in future randomized trials, and bias risk prevention should be optimized. 
M inim izing random error resulting from repeated testing when meta-analyses are 
updated is the essential strength of the TSA analysis, which also suggests the required 
sample size in a future trial [32]. An alternative methodology, simulations based on the 
posterior distribution of the possible intervention effect derived from a meta-analysis, 
an open form sample size estimation, may be a more valid method [32]. In contrast,TSA 
provides a less complicated tool taking heterogeneity and bias risk in previous trials 
into consideration, although it only provides a closed form estimation of the required 
ISthatdoes not takethew hole posterior distribution into consideration but merelythe 
meta-analytic point estimate reached so far [32].
As a minimum, the four criteria used for methodological quality assessment must be 
adequate to consider a randomized trial as having a low risk of bias [5,26]. Secondly, 
primary and secondary outcome measures should be separated clearly to focus on 
obtaining a valid answer to the initial clinical question [33].Thirdly, future trials should 
focus on a well-defined complication and SAE. We have learned that some trials with a 
high riskof bias.focusingon a distinct research question,found no complications, ordid 
not record complications, causing the zero-event problem [21]. As these trials with a 
high risk of bias did not focus on complications, they probably simply have not registered 
what happened. Additionally, proper sample-size considerations must be fulfilled, to 
obtain correct estimation of precision and power [34].
CONCLUSION
Our results provide strong incentives to conduct a new trial with a low risk of bias 
focusing on reduction of SAE.This may require a new and sensible composite outcome 
measure.The required IS forfirm  conclusions on a low bias-based estimated RRR of 30% 
and a CER of 16% may be obtainable with a new trial.
In general, we advocate incorporating TSA in future meta-analyses to adjust signifi­
cance levels, reduce the risk of random errors, and to estimate the required IS to evaluate
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w h ether additional randomized clinical trials are desirable.
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Randomized clinical trial of 
small-incision and laparoscopic 
cholecystectomy in patients with 
symptomatic cholecystolithiasis - 
primary and clinical outcomes
F. Keus, J. E. M. Werner, H. G. Gooszen, H. J. M. Oostvogel, C. J. H. M. van Laarhoven
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ABSTRACT
Objective
To evaluate the primary and clinical outcomes in laparoscopic and sm all-incision 
cholecystectomy
Design
Blinded randomized single-center trial emphasizing methodologic quality and gene- 
ralizability.
Setting
General teaching hospital in the Netherlands.
Patients
A total of 257 patients undergoing cholecystectomy for symptomatic cholecystolithiasis. 
Interventions
Laparoscopic cholecystectomy and small-incision cholecystectomy performed mainly 
by surgical residents.
M ain Outcome Measures
Complications and symptom relief were primary outcome measures; conversion rate, 
operative time, and hospital stay were secondary outcome measures. Feasibility of per­
forming both procedures by residents was evaluated as well.
Results
In the 257 patients, surgical residents performed 105 laparoscopic and 118 small-incision 
cholecystectomies.There were no significant differences in complications, conversion 
rates, and hospital stay. Operative time was significantly shorter with the small-incision 
technique.
Conclusions
No differences in primary clinical outcome measures were found between laparoscopic 
and small-incision cholecystectomy in this randomized trial with emphasis on metho­
dologic quality and generalizability.The gold standard status of laparoscopic cholecys­
tectomy is questionable.
Trial Registration
isrctn.org Identifier: ISRCTN67485658
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INTRODUCTION
Langenbuch’s classic cholecystectomy was the gold standard for treating cholecys- 
tolithiasis for more than a century [i]. Shortly after surgeons began making incisions 
smaller to speed recovery [2-5], laparoscopic cholecystectomy (LC) was introduced and 
rapidly conquered the world. Its popularity was based on the appeal of the technological 
innovation as well as enthusiastic marketing by industry, rather than resulting from an 
evidence-based approach [6,7].
This technique was accepted as the gold standard by consensus in 1993, without a high 
level of evidence for its superiority [8]. Now, in the modern era of new laparoscopic 
developments, LC has become the “ideal model” of implementation and justification 
for a laparoscopic technique. In newer areas for laparoscopic techniques, advantages 
over previous practice are still under debate. However, true evidence of the superiority 
of LC to other procedures, such as sm all-incision cholecystectomy (SIC) and open 
cholecystectomy (OC), has yet to be assessed.
Whereas the comparison of LC with OC seems to favor LC [9], conflicting results are 
found in randomized controlled trials comparing LC with SIC [10-21]. Nearly all trials did 
not discriminate between primary and secondary outcome measures, and only a few trials 
included surgical residents performing the operations. Differences in methodologic 
quality of the studies raise doubts about validity, and expert settings bring into question 
the generalizability.
Therefore, the principal aim of this study, with emphasis on methodologic quality, was 
to test the generalizability of the comparable outcome of LC and SIC in a general 
teaching hospital with predominantly surgical residents performing the operations.
METHODS
Our aim was to perform a randomized trial focusing on 3 issues: discrimination between 
primary and secondary outcome measures, methodologic quality, and generalizability
M ortality and complication rate are primary outcome measures and the ultimate 
determ ining factors in deciding between LC and SIC. On the basis of the available 
literature, we hypothesized that no major differences in primary outcome measures 
would be found between LC and SIC. All other outcomes are secondary outcomes (e.g., 
cost-minimization analysis) and eventually may be deciding factors for choosing one 
procedure over the other. However, before it is justified to focus on secondary outcomes,
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we have to show results of primary outcomes in our study population comparable with 
those in the literature.
The second issue relates to methodologic quality. Many methods of scoring the intrinsic 
quality of a randomized trial exist, but none is sufficient. However, only 4 methodologic 
quality items have proved to be important factors for minimization of bias [22]. We have 
tried to optimize trial quality in these 4 key domains: generation of the allocation 
sequence, allocation concealment, blinding, and follow-up.
The third issue relates to generalizability. If a small number of highly experienced sur­
geons perform all operations in a trial, excellent results might be expected. However, our 
real world includes surgeons w ithout a high level of experience who also perform 
cholecystectomies and the training of residents, possibly leading to completely different 
results. To maximize applicability of the trial results, we needed to include residents 
performing operations.
This article presents the clinical outcomes of the trial, highlights efforts to minimize 
bias, and discusses the generalizability of our real-world findings.
Outcome measures
We evaluated the usual baseline characteristics (age, sex, body mass index, and American 
Society of Anesthesiologists (ASA) score), preoperative biochemistry results, classic 
diagnostic symptoms, and recovery after complicated gallstone disease.The following 
outcomes were examined: mortality, complications, symptom relief, operative time, 
hospital stay, conversion rate, and intraoperative technical aspects. The number of 
operations performed by residents was recorded as well. Symptom relief was measured 
by asking all patients whether painful episodes had recurred, as well as whether 
cholecystectomy had resolved their primary complaint.
Patients
Approval from the Medical Ethics Committee for this single-center trial was obtained 
in September 2000. Patients were recruited between January 1, 2001, and January 31, 
2004. If patients referred to the surgical outpatient clinic met the inclusion criteria and 
no exclusion criteria were present, written informed consent was obtained. Patients 
were placed on the w aiting list for elective cholecystectomy. If patients wanted to 
reconsidertheir participation in the trial,they could be excluded on theday of admission, 
before randomization.
Inclusion and exclusion criteria
Inclusion criteria were symptomatic cholecystolithiasis (confirmed by ultrasonography)
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in male or female patients, 18 years or older at recruitment, reasonable to good health 
(ASA score of 1 or 2), no known relevant allergies, and signed informed consent letter.
Exclusion criteria were age younger than 18 years, choledocholithiasis (icterus, acholic 
feces, and/or bilirubin level of twice the upper limit of normal), cholangitis, known preg­
nancy, moderate to severe systemic disease (ASA score of 3 or higher), known cirrhosis 
of the liver, history of abdominal m alignant neoplasm, previous upper abdominal 
surgery (precluding laparoscopic approach), psychiatric disease, or other factor (eg, lack 
of knowledge of the Dutch language) that might make follow-up or completion of 
questionnaires unreliable.
Obesity was recorded but was not an exclusion criterion [14]. Recovery after successful 
endoscopic treatment of choledocholithiasis was not a contraindication. Acute cholecys­
titis is a different disease with different complication rates, morbidity, and conversion 
rates and therefore was cause for exclusion.
Randomization
A random-number table was used for generation of the allocation sequence [23], and 
the allocation concealment was guaranteed by using sealed envelopes (no blocking, no 
stratification). To eliminate bias caused by preoperative expectations, patients were 
randomly assigned in the operation room after induction of anaesthesia. A telephone 
call was placed to the secretarial office and an employee opened an envelope to deter­
mine the surgical method. Details of surgery were recorded in a case record form. Other­
wise, the procedure was recorded as “trial cholecystectomy”. We did not use sealed 
envelopes for record keeping [17].
Surgical procedures
All consultant surgeons participating in the trial had experience in LC and were trained 
in SIC in a pilot phase before the trial. After this learning phase, each consultant surgeon 
was considered equally fam iliar with the 2 techniques. Operations were supervised by
1 of the consulting surgeons. Our hospital is a training hospital; thus, residents (from 
second year on) performed most of the operations, which enabled us to test external 
validity in a teaching hospital.
Although discussions in the literature on intraoperative cholangiography continue, the 
policy in our hospital was not to perform cholangiography in any patient undergoing 
elective cholecystectomy. Performing standardized laboratory tests and, on indication, 
preoperative endoscopic retrograde cholangiopancreatography is the national policy in 
the Netherlands, based on the broad availability of high-quality endoscopy facilities.
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All patients had a standard anesthesia regimen. Premedication, medications for induc­
tion and continuation of anesthesia, and respiration during surgery were standardized. 
Analgesics and medication for nausea were supplied according to a standard scheme.
All patients had nasogastric intubation during the operation that was removed imme­
diately afterward. Operating time was measured from the first skin incision to the last 
suture placement for both techniques. In case of technical difficulties or for any other 
reasons, either technique could be converted to OC. No suction drains were left in the 
subhepatic space at the end of the procedure. Abdominal wall and skin closure were 
standardized. The wounds were covered with standard wound dressings, with iodine 
stains applied to the wound dressings to allow blind assessment during clinical stay 
[14]. We did not use local anaesthetic techniques or intercostal nerve blocks because 
their application in LC and SIC differs, thereby possibly introducing bias. Identical systemic 
administration of analgesics in both procedures was used, giving less potential for bias.
Laparoscopic Cholecystectomy
Open introduction was performed in all patients, regardless of previous abdominal 
surgery. Pneumoperitoneum was created with intra-abdominal pressures up to 12 mm 
Hg, and 3 trocars were inserted.The dissection of the cystic duct and artery, identifying 
the Calot triangle, was performed by means of a 3-point “flag” technique [24]. The 
cystic duct and artery were clipped and transected. After complete dissection, the gall­
bladder was removed. If conversion to OC was necessary, the reasons for conversion 
were recorded.
Small-lncision Cholecystectomy
In accordance with the literature, a cutoff point of 8 cm was used to differentiate between 
SIC and OC [11-21]. As part of a separate research question, all patients underwent 
preoperative ultrasound for location of the gallbladder. We used the craniocaudal 
position of the mark for incision. The incision was placed over the musculus rectus 
abdominis. Only standard instruments were used, with no special equipment. Access to 
the peritoneum was obtained by a muscle splitting (and not transection) technique 
(comparable to open appendectomy).The gallbladder was dissected by a “fundus-first” 
technique. If necessary, the gallbladder was punctured to remove its liquid contents. 
The cystic duct and artery were ligated and the gallbladder was removed. Posterior and 
anterior fascias were closed separately. After wound closure, the length of the incision 
was measured; if it exceeded 8 cm, the operation was considered a conversion to OC.The 
reasons for conversions were recorded.
Postoperative protocol
Early oral intake and mobilization were encouraged. Patients left the hospital as soon
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as they were able to do so. Although ambulatory cholecystectomy has been proved 
feasible, it was not practiced in our hospital [25]. Hospital stay was defined as the num­
ber of postoperative nights in the hospital. Shortly before discharge, wound dressings 
were removed for wound inspection. Follow-up took place after 2 weeks, 6 weeks, and
3 months. For logistic reasons, we were not able to blind the surgeon at follow-up. 
Patients were encouraged to resume work and normal daily activity as soon as they felt 
able to do so.
Analysis and sample size
Assuming no differences in primary outcome measures, sample size calculation was 
based on differences of costs. For this purpose, the direct costs of the first 50 patients 
in the trial were calculated to estimate the likely range of differences in costs and their 
standard deviations. On this basis, we estimated that 120 patients per group would be 
needed to detect a difference of 10% in direct costs using an a  of 0.05 and a 3 of 0.9. 
Although such analysis was not the purpose of this trial, a difference of 10% in compli­
cations would have been possible to detect with this sample size. Before the reporting 
of costs would be allowed, the data set of the trial had to be validated in regard to the 
primary outcome measures (complications and symptom relief). After primary outcomes 
comparable to those in the literature were demonstrated, it would be justified to 
report secondary outcomes such as costs. No interim analysis was planned, but the 
monitoring committee could stop the trial if a substantial difference in complications 
occurred.
All data were stored in a case record form and subsequently transferred to an Access 
database. Double data entry was performed to prevent typing errors. Data were sub­
sequently read into SPSS 11.0 (SPSS Inc, Chicago, Illinois) for statistical analysis.
Statistics
Comparisons were made on an intention-to-treat basis [26]. Calculations were made 
with SPSS n.o .Thex2test was used fordichotom ous outcomes. Forall continuous data, 
we present our results both as medians with ranges and as means with standard devi­
ations to facilitate their interpretation.
The normality of the data was checked by means of the Kolmogorov-Smirnov test. In 
case of deviations from normality, data were transformed to normality [27].The Levene 
test was used for checking the equality of variances. When the condition of normality 
and equal variances was met, the independent samples t test was used for independent 
data. When equality of variances was absent or normality could not be reached with 
transformation, the nonparametric Mann-Whitney test was used.
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RESULTS
All trial patients were operated on between January i, 2001, and March 31, 2004. 
Initially, 366 patients fulfilled the inclusion criteria and agreed to be included in the 
trial. A total of 102 patients were not randomized for a variety of reasons (Figure 1) [28]. 
After 264 patients were randomly assigned, another 7 patients were excluded for the 
following reasons: unwillingness to participate further (2 patients), intraoperative 
suspicion of malignant neoplasm (2 patients), transfer to another ward not participating 
in the trial (1 patient), participation in 2 trials (not in line with the Helsinki declaration)
Figure i: Revised consort statement diagram showing the f lo w  o f  participants through each stage o f  the randomised trial (35).
LC: laparoscopic cholecystectomy; SIC: small-incision cholecystectomy.
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(i patient), and insufficient knowledge of the Dutch language (i patient). A total of 257 
patients were left for analysis (Figure 1).
Baseline characteristics
The 2 groups did not differ with regard to age, sex, body mass index, and ASA classifi­
cation (Table 1) [29]. We evaluated the following classic diagnostic symptoms of chole- 
cystolithiasis in both groups [3o]:severe pain,episodic pain,epigastric pain, pain in the 
right upper quadrant, pain radiating to the back, pain lasting 1 to 5 hours, awakening at 
night, and the Murphy sign. There were no significant differences in the presence and 
the duration of these symptoms.The numbers of patients presenting with complicated 
gallstone disease and operated on in a later stage were also equally distributed (Table 1). 
Preoperative blood analysis consisting of erythrocyte sedimentation rate, white blood 
cell count, levels of C-reactive protein, alanine aminotransferase, aspartate aminotrans­
ferase, gamma-glutamyltransferase, alkaline phosphatase, and bilirubin showed no sig­
nificant differences between groups.
Laparoscopic Small-lncision p-value
Cholecystectomy Cholecystectomy
(n=i2o) (n=i37)
Sex, No. (%) 0.46
Male Bi (25.8%) 30 (21.9%)
Female 89 (74-2%) 107(78.1%)
Age,y
mean (SD) 48.4(14.1) 48.5 (14-0 ) 0.97
median (range) 49  (17-77) 48 (l8-80)
BMi
mean (SD) 27-5 (4 -8) 27.9 (4.6) 0.50
median (range) 26.8 (18.5-45.9) 27,2(18.0-43.3)
ASA (%) 0.86
1 81 (67.5%) 91 (66.4%)
II 39 (32.5%) 46 (33.6%)
Complicated gall stone disease, No 18 18 0.67
Acute cholecystitis 1 0 0.28
Cholangitis 3 3 0.87
Biliary pancreatitis 4 8 0.34
Bile duct stone and icterus 10 7 0.30
ERCP before cholecystectomy, No 12 13 0.89
Table 1: Patient characteristics.
Abbreviations: ASA, Am erican Society o f  Anaesthesiologists; BMI, body mass index (calculated as w eight in kilogram s 
divided by height in  meters squared); ERCP, endoscopic retrograde cholangiopancreatography.
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Operative results
Results are presented including data from converted operations (intention-to-treat) 
unless otherwise stated.
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision
Cholecystectomy
(n =i37)
Statistical
analysis
Complications, No. 21 16
intra-operative 5 3 p=o.36
postoperative 16 13 P=0-33
Conversion rate, No. (%) 14(11.7%) 22 (16.1%) P=°-3i
Failure of symptom relief, No. (%) 11 (9.2%) 14(10.2%) P=0-78
Operative time, min
mean (SD) 71.9 (25.8) 60.4(18.3) p<0.001
median (range) 68.5 (26-215) 6O.O (29-IO5)
Operative team, No. (%)
surgeon-resident 15 (12.5%) 19 (13.9%) p=0.52
resident-surgeon 84(70.0% ) 100 (73.0%) p=o.56o
resident-resident 21 (17.5%) 18 (13.1%) p=o.33
Incision length, mma
mean (SD) 76.1 (33.8) 76.0 (24.0) P=0.2
median (range) 65 (40-200) 66 (49-165)
Hospital stay, postoperative nights
mean (SD) 2 4 (4 .6 ) 3.1 (12.4) p=o.56
median (range) 1 o -  36) 2 (1 -144)
mean (SD) excluding 1 extrem e value 2-1 (3-4) 2.4 (24 ) p=o.88
N um bero f patients with:
1 night stay postoperative 67 (55.8%) 62 (45.3%) p=0.09
2 nights stay postoperative 38 (31-7%) 56 (40.9%) p=o.i3
Follow-up:
2 weeks 112 (93.3%) 133 (97.1%)
>£)ÒIICl
6 weeks IO6 (88.3%) 130 (94,9%) p=o.o6
3 months 96 (80.0%) 111 (8l.0%) p=o.24
Employed (n)
Return to work (weeks):
SO SI
mean (SD) 4-1 (2.3) 3-7 (2.0) P=°-3
median (range) 4(1-12) 3 (0.5-12)
Table 2: Comparison o f  operative results.
aincision length was m easured in  95 patients (12 conversions) in the laparoscopic g ro u p  and  734 patients 
(20 conversions) in  the sm all-incision group.
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Among intraoperative factors, we found more adhesions (x2=9-i5> p=o.oo2) and intra­
operative bile leakage (by gallbladder perforation) (x 2= io . 2 6 , p=o.ooi) in the LC group. 
Correspondingly, the skin was left open for secondary wound healing more often in the 
LC group (x2=3i-69, p<o.ooi). Intraoperative stone loss, presence of inflammation, and 
identification of the cystic duct and the common bile duct were not statistically diffe­
rent between the 2 groups.The cystic artery (p=o.oos) and Calot triangle (p<o.ooi) were 
identified more frequently in the LC group, and in the SIC group a combined ligation of 
the cystic duct and artery was performed more frequently (p<o.ooi).
Surgical residents performed 105 LCs (87.5%) and 118 SICs (86.1%). Operative time was 
shorter for SIC (60 vs 72 minutes; 11=6013.0; p<o.ooi) (Table 2). Conversion rates were 
similar, with similar distribution of reasons for conversion (Table 3).Total incision length 
of scars, measured in 229 patients, appeared to be not statistically different between the 
LC and SIC groups.
Complications
There were no deaths in the trial. There were 5 intraoperative complications in the LC 
group and 3 in the SIC group (Table 4). Most importantly, 1 common bile duct injury 
occurred in each group (treated by T-drainage and hepaticojejunostomy). Considering 
postoperative complications, we did not find a difference in the number or severity 
between the 2 groups.
Laparoscopic Cholecystectomy Small-lncision Cholecystectomy
Because o f adhesions 5 Insufficient view  9
Unclear anatom y /  no overview 3 Cholecystitis 3
Obesity (gallbladder tear, technical problems) 2 Gallbladder to deep under rib cage (insufficient view) 3
Inflamm ation (cholecystitis and empyema) 1 Bleeding (from cystic artery) 3
Uncontrollable bleeding from  cystic artery 1 No progress after 50 m inutes 1
Common bile duct injury Hepatic duct injury (T-drainage) 1
(conversion and choledocho-jejunostomie) 1
Inadequate positioning o f gallbladder Stone w as impacted in cystic duct,
over liver (insufficient view) 1 impossible to remove 1
By accident larger incision (10cm) 1
Total 14 Total 22
Table 3: Reasons f o r  conversions.
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The numbers of complications in the “resident-resident” operative team subgroups 
were compared in an exploratory subgroup analysis.These numbers (3 and 4 in the LC
Laparoscopic Cholecystectomy (total) 21 Small-lncision Cholecystectom y (total) 16
Intraoperative com plications Intraoperative complications
Asystole 1 Cardiac ischemia, no elevated enzymes 1
Common bile duct (CBD) injury, eventually 
hepatico-jej unostomy, com plicated prolonged 
ICU stay, stenosis bile duct. 1
CBD injury,conversion,T-drain, ERCP and 
papillotomy for CBD stone 1
Bleeding requiring conversion
(and transfusion) 1
Hepatic parenchyma rupture,
conservative treatm ent (transfusion) 1
Bowel injury at introduction (sutured) 1
Cerebrovascular accident at recovery 1
Total intraoperative 5 Total intraoperative 3
Postoperative com plications Postoperative com plications
Pneumonia 1 Cystic duct leakage (ERCP + stent) 1
Cerebrovascular accident (6 weeks postoperative) 1 CBD injury, m ultiple relaparotomies and ICU stay 1
Intra-abdominal fluid collection (haematoma); 
icterus (ERCP: no stones, com plicated by bleeding) 1
CBD stone (ERCP) and abscess intra-abdominal 
(ultrasound drainage) 1
Pancreatitis (conservative treatm ent) 1 CBD stone w ith mild pancreatitis (ERCP) 1
Intra-abdominal abscess (re-la pa roseo py) 1 Urinary tract infection (antibiotics) 1
Epididimitis (operation by urologist) 1 Urinary retention 1
Phlebitis 3 Wound infection 3
Urinary tract infection (urologist) 1 W ound dehiscence (no macroscopic infection) 4
Wound infection: um bilical 3
Wound haematoma 2
Wound infection: subxiphoidal 1
Total postoperative 16 Total postoperative 13
Table 4: Intraoperative and postoperative complications.
ERCP: endoscopic retrograde cholangiopancreatography.; ICU: intensive care unit.
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and SIC groups, respectively) were not different from complication rates in operative 
teams that included a surgeon.
Postoperative complaints
The follow-up rate between the groups was not statistically different. Follow-up in the 
LC and SIC groups, respectively, was 88.3% and 94.9% at 6 weeks, 80.0% and 81.0% at 3 
months, and all patients showed up at either their 6-week or their 3-month follow-up 
appointment. All patients who did not show up at their 2-week or 6-week follow-up 
appointment appeared not to have any problems at their next scheduled follow-up 
appointment.
W hether symptom relief was achieved and whether symptoms had recurred was 
ambiguously reported by some patients. With unclear cases included, it appeared that 
9.2% and 10.2% of patients in the LC and SIC groups, respectively, experienced failure of 
symptom relief (Table 2).
Postoperative complaints at follow-up were evaluated and appeared comparable 
between the LC and SIC groups, including dietary complaints (26 vs 30 patients; p=o.g6), 
diarrhea (17 vs 15; p=o.44), fatigue (13 vs 6; p=o.o4g), and complaints suggesting the 
presence of common bile duct stones (6 vs 9; p=o.5g). There was also no statistical 
difference in the number of patients undergoing endoscopic retrograde cholangiopan­
creatography or magnetic resonance cholangiopancreaticography postoperatively 
(2 vs 5; p=o.24).
COMMENT
There were no differences in baseline characteristics between the 2 groups of patients, 
suggesting an effective randomization process. We found no significant differences in 
primary and secondary outcome measures between LC and SIC: complication rate (both 
intraoperatively and postoperatively),symptom relief,conversion rate,and hospital stay. 
Operative time was shorter in the SIC group.The results of this study compare well with 
those in the literature but add to it in terms of methodologic quality and real-world 
general teaching hospital setting.
Results of previous randomized controlled trials have been contradictory. Trials in the 
literature together include more than 2000 patients. Most trials found no difference 
in complication rates between LC and SIC [10,12,14,16], whereas in 2 trials complication 
rates were lower with SIC [15,17]. However, complication rates vary substantially between 
the different trials, without unambiguously showing lower complication rates in trials
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with expert settings. Differences in intrinsic validity probably also play a role in varying 
complication rates.
Most trials found a shorter operative time for SIC [14,15,17], whereas 2 other trials did not 
[10,12]. Results for hospital stay [10,12-17,19,20] and convalescence [10,14,16,17] are 
conflicting as well. Overall, most authors conclude that there is no difference between 
the 2 procedures [12-15,17]. Considering these conflicting but numerous data, pooled 
estimates by meta-analysis are needed to derive strong conclusions [31].
Minim izing bias gives considerable strength to results. Although it is not possible to be 
sure that all patients really were blinded to their treatment, expectations of ward 
personnel influencing postoperative recovery probably is a much more important fac­
tor in convalescence.
Generalizability includes extrapolation of study results to other patient categories or 
other surgical units. We believe that extrapolation of these results (surgery performed 
largely by residents) to other surgical units is possible without increased risk. However, 
extrapolation to other patient categories (ie, those with ASA scores of 3 or 4, or patients 
with cholecystitis) is dangerous because it uses assumptions that may not hold true. Ad­
ditional research exploring the appropriateness of extrapolation of these results to 
other patient categories is necessary. Unlike the evidence in expert studies [14], we have 
shown the feasibility of SIC and LC in a general teaching hospital with mainly surgical 
trainees (86% and 88%) performing the operations. We believe that this reflects a real- 
world situation and adds to the generalizability
In a short training phase, surgeons were taught the SIC technique. After this introduc­
tory phase, all participating surgeons were considered equally fam iliar with both tech­
niques. In reality, they probably were more experienced with LC. Explorative analysis of 
this theoretical difference in experience by comparing early with later results did not 
show any difference in outcome.
Opportunities to learn the OC technique are few because conversion rates are too low 
to provide enough numbers. Small-incision cholecystectomy with extended incision if 
necessary appears to be a valuable alternative. An advantage of this strategy is that it 
familiarizes residents with the open approach and precludes the performance of an 
unknown procedure. It seems useful to add the small-incision technique to the repertoire 
of the general surgeon.
At the time the trial started, general policy in the Netherlands (and in our hospital) was 
not to perform intraoperative cholangiography. Discussions on selective use vs standard
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or no cholangiography continue. Recent research shows the benefit of intraoperative 
cholangiography [32]. Possibly this policy should be reconsidered on the basis of these 
findings, both in our hospital and on a national level. This issue is currently being 
studied by a national committee on guideline development of diagnosis and treatment 
of gallstones.
Hospital stay in this study might be considered long compared with everyday practice. 
Although ambulatory cholecystectomy has proved feasible with both the laparoscopic 
and small-incision techniques [33,34], it was not the policy in this hospital at the start 
of the trial. Both cultural factors and differences in expectations of patients, as well as 
arrangements with insurance companies at that time, were responsible. In addition, it 
should be remembered that hospital stay is a surrogate marker for recovery and that it 
is influenced by many factors, some unknown.
Evidence of superiority of LC to SIC is lacking, and conflicting data arise from the exis­
ting randomized trials [10-21]. It is remarkable, however, that the acceptance of LC was 
extremely rapid: within 3 years, from 1989 to 1992, the rate of laparoscopy for cholecys­
tectomy in the United States changed from 0% to 80% [35]. Moreover, it became the 
treatment of choice by consensus of the National Institutes of Health in 1993. This is 
especially remarkable because there had been no possibility of acquiring an adequate 
level of evidence within this very short period [8]. Analysis afterward showed that 
access to positive information, more favorable adoption costs-related conditions, and 
the role of the “early adopters” had been most important in this process [6].
Whereas in the 1980s, the “age of optimism”, technical innovation dominated decision 
making in medical science, currently health technology assessments and cost-effective- 
ness analyses of treatments play a dominant role [7]. It was, therefore, interesting to 
compare the presumed clinical superiority of LC, the ideal example of laparoscopic 
innovation, with more basic minimally invasive techniques such as SIC. With budget 
restrictions in mind, it is worthwhile looking at other factors that may play a role in 
future decisions on laparoscopic surgery.
CONCLUSIONS
This randomized controlled trial with emphasis on methodologic quality and genera- 
lizability shows no benefit in clinical outcome measures of LC compared with SIC.The 
question arises of which other measures do differ to persuade us of superiority of one 
minimally invasive technique over the other. In extending these conclusions to the broad 
discussion on laparoscopic gastrointestinal surgery, should we be lookingforotherout-
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come measures, such as cost-effectiveness? Or should we look for other factors such as 
fast-track recovery programs that seem to outweigh some of the effects of laparoscopic 
surgery, rendering the surgical approach of secondary interest?
Surgical decision making should be evidence based. A systematic review of all ran­
domized controlled trials on this topic should derive the highest possible evidence and 
surgeons should dare to act accordingly.
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Anaesthesiological considerations 
in small-incision and laparoscopic 
cholecystectomy in symptomatic 
cholecystolithiasis: implications 
for pulmonary function. 
A randomized clinical trial
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ABSTRACT
Background
Upper abdominal surgery, including laparoscopic cholecystectomy (LC), is associated 
with post-operative pulmonary dysfunction. LC has, by consensus, become the treat­
ment of choice for symptomatic cholecystolithiasis. Small-incision cholecystectomy 
(SIC), a procedure that does not require a pneumoperitoneum, threatens to be lost to 
clinical practice, even though there is evidence of equality. We hypothesized that the SIC 
technique should be equal, and might even be superior, to LC when considering post­
operative pulmonary function because of the short incision length.
Methods
A single-centre randomized clinical trial was performed including patients scheduled for 
elective cholecystectomy. Pulmonary flow-volume curves were measured pre-operatively, 
post-operatively, and at follow-up. Blood gas analyses were measured pre-operatively, 
in the recovery phase, and on postoperative day i. Anaesthesia, analgesics, and peri­
operative care were standardized by protocol. Post-operatively, patients and caregivers 
were blind to the procedure.
Results
Two hundred and fifty-seven patients were analysed.There was one pulmonary com­
plication (pneumonia) in the LC group. In both groups, similar reductions of approxi­
mately 20% in pulmonary function parameters occurred, with complete recovery to 
pre-operative values. Patients in the SIC group consumed more analgesia when com­
pared with the LC group, without any impact on blood gas analysis. Patients converted 
to a conventional open technique showed significant differences in six of the eight 
parameters in pulmonary function tests.
Conclusion
When evaluated with strict methodology and standardization of care, no clinically 
relevant differences were found between SIC and LC with regard to pulmonary function. 
Our results suggest that the popularity of the laparoscopic technique cannot be attri­
buted to pulmonary preservation.
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BACKGROUND
Subsequent to its publication in 1882 [1], open cholecystectomy (OC) was considered as 
a safe standard for cholecystectomy for about 100 years, although this technique was 
associated with relevant anaesthesiological and pulm onary risks. A decrease in the 
length of the incision, known as small-incision cholecystectomy (SIC), with a concomitant 
decrease in post-operative morbidity, was reported as early as the mid-1970s [2]. 
However, before SIC could find general acceptance, laparoscopic cholecystectomy (LC) 
was introduced in the late 1980s [3]. The LC procedure gained rapid and immense 
popularity [4], and became the surgical treatment of choice, even though its superiority 
has not been demonstrated [5].
Many important factors have been implicated in the pulmonary compromise seen after 
upper abdominal surgery, as well as in the cardiovascular risks. These factors include 
the site and size of the incision, post-operative pain, and reflex inhibition of diaphrag­
matic function [6]. Com pared with the traditional open technique, the cardiopulmonary 
changes, particularly heart rate and arterial blood pressure changes, following LC have 
been suggested to be of a lesser order.This combination has convinced many anaesthe- 
siologists that patient care is improved using the laparoscopic technique [7]. However, 
LC involves adaptation of anaesthesia techniques, as well as patient selection. Pneu­
moperitoneum has its own procedure-related effects. Intra-abdominal pressure has 
been associated with extensive elevation of the diaphragm and increased intrathoracic 
as well as intracranial pressure. Depression of haemodynamic functions, particularly in 
cardiac output, may place patients with congestive heart failure at increased risk, 
whereas those with pulmonary disease are exposed to increases in V a/ O  mismatch, in­
creased ventilation requirements, and the risk of pneumothorax peri-operatively [8-10].
A loss of functional residual capacity (FRC), as well as the diaphragmatic contribution 
to tidal volume, has been suggested to be principally a result of pain-induced shallow 
breathing (splinting) [6,11,12]. However, only partial restoration of pulmonary function 
is demonstrated when analgesia is adequately applied [13], implicating other factors 
and invalidating the eloquent argum ent that a laparoscopic technique is justified 
for pulmonary reasons. Controlled prospective studies between LC and SIC, in which 
anaesthesia considerations and pulmonary function are the principal outcomes, have 
not been reported.
With improvements in the insight into differences between splinting and pulmonary 
dysfunction, leading to adaptations in peri-operative management and pain control 
methods, such as patient-controlled analgesia (PCA), the suggestion that the laparosco­
pic technique should be preferred over the small-incision technique can be questioned.
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Pulmonary function differences between LC and SIC have been studied in only a few, 
technically oriented, randomized trials, which have reported inconsistent outcomes [14-20], 
involve small numbers of patients [14,18,19], and seem to incorporate some important 
methodological shortcomings [15,19,20].
As the literature is ambiguous, we decided to perform a large single-centre randomized 
trial. The aim was to evaluate pulmonary function in patients randomized between LC 
and SIC by measuring flow-volume curves and blood gases in a blind fashion.
METHODS
Ethics committee approval for this trial was obtained from St. Elisabeth Hospital (Tilburg, 
The Netherlands) in September 2000. Patients were recruited from January 2001 to 
January 2004. Patients referred to our surgical outpatient clinic with symptomatic 
cholecystolithiasis were eligible for inclusion in the trial. All patients had symptomatic 
gallstones confirmed by ultrasonography. If patients met the inclusion criteria, and no 
exclusion criteria were present, written informed consent was obtained and patients 
were consecutively scheduled for elective cholecystectomy.
Endpoints and outcome
The principal outcome measures of this paper are pulm onary function and related 
aspects. For the study as a whole, multiple outcomes were evaluated, including mortality, 
complications, health status, cosmetic results, and cost analyses [21]. Although not the pri­
mary focus of this paper, complication rates [22] are mentioned to allow for comparison.
Inclusion and exclusion criteria
The inclusion criteria were as follows: male or female patients with symptomatic 
cholecystolithiasis; age of 18 years or older at recruitment; American Society of Anes­
thesiologists (ASA) classification I or II [23]; no known relevant allergies; a signed informed 
consent letter. Obesity was not considered as an exclusion criterion.
The exclusion criteria were as follows: age younger than 18 years; choledocholithiasis 
(icterus, acholic stools, and bilirubin of twice normal range); cholangitis; known pregnancy; 
ASA class III and higher; known cirrhosis of the liver; history of abdominal malignancy; 
previous surgery which would exclude a laparoscopic procedure; psychiatric disease or 
other reasons (e.g. inadequate Dutch language skills) making follow-up or answers on 
the questionnaires unreliable.
Patients suffering from acute cholecystitis could only be included after a cooling down
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period of 3 months and normalization of biochemistry. Inclusion of patients with 
choledocholithiasis after successful endoscopic treatment was also allowed when liver 
enzymes had normalized.
Randomization and blinding
A random number table was used to generate the allocation sequence, with allocation 
concealment guaranteed by sealed envelopes [24]. To further eliminate bias, patients 
were randomized in the operation theatre after induction of anaesthesia by calling the 
secretary who opened an envelope. All patient data were recorded in a case record form, 
with the procedure reported a s ‘trial cholecystectomy’ [25]. Wounds and port sites were 
dressed with identical opaque dressings, stained using iodine, regardless of the surgical 
procedure performed, to allow blinding for patients, nurses, technicians, and physicians 
during the post-operative period [26].The type of operation was revealed on the morning 
of discharge.
Standardized anaesthesia protocol
To avoid bias during the peri-operative recovery, all patients were subjected to a standard 
anaesthesia regime. Any violations to this regime were recorded. Standard pre-medi- 
cation included diazepam (Valium) (5 mg orally when <50 kg or >6syears; otherwise 10 
mg orally) and atropine (0.25 mg intramuscularly when <50 kg or >65 years; otherwise 
0.5 mg intramuscularly), given 60 minutes before the operation.
At induction, all patients received 2gcefazoline (Kefzol) intravenously.The patients were 
preoxygenated with 100% 0 2 for 3 min. Anaesthesia was induced with thiopental 
(Pentothal) (5 mg/kg intravenous bolus in 2 min), sufentanil (Sufenta) (0.1 Mg/kg intra­
venous bolus; +0.05 Mg/kg bolus when indicated) and rocuronium bromide (Esmeron) 
(0.6 mg/kg intravenously). Routine use of neostigmine with atropine (Prostigmin) was 
avoided, except where neuromuscular monitoring (TOF-guard) showed a train-of-four 
of less than four twitches, with fade of more than 30%. Intubation took place with an 
endotracheal tube (size 8 or 9), and respiration was initiated with a tidal volume of 8 
ml/kg, respiration rate of 12 breaths/min, positive endexpiratory pressure (PEEP) of 5 
cmH20  and an end-tidal C0 2 target of 4.0-4.7 kPa.This has been documented to achieve 
a PaC0 2 of end-tidal C0 2 + 0.8 kPa. Average intra-abdominal pressures during LC vary 
between 10 and 14 mmHg in our hospital, with the maximum pressure limited to 14 
mmHg. If needed to maintain normocapnia, tidal volume increases of i-m l/kg steps 
were alternated with increasing ventilation frequency. Particularly duringthe termina­
tion of anaesthesia, no C0 2 over 7.3 kPa was accepted.
Respiration was continued with 0 2 at 40% in air and sevoflurane (Ultane) at 1 MAC 
(minimal alveolar concentration), corrected for age. Sufentanil (Sufenta) (0.05 Mg/kg
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intravenous bolus) was given if there was a change in blood pressure or heart rate from 
the pre-operative value of more than 30%. Rocuronium bromide (Esmeron) (0.125 mg/kg 
intravenous bolus) was given when indicated by a change in respiratory pressure or 
when requested by the surgeon.
After induction, patients were positioned on the operation table at an anti-Trendelenburg 
position of 200. In accordance with good clinical practice, values of <20%  of baseline 
were maintained. Patients left the operation room pain-free and without nausea. Patients 
were moved directly to recovery, where they were given 2 l/m in oxygen via a nasal 
cannula.This was up through the arterial blood gas evaluation.They were attached to 
the standard, non-invasive monitoring up through the moment of the arterial blood 
gas evaluation. Nursing staff (one nurse to three patients) followed all patients. Criteria 
for discharge from recovery were checked using the Aldrete score, and were confirmed 
by the anaesthesiologist responsible.
Analgesics in the post-operative period were supplied according to a standard scheme. 
On arrival in recovery, 1 g paracetamol (suppository) was given, followed, as needed, by 
diclofenac (Voltaren) (75 mg intravenously to a maximum of 3 times a day). In the 
recovery room, pethidine (Demerol) 0.5 mg/kg was given once if requested. Morphine 
10 mg intravenously, followed by boluses of 5 mg intravenously, to a maximum of 4 
times a day, was given for further pain relief. Paracetamol (1 g suppository) was given 
every 6 h for the first 48 h post-operatively.
Medication for nausea consisted of metoclopramide (Primperan) (10 mg intravenously 
in 5 min), haloperidol (Haldol) (2.5 mg; and, when indicated, 2.5 mg extra) and ondanse­
tron (Zofran) (4 mg intravenously), if necessary.
The supply of analgesics for pain minimization was objectified using a visual analogue 
scale (VAS) ruler. Both pain and nausea scores were measured by the VAS ruler in the 
recovery room every 10 min for 60 min, and were noted in the case record form. When 
the score was >4, the next step in medication was taken. Patients stayed in the reco­
very room for at least 1 h to guarantee adequate pain control. Patients were sent to the 
ward pain-free and without nausea. On the ward, the pain and nausea scores (scored 
every 2 h) and the standard medication regime were continued until patients had a 
score of < 4  for at least 12 h.
Surgical techniques
For LC, an open introduction was performed in all patients, regardless of previous 
abdominal surgery. Pneumoperitoneum was created with intraabdominal pressures of 
up to 12 mmHg.Three trocars were inserted.The dissection of the cystic duct and artery,
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and identification of Calot’s triangle were performed using a three-point‘flag’ technique 
[27].The cystic duct and artery were clipped and transected. After complete dissection, 
the gallbladder was removed.
The SIC approach involved a transverse incision of no more than 8 cm over the right 
musculus rectus abdominis [19]. Only standard surgical instruments were used, as well 
as regular operation room (OR) lights; no special equipment was employed. Access to the 
peritoneum was obtained by a muscle splitting technique, as opposed to transection, 
comparable with the technique used in an open appendectomy. The gallbladder was 
dissected ‘fundus first’. If necessary, the gallbladder was punctured to remove its liquid 
contents. The cystic duct and artery were ligated and the gallbladder was removed. 
Posterior and anterior fascias were closed separately. After wound closure, the length of 
the incision was measured. If the length of the incision exceeded 8 cm, the operation 
was considered as a conversion to OC.
A learning curve for the SIC technique was allowed prior to the study. As all surgeons had 
extensive experience with OC, after approxim ately five procedures each, adequate 
experience in the procedure was deemed to be present.
Pulmonary function tests
Pulmonary function tests were performed immediately pre-operatively, on the first post­
operative day, and at the 6-week outpatient check-up. During the tests, the best flow- 
volume curve of three attempts was taken for analysis. The maximal vital capacity 
(VC max ), forced expiratory volum e in 1 s (FEV), forced vital capacity (FVC), maximum 
expiratory flow when 25%,50%,and 75% ofthe FVC has been exhaled (FEF25, FEF50, FEF75), 
peak expiratory flow (PEF), and forced inspiratory volume in 1 s (FI Vi) were documented. 
The FEF values have been suggested to be particularly sensitive for detecting peri­
operative function changes [28]. The pulmonary function tests were performed in our 
respiratory laboratory using Jaeger-masterscreen PFT (Viasys, Hoechberg, Germany).
Arterial blood gas analyses were performed three times. The pre-operative and 24-h 
post-operative samples were taken under room air conditions; the sample during reco­
very was taken at a fraction of inspired oxygen (F¡0 2) of 34% (2 I flow via nasal cannula) 
at 1 h after detubation. From these arterial blood samples, oxygen saturation, acidity 
(pH), partial oxygen pressure (p0 2), partial carbon dioxide pressure (pC0 2), base excess, 
and bicarbonate concentration (HC0 3) were determined.
Post-operative protocol
Early oral intake (within 4 h) and mobilization were encouraged, and patients were 
eligible for discharge as soon as they felt well enough. Standard practice was to keep all
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patients at least one night; some, because of limitations in their home environment, 
for example, stayed longer. In effect, many patients elected to leave the hospital on the 
afternoon of the first or second post-operative day. Shortly before discharge, wound 
dressings were removed for wound inspection, and the type of operation was revealed. 
Follow-up took place after 2 weeks, 6 weeks, and 3 months, according to a standardized 
scheme.
Sample size
To avoid post hoc analyses, multiple outcome measures were defined for evaluation in 
this trial. Analysis of cost aspects was used to determine the power and sample size of 
the study as a whole. On this basis, we estimated that 120 patients per group would be 
needed to detect a difference of 10% in direct costs with a  = 0.05 and b = 0.9.
No interim analysis was planned, but a monitoring committee was tasked to terminate 
inclusion if a substantial difference in mortality and complication rate occurred. They 
were supplied with information on request and this was performed once during the 
study.
Statistics
The administration and collection of data were based on a patient-linked trial registra­
tion number to guarantee the patients’ privacy and to facilitate a blind evaluation. 
An Access® database was set up for collection and analysis of data. Calculations were 
made using SPSS 11.0® (SPSS Inc., Chicago, IL).
Principal comparisons were made on an intend-to-treat basis. In the main comparison, 
the pulmonary function parameters of all LCs were compared with those of all SICs. 
Three subgroup analyses followed. In the first, successful LCs were compared with 
successful SICs, in order to evaluate differences in per protocol treatments. In the 
second subgroup, all successful cholecystectomies were compared with all converted 
cholecystectomies, regardless of randomization, to demonstrate a difference between 
per protocol and converted procedures. Finally, the third subgroup compared conver­
ted LCs with converted SICs, in order to demonstrate any superiority of LC, even when 
converted. The second subgroup was also used to validate the sensitivity of the pul­
monary function test.
Results of normally distributed, continuous data are presented as means with their 
standard deviations (SDs) in parentheses, or as medians with ranges in the case of a 
non-Gaussian distribution.The normality of the data was checked usingthe Kolmogorov- 
Smirnov test. Levene’s test was used to check the equality of variances. When the con­
dition of normality and equal variances was met, the t-test was used for independent
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data. When the equality of variances or normality was absent, the non-para metric 
Mann-Whitney U-test was used for independent data.The repeated measures analysis 
of variance (ANOVA) test was used to analyse the pulm onary function test results, 
as well as the arterial blood gas analyses, as these measurements were performed 
repeatedly in time. For dichotomous outcomes, the chi-squared test was used.
Figure i: Revised consort statement diagram showing the f lo w  o f  participants through each stage o f  our randomised trial [34]. 
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RESULTS
All trial patients were included and operated on between January 2001 and March 2004. 
During this period, 366 patients visiting our outpatient clinic for symptomatic chole- 
cystolithiasis fulfilled the inclusion criteria, gave informed consent, and were initially 
included in the trial. One hundred and two patients did not reach randomization for a 
variety of reasons (Figure 1). Of the remaining 264 patients, seven patients were excluded 
after randomization: unwilling to continue in the trial (n = 2), intra-operative suspicion 
of malignancy (n = 2), transfer to a nonsurgical ward (n = 1), inadvertent participation 
in multiple trials (n = 1), and inadequate Dutch language skills (n = i).Two hundred and 
fifty-seven patients were left for analysis (LC, n = 120; SIC, n = 137; Figure 1).
The groups were similar with regard to age, sex, body mass index (BMI) and ASA classi­
fication (Table 1).
A number of anaesthesiological complications occurred in the direct peri-operative 
period. In the LC group, one patient became asystolic during insufflation of the pneu­
moperitoneum and one patient had a limited cerebrovascular accident (thrombotic) in 
recovery. In the SIC group, one patient developed positive cardiac enzymes compatible 
with ischaemia. During the post-operative period, three patients in the LC group deve­
loped phlebitis and one developed pneumonia. Although no mortalities occurred during 
the study, 21 (18%) and 16 (12%) complications occurred in the LC and SIC groups, respec­
tively. The majority (16 and 13, respectively) occurred post-operatively on an incidental
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision 
Cholecystectomy 
(n =137)
Statistical
analysis
Male 31 (26%) 30 (22%) ns
Female 89 (74%) 107(78% )
Age
mean (SD) 48.4(14.1) 48.5 (i4 -o) ns
median (range) 49 (18-77) 48 (18-80)
Body mass index
mean (SD) 27-5 (4 -8) 27.9 (4.6) ns
median (range) 26.8 (27.4) 27.2 (25.2)
ASA classification
1 81 (68%) 91 (66%) ns
II 39 (32%) 46 (34%)
Table 1: Patient characteristics.
ASA, Am erican Society o f  Anaesthesiologists; ns, n o t significant; SD, standard deviation.
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basis. Actual skin-to-skin time varied from 72 min (SD, 26 min) to 60 min (SD, 18 min) 
(P < 0.001) for LC and SIC, respectively, with total anaesthesia also being shorter for the 
SIC group. Conversion rates were 12% and 16%, respectively.The hospital stay was not 
significantly different (LC, 2.4 days (SD, 4.6 days); SIC, 3.1 days (SD, 12.4 days); P = 0.560). 
The consumption of analgesics and muscle relaxants was equal and unremarkable.
The mean pulmonary function test results for the three consecutive measurements are 
listed in Table 2. In both groups, an overall 20% post-operative reduction in pulmonary
Parameter Laparoscopic
Cholecystectomy
(n=ic>3)
Small-incision
Cholecystectomy
(n=ii8)
Statistical
analysis
VCmix (%) preop 105,0 (14,0) 105,9 (15,0)
postop 82,7 (l8,l) 81,0 (19,4) ns
fo llo w -u p 105,5 (14.5) 106,3 (15,4)
FEV, (%) preop 103,2(15,0) 103,7(16,2)
postop 80,9 (19,1) 79,8 (19,9) ns
fo llo w -u p 102,2 (15,4) 103,4 (16,6)
FVC (%) preop 106,2 (14,6) 107,0 (15,5)
postop 83,6(19,8) 81,8 (20,6) ns
fo llo w -u p 106,0 (15,0) 107,5 (15,9)
f e f25 (%) preop 101,1 (21,6) 100,4(24,9)
postop 77,6 (23,2) 77,5 (22,4) ns
fo llo w -u p 101 (22,6) 98,1 (24,5)
FEF5o(%) preop 86,4(25,8) 86,6 (27,1)
postop 67,7 (23,4) 67,3 (23,5) ns
fo llo w -u p 84,8 (25,8) 84,4(26,9)
fe f75(%) preop 75,1 (30,1) 77,5 (30,0)
postop 55,6 (25,4) 57,8 (24,0) ns
fo llo w -u p 70,0 (29,5) 73,3 (30,2)
PEF (%) preop 103,1 (16,9) 105,2 (18,5)
postop 76,1 (21,4) 76,0 (20,8) ns
fo llo w -u p 104,1 (l8,4) 104,8 (19,3)
FIVi (L) preop 3,50 (0,91) 3,52 (0,97)
postop 2,57 (0,85) 2,45 (0,73) ns
fo llo w -u p 3,59 (0,88) 3,55 (0,95)
Table 2: Overview o f  pulm onary function results comparing laparoscopic cholecystectomy (LC) and small-incision cholecystectomy 
(SIC) patients. Results are presented as means (with standard deviation) o f  percentages o f  individual predictive values.
VCmax: m axim al vital capacity; FEV : fo rced  expiratory volum e in  7 second; FVC:forced vital capacity; FEE25, FEFso, FEF75: 
m axim um  expiratory f lo w  w hen 25%, 50% and  75% o f  the FVC has been exhaled; PEF: peak expiratory flo w ; FI Vi: fo rced  
inspiratory volum e in 1 second; ns: no t significant.
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function was documented, as well as complete return to baseline at the 6-week 
follow-up. Statistical analysis (ANOVA) of these data showed no significant differences 
between the two groups for any of the eight parameters. The results are shown as a 
percentage of the predicted test result for the individual patient (FIVi in litres).
Blood gas data are presented in Table 3. Although there are statistically significant 
differences between the two techniques for the parameters p0 2, pC0 2, and pH, these 
had no influence on discharge from recovery. p 0 2 was slightly lower in both groups, 
both in recovery (11.4 vs. 12.0 kPa for the LC and SIC groups, respectively) and on the first 
post-operative day (11.5 vs. 10.8 kPa, respectively), despite supplemental oxygen during 
the first hour of recovery in all patients.This p 0 2 decrease was, interestingly, largest in 
the LC group. pC0 2 was higher in the recovery measurement for both groups, with a 
slightly larger increase in the SIC group (5.9 vs. 6.1 kPa), and a concomitant change in pH. 
No significant difference was found between the two groups in the time of stay in 
recovery (LC, 85 min (SD, 19 min); SIC, 85 min (SD, 17 min)).
Parameter Laparoscopic
Cholecystectomy
(n=93)
Small-lncision
Cholecystectomy
(n=i26)
Statistical
analysis
p0 2 (kPa) preop 12.5 (2.9 ) 12,8 (3,6)
recovery 11.4(2,1) 12,0 (3,6) p=0,025
postop 11.5 (2,4) 10,8 (2,2)
pCOï (kPa) preop 5.3 (o.5) 5.3 (0,5)
recovery 5.9 (o,7) 6,1 (0,6) p=0,042
postop 5.2 (0,5) 5.2 (0,5)
0 2 Saturation (%) preop 96 ,9  (4 .4 ) 97,2 (1,9)
recovery 96,1 (i,8) 95.8 (2,8) ns
postop 96,8 (2,2) 9 6 ,4 (3 .6 )
pH preop 7,41 (0.02) 7,41 (0,02)
recovery 7,34 (0,04) 7,33 (0,03) p=0,032
postop 7,41 (0.02) 7,41 (0,02)
Bicarbonate preop 24.9 (1.9) 24,9 (2,0)
(mmol/L) recovery 23.0 (2,0) 23,3 (2,0) ns
postop 24.1 (2,1) 24,4 (2,0)
Base excess preop 0,7 (1,7) 0,8 0,8)
(mmol/L) recovery -2,4 (1.9) -2,3 (1,8) ns
postop -0,1 (1,7) 0,3 (1,8)
Table y. Overview o f  blood gas analyses results com paring laparoscopic cholecystectom y (LC) and sm all-incision cholecystec­
tom y (SIC) patients. Results are presented as means (with standard deviations) o f  percentages o f  individual predictive values.
ns: n o t significant; p 02: partial oxygen pressure; pC02: pa rtia l carbon dioxide pressure; 
02saturation: oxygen saturation; pH: acidity.
146 Chapter 9
Subgroup analysis comparison of the two groups, with exclusion of data from all con­
verted cases from both groups, showed a comparable decrease in pulmonary function 
without clinical or significant differences.
The second subgroup analysis compared all successful procedures with all converted 
procedures. Analysis showed that there were significant differences in six of the eight 
parameters (Table 4). Conversion of either technique resulted in an average decrease 
in pulmonary function parameters of about 30%. Although not significantly different, 
the parameters FEF75 and FIVi showed the same tendency.
Parameter Not converted 
(n=i8g)
Converted
(n=32)
Statistical
analysis
VCmix (%) preop 105,8 (14,7) 103,7(13.5)
postop 83,0 (18,9) 74.1 (19.8) p=0,012
fo llo w -u p 106,0 (15,0) 105,2 (14.4)
FEV, (%) preop 103,6(15,6) 102,6 (15,6)
postop 8l,6 (l9,l) 72,7 (20,5) p=o,oi6
fo llo w -u p 102,9 0 6 ,4) 102,6 (13,7)
FVC (%) preop 106,9 05.2) 105,2 (14,4)
postop 84,0 (20,0) 74.4(19.8) p=o,oo7
fo llo w -u p 106,9 05 .8) 106,4(13,9)
f e f25 (%) preop 100,9 (23.7) 99.4(21,4)
postop 79,1 (23,0) 68,2 (18,6) p=0,046
fo llo w -u p 100,0 (24,3) 96,3 (19.0)
FEF5o(%) preop 86,5 (26,6) 86,7 (26,4)
postop 69,1 (23,6) 57,7 0 9 ,8) p=o,oi8
fo llo w -u p 85 (27,0) 81,9 (22,5)
fe f75(%) preop 76,8 (30,3) 73,8 (28,2)
postop 58,3 (24.3) 47,6 (25,0) ns
fo llo w -u p 72,6 (29,5) 66,8 (32,1)
PEF (%) preop 104,3 (18,0) 103,7(16,5)
postop 77,3 (21,0) 68,1 (19,8) p=o,045
fo llo w -u p 104,7 (19,3) 103,2 (l6,0)
FIVi (L) preop 3,54 (0,96) 3,3 4 (o,8i)
postop 2,55 (0,81) 2,20 (0,59) ns
fo llo w -u p 3.59 (0,94) 3,4 4 (o,8o)
Table 4: Overview o f  pulm onary fu nctio n results comparing converted and non-converted patients. 
Results are presented as means (with standard deviation) o f  percentages o f  individual predictive values.
VCmax: m axim al vital capacity; FEV : fo rced  expiratory volum e in  7 second; FVC:fo rced  vital capacity; FEF25, FEFso, FEF75: 
m axim um  expiratory f lo w  w hen  25%, 50% and  75% o f  the FVC has been exhaled; PEF: peak expiratory flo w ; FI V :fo rced  
inspiratory volum e in 1 second; ns: no t significant.
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In the third subgroup analysis, involving 14 and 22 patients from the LC and SIC groups, 
respectively, no significant differences between any of the eight pulmonary function 
parameters were found, with a slightly larger decrease in the SIC group.
The amounts of analgesics used per patient (VAS >4) during the post-operative period 
up to discharge, as well as the number of violations in the analgesic protocol, are reported 
in Table 5a, sb.The number of potential violations was calculated based on the number 
of VAS measurements for each patient during the total post-operative period. Pain was 
regulated carefully in our hospital via the use of a nurse-driven acute pain service. Whilst 
in recovery, the SIC group consumed significantly more morphine per patient than the 
LC group, but the consumption was similar in the two groups once on the ward.
Laparoscopic
Cholecystectomy
Small-lncision
Cholecystectomy
Statistical
analysis
Analgesic consumption
Visua 1 Ana logue Score 
available for analysis 105/120 (87%) 126/137 (92%)
sum (mg) Mean consumption 
per patient (mg)
sum (mg) Mean consumption 
per patient (mg)
pethidine 3716 35 4634 37 ns
diclofenac 8200 78 10700 85 ns
morphine 433 4 1010 8 p<o,ooi
Table 5a: Overview o f analgesic use in the recovery room.
Laparoscopic
Cholecystectomy
Small-lncision
Cholecystectomy
Violations
N um bero f violation opportunities: 856 1097
tim es committed: tim es committed:
No pain medication w ith VAS>4 35 (4.1%) 76 (6,9%)
Pain medication w ith VAS<4 9 0.1%) 5 (0,5%)
Table 5 b: Overview o f  violations o f  the protocol.
ns: no t significant; VAS: visual analogue scale score.
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DISCUSSION
The acceptance of LC as the technique of choice appears to have little foundation. Our study 
was set up to specifically evaluate the arguments used for this preference. It included pul­
monary function changes after open upper abdominal surgery, and the suggestion that 
optimal pain management at the same time would further decrease pulmonary function.
Using a prospective, randomized methodology, 257 patients were analysed in an LC vs. 
SIC trial to determine the impact of these techniques on selected pulmonary function 
tests and arterial blood gas measurements.
Our findings of a comparable clinical outcome for LC and SIC are in line with other data 
[29]. We also found pulmonary dysfunction in the immediate postoperative period and 
an increased consumption of morphine in the SIC group during the post-operative 
period. However, this increased consumption seemed to have no clinical consequences 
and produced no measurable differences in pulmonary function tests orarterial blood 
gas analyses, although other studies have reported different results [14-20].
In some earlier clinical studies comparing LC and SIC, the methodology as well as the 
choice of the parameters evaluated may have skewed the results [29-32]. In order to 
avoid subtle opportunities for bias, strict standardization of anaesthesia management, 
analgesic use, and peri-operative care must be guaranteed by the protocol. Single-centre 
trials have a natural advantage in the standardization of treatment. Our study has 
addressed a num berofthese limitations, whilst focusing on anaesthesia and pulmonary 
function. Pulmonary aspects are deemed to be an important clinical reason why many 
anaesthesiologists prefer a laparoscopic technique over an open technique [14-16,18-20].
In the trials reported to date, only two or three pulmonary function parameters were 
selected. Arguments supporting this selection were absent [14-16,18-20]. Moreover, three 
trials suggested the superiority of a specific procedure on the basis of a difference in only 
one [15,19] or two [14] pulmonary function parameters.Three trials incorporated sample 
sizes of less than 15 patients perarm [14,18,19], and only one trial used a blind approach 
[18]. Details on peri-operative anaesthesia management were not provided in five trials 
[14-16,18,19]. One larger trial, with 64 patients in each group, found that the laparoscopic 
technique was superior, and included pulmonary function testing and analgesic use. 
However, this multicentre trial did not attempt to blind patients or physicians, details 
on anaesthesia management were not provided, and an incision of 10 cm was consi­
dered as small, ignoring the more acceptable 8-cm limitation [16]. Harju et al. [20] 
evaluated pulmonary function in only a proportion of their included patients, and found 
no difference between LC and SIC.
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Impairment in pulm onary function was found post-operatively with no differences 
between the two groups.This impairment increased markedly from 20% to 30% in the 
converted operations for both groups, indicating that measurements by flow-volume 
curves are a valid tool to detect differences in pulmonary function. Considering the 
diversity in the literature, it is not clear w hether a single pulm onary function test 
parameter can be designated as the most appropriate for identifying pulmonary dys­
function following upper abdominal surgery. A reduction in FEF has been suggested by 
some authors to be effort-independent, unlike VC, PEF, and FIV. Our results do not 
support this suggestion, as the actual changes between pre-and post-operative mea­
surements were similar for the parameters V C m a x , FEV, PEF, and the FEF series [33].The 
suggestion that muscular damage and resultant pain should be designated as the 
factors limiting pulmonary function could also not be substantiated [11-13,28]. We noted 
with interest that a lower p0 2 was found in the LC group despite the lower opioid intake 
in this group. Although more pain medication was given to the SIC group, this was only 
in the immediate post-operative period and had no apparent clinical significance (Table 
5A).This difference in consumption did not impact on the eligibility for discharge from 
recovery or hospital. Although daycare surgery is now general practice, at the time of the 
trial in our hospital it was not, and all patients stayed overnight. Although not an end­
point, and in recognition that this type of surgery is increasingly being performed as 
day-care surgery, based on the lack of a difference in recovery stay, we propose that, 
using the Aldrete score, and with the general requirement that patients be adequately 
responsive before leaving recovery, opioid consumption should not limit early discharge. 
For discharge eligibility in day surgery in our hospital, patients must have consumed 
fluids and a light meal, as well as be pain free, adequately responsive, and self-suppor­
ting. No patient is allowed to leave the hospital unaccompanied.
With the increased interest in day-care techniques, the relevance of rapid and safe 
surgical procedures is on the rise. A significantly shorter operative time was found in SIC. 
Theoretically, with increasing experience, this operative time could be reduced further, 
impacting on the duration of anaesthesia and allowing ample time for discharge without 
an overnight stay.
The one case of pneumonia should be considered a coincidence. Our findings suggest 
that there are no clinically relevant differences in pulmonary function following LC and 
SIC. As pulmonary function was measured on the first day and 6 weeks post-operatively, 
differences between the two techniques might have been missed during the first 2 
weeks post-operatively. Future research should focus on this recovery period.
Our findings should be generally applicable in general surgical practice.The SIC procedure 
was associated with a shorter total anaesthesia time, no increase in complication rates,
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and no increase in the length of hospital stay. However, ASA III and IV patients were not 
included in the study. In these specific populations, the clinically unimportant pulmo­
nary function changes observed may have a much larger impact.The C0 2 burden in LC, 
requiring greater ventilation, in combination with decreased cardiac output, may also 
be relevant in ASA III and IV patients. Moreover, the anaesthetic management of SIC 
seems to be straightforward, and involves a decrease in some peri-operative risks attri­
buted to the pneumoperitoneum.
Our acute pain service quickly recognized that, with good immediate post-operative 
pain management, the consumption of medication was low, raising the question of the 
need for PCA techniques for this procedure. In our study, we were unable to differen­
tiate between the mechanisms suggested to limit pulmonary function (i.e.splintingor 
diaphragmatic dysfunction). Further research is needed in ASA III and IV patients to 
quantify pulmonary function changes.
CONCLUSION
Our study concurs with historical data, demonstrating a temporary decrease in pul­
monary function in all forms of upper abdominal surgery, laparoscopic or open. This 
study demonstrates that SIC is comparable with LC in terms of the decrease in pulmo­
nary function and blood gas analysis. Although initial analgesic consumption was higher 
in the SIC group, this did not impact on the time to discharge from recovery or the uti­
lization of analgesia on the ward. Our study suggests that, from an anaesthesiological 
approach to peri-operative management, pulmonary and analgesicarguments indicate 
that these techniques are interchangeable when performed in an ASA I and II population.
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ABSTRACT
Background
Gallstones are a major cause of morbidity, and cholecystectomy is a commonly perfor­
med procedure. Minimal invasive procedures, laparoscopic cholecystectomy (LC) and 
small-incision cholecystectomy (SIC), have replaced the classical open cholecystectomy. 
No differences have been found in primary outcome measures between LC and SIC, 
therefore secondary outcome measures have to be considered to determine preferences. 
The aim of our study was to examine health status applying evidence-based guidelines 
in LC and SIC in a randomised trial.
Methods
Patients with symptomatic cholecystolithiasis were included in a blind randomised trial. 
Operative procedures, anaesthesia, analgesics, and postoperative care were standardised 
in order to limit bias. Questionnaires were filled in preoperatively, the first day post- 
operatively, and at outpatients follow-up at 2, 6, and 12 weeks. In accordance with 
evidence-based guidelines, the generic short form (SF-36) and the disease-specific gast­
rointestinal quality of life index (GIOLI) questionnaires were used in addition to the 
body image questionnaire (BIO).
Results
A total of 257 patients were randomised between LC (120) and SIC (137). Analyses were 
performed according to intention-to-treat (converted procedures included) and also 
distinguishing converted from minimal invasive (nonconverted) procedures. Question­
naires were obtained with a response rate varying from 87.5% preoperatively to 77.4% 
three months postoperatively. Except for two time-specific measurements in one 
SF-36 subscale, there were no differences between LC and SIC. There were significant 
differences in several subscales in all three questionnaires comparing minimal invasive 
versus converted procedures.
Conclusions
Applying adequate methodological quality and evidence-based guidelines (by using 
SF-36 and GIOLI), there are no significant differences in health status between LC and SIC.
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BACKGROUND
Cholecystectomy is a commonly performed procedure in patients with symptomatic 
cholecystolithiasis. With an estimated incidence up to 2.17 per thousand inhabitants 
[1, 2], and 500,000 cholecystectomies performed annually in the USA [3] and 21,000 in 
The Netherlands (an incidence of 1.31 per thousand inhabitants) [4, 5], gallstones are a 
major cause of morbidity in the Western world. During the 1980s, the preferred surgical 
technique for cholecystectomy changed from the classical open procedure to a smaller 
incision approach [6, 7] and eventually to laparoscopic cholecystectomy. Although 
evidence of superiority was never delivered, the laparoscopic technique was accepted 
as the gold-standard procedure by consensus [3].
Multiple randomised trials comparing laparoscopic (LC) and small-incision cholecys­
tectomy (SIC) have been performed and results are inconsistent. Some favour the SIC 
technique, others favour the LC technique, and many take a neutral position. All these 
randomised trials are included in our Cochrane review. Our review showed no differences 
in primary outcome measures between LC and SIC [8].
In comparing (surgical) treatments, primary outcome measures (mortality and severe 
complications) have to be considered prior to secondary outcome measures. As no sig­
nificant differences between LC and SIC in primary outcome measures were found [8], 
it is justified to consider health status, an im portant secondary outcome measure. 
Frequently, quality of life is confused with health status. Quality of life measures the 
subjective judgm ent of patients about their condition, while health status refers to the 
impact of disease on patients’ lives in the physical, psychological, and social domains.
Questionnaires, both generic and condition-specific, have been shown to be useful in 
measuringchanges in health status after cholecystectomy [9-11]. Several studies showed 
that health status was improved, both after LC and open cholecystectomy in patients 
suffering socially disabling uncomplicated symptomatic cholecystolithiasis [12-14]. 
Differences between the open and laparoscopic technique are not clear [15], although 
some studies found superior results using the laparoscopic technique [16,17].
To date, differences in health status between LC and SIC are not very well examined [18- 
20].Moreover, as the previous studies did not use the appropriate questionnaires as ad­
vised by evidence-based guidelines, there had been no possibility to correctly find 
differences in health status between both operating techniques.
The gastrointestinal quality of life index (GIOLI) and the short form (SF-36) are frequently 
used and validated questionnaires (disease-specific and generic, respectively) and are
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most suitable for evaluating patients’ functional recovery after cholecystectomy [21].
Objective
The aim of our study was to examine differences in health status in patients with 
symptomatic cholecystolithiasis before and after LC and SIC in a blinded randomised 
clinical trial. We used the GIOLI and the SF-36 questionnaires, as recommended by 
evidence-based guidelines [21].
METHODS
All patients with symptomatic cholecystolithiasis visiting the outpatients clinic of the 
St. Elisabeth hospital in Tilburg were considered for inclusion in a blind randomised trial 
comparing laparoscopic and small-incision cholecystectomy.Verbal and written informed 
consent was obtained from each patient, and patients were consecutively listed for elec­
tive cholecystectomy. Health status was a secondary outcome measure as part of the 
randomised clinical trial.
Sample size
No differences in primary outcome measures (mortality and complications) were 
expected between LC and SIC [8]. Consequently, a secondary outcome measure should 
be used to decide on preferences between both techniques. We decided to focus on 
costs between both techniques as the most important secondary outcome measure. 
Based on an anticipated difference of 10% in direct costs 120 patients had to be inclu­
ded in each group. However, multiple outcome measures including health status were 
evaluated in this randomised trial.
Based on a previous study [18], it was calculated that 128 patients were needed in each 
group to detect a difference of 5 points (assuming a standard deviation of 20) in the 
gastrointestinal quality-of-life index (GIOLI) questionnaire with a type I error of 0.05 
and a power of 0.8.
Randomisation
As randomised trials with high bias risk may overestimate intervention effects [22], 
results of randomised trials with low bias risk are considered more reliable.Therefore, 
attention is warranted for correct generation of the allocation sequence, allocation con­
cealment, blinding, and follow-up.
A random-number table was used for the generation of the allocation sequence and 
allocation concealment was guaranteed by using sealed envelopes. To eliminate bias
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caused by preoperative expectations, patients were randomised in the operation theatre 
after induction of anaesthesia. A telephone call to the secretary office was made and an 
employee opened an envelope. All patient data were recorded in a case record form, 
with the procedure reported as ‘trial cholecystectomy’. Wounds and port sites were 
dressed with identical opaque dressings, stained using iodine, regardless of the surgical 
procedure performed, to allow blinding for patient, nurses, and physicians during the 
postoperative period. The type of operation was revealed just before discharge.
No patients were lost to follow-up. Operative procedures were standardised apart from 
using a laparoscopic or small-incision technique. Anaesthesia, postoperative care, and 
analgesic use were also standardised.
Inclusion and exclusion criteria
Inclusion criteria were: male or female patients with symptomatic cholecystolithiasis, 
age 18 years or older at recruitment, with reasonable to good health according to 
American Society of Anaesthesiologists (ASA) classification (ASA I or II) [23], no known 
relevant allergies, and a signed letter of informed consent.
Exclusion criteria were: age younger than 18 years, choledocholithiasis (icterus, acholic 
faeces, and/or bilirubine twice normal range), cholangitis, known pregnancy, moderate 
to severe systemic disease (ASA III and higher), known cirrhosis of the liver, history of 
abdominal malignancy, previous upper abdominal surgery (precluding laparoscopic 
approach), psychiatric disease, or another reason (e.g. lack of knowledge of the Dutch 
language) for making follow-up or completion of questionnaires unreliable.
Obesity was indexed but not considered an exclusion criterion [24]. Recovery after 
successful endoscopic treatment of choledocholithiasis was not a contraindication. 
Acute cholecystitis is a different disease with other complication rates, morbidity, and 
conversion rates, and patients suffering acute cholecystitis were, therefore, not included.
Surgical procedures
The policy in our hospital was not to perform operative cholangiography in any patient 
in elective cholecystectomy. All patients had nasogastric intubations during the opera­
tion that were removed immediately afterwards. Bladder drainage was not performed. 
Abdominal wall and skin closure were standardised. In case of technical difficulties or 
for safety reasons, both laparoscopic and small-incision cholecystectomies were con­
verted to open cholecystectomy by a subcostal incision (>8 cm). Reasons for conversion 
were registered.The wounds were covered with standard wound dressings as described 
by Majeed [24] to blind patient and ward personnel postoperatively.We did not use any 
local anaesthetic technique into the wounds nor intercostal nerve blocks.
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Laparoscopic cholecystectomy
Open introduction of trocars was performed in all patients, regardless of previous 
abdominal surgery. Pneumoperitoneum was created usingthe subumbilical trocar with 
an intra-abdominal pressure up to 12 mmHg.Three trocars for instruments were inserted. 
The dissection of the cystic artery and cystic duct, identifying Calot’s triangle, was per­
formed using a three-point‘flag’ technique [25]. The cystic duct and artery were clipped 
and transsected. After complete dissection of the gallbladder, it was removed either 
through the subumbilical or the subxyphoidal trocar. Fascia defects as a result of the 
insertion of 10mm trocar and the open introduction of the subumbilical trocar were 
closed with UR6 vicryl 1.0/2.0® sutures. All instruments, except for the subumbilical 
trocar, were reusable. No suction drains were left in the subhepatic space at the end of 
the procedure.
Small-incision cholecystectomy
In the literature most authors used 8 cm (or less) as a cut-off point to differentiate 
between small-incision and open cholecystectomy [24,26-32].Therefore, we performed 
small-incision cholecystectomy principally through an incision of 6 cm, m axim ally 
extended to 8 cm. As part of a separate research question, all patients had a preoperative 
ultrasound scan and the location of the fundus of the gallbladder was marked on the 
skin. We used the craniocaudal position of the mark for incision. The mediolateral 
position of the mark was not used, because in the pilot phase we found that the inci­
sion would be too lateral for adequate view of the hilus. The incision was placed over the 
musculus rectus abdominis. Only standard instruments were used and no special equip­
ment. Access to the peritoneum was obtained by a muscle splitting (and not transsec­
tion) technique of the musculus rectus abdominis (like in an open appendectomy). The 
gallbladder was dissected by a fundus-first technique. If necessary the gallbladder was 
punctured to remove its liquid contents. The cystic duct and artery were ligated and 
the gallbladder was removed. No suction drains were left in the subhepatic space at 
the end of the procedure. Posterior and anterior fascias were closed separately with 
PDS 3.0® runningsuture.Afterwound closure, the length of the incision was measured. 
When the length exceeded 8 cm, the operation was considered to be a conversion to 
open cholecystectomy.
Postoperative protocol
Early oral intake and mobilization were encouraged. Patients left the hospital as soon 
as they felt capable. As patients were admitted at the day of operation, hospital stay was 
defined as the number of nights (postoperative) in hospital. Shortly before discharge, 
wound dressings were removed for wound inspection. For logistic reasons, we were not 
able to blind the surgeon at the patients’ follow-up. Follow-up took place according to 
a standardised scheme after 2 weeks, 6 weeks, and 3 months. Patients were encouraged
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to resume work and normal daily activity as soon as they felt capable to do so.
Measurements
In accordance with evidence-based guidelines [21], we decided to use the generic short 
form (SF-36) and the disease-specific gastrointestinal quality-of-life index (GIOLI) ques­
tionnaires. These questionnaires were completed preoperatively, on the first day post­
operative, and at each follow-up visit after 2 and 6 weeks and after 3 months. In addition, 
the body image questionnaire (BIO) was completed preoperatively and at 6 weeks post- 
operatively in order to estimate differences in the patients’ perception of their body 
image and cosmetics [33].
The SF-36 is a generic health status questionnaire that has 36 questions to assess eight 
domains (physical functioning, role physical, bodily pain, general health, vitality, social 
functioning, role emotional,and mental health) [34]. Internal consistency measured by 
Cronbach’s alpha was shown to be high (above 0.80 in all subscales) [34]. The Dutch 
version has been validated [35].
The GIOLI is a disease-specific health status measure. It includes both specific ques­
tions on gastrointestinal symptoms, for both the upper and the lower gastrointestinal 
tract, as well as questions on physical, emotional, and social capabilities [36]. It is a 
mixed questionnaire that includes both generic and specific questions. Based on face 
validity, five subscales are distinguished in addition to a total score. Internal consistency 
measured by Cronbach’s alpha was shown to be high (above 0.90 in all subscales) [36]. 
The Dutch version has been validated [37].
The body image questionnaire (BIO) consists of nine questions evaluating three sub­
scales: body image, cosmetic, and self-confidence.The BIO has shown to consist of two 
factors, a body image and a cosmetic factor [33]. The body image scale measures 
patients’ perception of and satisfaction with their own body and explores patients’ 
attitudes toward their bodily appearance. The cosmetic scale assesses the degree of 
satisfaction of patients with respect to the physical appearance of the scar. Additio­
nally, a question is added to assess patients’ self-confidence before and after surgery. 
Internal validity (measured by Crohnbach’s alpha) reliability coefficients were shown 
to be high for both the body image (0.80) and cosmetic scales (0.83) [33].
Statistical analysis
Analyses were performed according to the type of operative procedure used, based on 
the intention-to-treat principle. Apart from this main analysis, one subgroup analysis 
was performed:converted procedures (LC and SIC) were compared with minimal invasive 
procedures (LC and SIC).This subgroup analysis was performed in order to illustrate the
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sensitivity of the questionnaires. Calculations were made using SPSS version 11.0®.
Repeated measures analysis of variance (ANOVA) was used to evaluate health status 
differences over time between the two operative techniques.
Additional independent t-tests were performed to test for time-specific differences in 
scores at the preoperative measurements between two groups in order to check for a 
correct randomisation procedure. If appropriate, additional independent t-tests were 
performed to test for other time-specific differences in measurements.
Figure i: Revised consort statement diagram showing the f lo w  o f  participants through each stage o f  the random ised trial [38].
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RESULTS
All trial patients were included and operated between January 2001 and March 2004. 
Leaving unwilling and excluded patients out of consideration, 366 patients initially fu l­
filled the inclusion criteria and were initially included in the trial. A total of 102 patients 
were not randomised fora variety of reasons (Figure 1). After randomizing 264 patients, 
another seven patients were excluded (after their cholecystectomy) for the following 
reasons: unwillingness for further participation in the trial (2), intraoperative suspicion 
of malignancy (2), transfer to another ward not participating in the trial (1), participa­
tion in two trials (not in line with the Helsinki declaration) (1), and insufficient know­
ledge of the Dutch language (1). Excluding the data of these seven patients from our 
analyses did not affect the results of our questionnaires in any way. A total of 257 
patients were left for analysis (LC:i20 and SIC:i37).
Baseline characteristics and operative results
The groups (LC and SIC) did not differ regarding age, sex, body mass index (BMI) and 
ASA classification (Table i).The classical diagnostic symptoms of cholecystolithiasis as 
well as the duration of these symptoms were also equally distributed in both groups. 
In addition,the num berof patients presenting with complicated gallstonediseasew ho 
had received treatment by endoscopic retrograde cholangiopancreaticography (ERCP) 
(and papillotomy) were equally distributed and operated on in a later stage (Table 2).
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision
Cholecystectomy
(n=i37)
P value
Male 31 (25.8%) 30 (21.9%) 0.46
Female 89 (74-2%) 107(78.1%)
Age
mean (SD) 48.4(14.1) 48.5 ( i4 -o) 0.97
median (range) 49  (17-77) 48 (18-80)
BMI
mean (SD) 27-5 (4 -8) 27.9 (4.6) 0.50
median (range) 26.8 (18.5-45.9) 27,2(18.0-43.3)
ASA classification
1 81 (67.5%) 9I (66.4%) 0.85
II 39 (32.5%) 46 (33.6%)
Table 1: Patient characteristics.
BMI: body mass index; ASA: Am erican Society o f  Anaesthesiologists.
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There was no mortality. There were five intraoperative complications in the LC group 
compared with three in the SIC group.There were 16 postoperative complications in the 
LC group and 13 in the SIC group.There were 21 and 16 total complications (intra- and 
postoperative) in the LC and SIC group, respectively. Of these, 11 and 7 complications 
were serious in the LC and the SIC group, respectively (Table 3). We did not find a diffe­
rence in the number or severity of the complications.
Operative time was shorter for SIC compared to LC (60 versus 72 min, respectively; 
U = 6013.0, p < 0.001). Conversion rates were similar (p = 0.312), with similar reasons for
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision 
Cholecystectomy 
(n =137)
Statistical
analysis
Patients w ith complicated gallstone
diseases before cholecystectomy 18 18 0.67
Endoscopic retrograde
cholangiopancreaticography 12 13 0.89
Duration o f sym ptom s (weeks): n = i0 7  (89.2%) (1=130 (94.9%) 0.44
mean (SD) 61.1 (108.8) 70.3 (1472)
median (range) 26 (2 -8 8 4 ) 17.5(1-1040)
Incision length (mm)#: N=95 (12 conversions) N =i34 (20 conversions)
mean (SD) 76.1 (33.8) 76.0 (24.0) 0.20
median (range) 65 (40-200) 66 (49-165)
Inflammation 21 25 0.88
Operative team:
surgeon-resident 15 (12.5%) 19 (13-9%) 0.52
resident-surgeon 84(70.0% ) 100 (73.0%) 0.60
resident-resident 21 (17.5%) 18 (13.1%) 0.33
Hospital stay *:
mean (SD) 2 4 (4 .6 ) 3.1 (12.4) 0.56
median (range) 1 o - 36) 2 (1 -144)
Hospital stay * (without 1 extreme value):
mean (SD) 2.1 (3.38) 2.04(2.42) 0.88
Employed (n)
Return to work (weeks):
50 51
mean (SD) 4-1 (2.3) 3-7 (2.0) 0.30
median (range) 4(1-12) 3 (0.5-12)
Table 2: Operative features and difficulties o f  laparoscopic and small-incision cholecystectomy.
Conversions were included in incision length m easurem ents; *h os pita I stay in postoperative nights.
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conversion. The follow-up rate between the groups was not statistically different. 
Follow-up was 91.4-96.3% at six weeks, 82.2-82.8% at three months and 100% at either 
six weeks or three months. Complaints at follow-up were comparable.
There were no differences in the preoperative measurements of the SF-36 subscales, all 
the GIOLI subscales, the total GIOLI score, and the BIO subscales.
Health status
The questionnaires were obtained with a response rate varying from 87.5% preoperatively
Laparoscopic Cholecystectom y 11 Small-incision Cholecystectomy 7
Intraoperative com plications Intraoperative com plications
Asystole 1 Cardiac ischemia, no elevated enzymes 1
Common bile duct (CBD) injury, eventually 
he pat ico-jej u nostomy, com pi icated 
prolonged ICU stay, stenosis bile duct. 1
CBD injury, conversion,T-drain, ERCP
and papillotomy for CBD stone 1
Bleeding requiring conversion (and transfusion) 1 Hepatic parenchyma rupture,
r i ì n c p r w 3 Ì Ì \ / p  ( t r a  n c f i  i c i n n  i
Bowel injury at introduction (sutured) 1
LU 1 1 3C 1 V d L1 VC M C d L IIIC M L   ^L I a 1 1 i  1 U i  1U 1 1 j
Cerebrovascular accident at recovery 1
Total intraoperative 5 Total intraoperative 3
Postoperative complications Postoperative com plications
Pneumonia 1 Cystic duct leakage (ERCP + stent) i
Cerebrova sc u la r accident (6 weeks postoperative) 1 CBD injury, m ultiple relaparotomies and ICU stay i
Intra-abdominal fluid collection 
(haematoma); icterus (ERCP: no stones, 
complicated by bleeding) 1
CBD stone (ERCP) and abscess
intra-abdominal (ultrasound drainage) i
Pa nere at it is (conservative treatm ent) 1 CBD stone w ith pancreatitis (ERCP) i
Intra-abdominal abscess (re-laparoscopy) 1
E pid id im it is (operation by urologist) 1
Total postoperative 6 Total postoperative 4
Table 3: Serious complications in laparoscopic a nd small-incision cholecystectomy (intraoperative and postoperative).
CBD: com m on bile duct; ICU: intensive care unit; ERCP: endoscopic retrograde cholangiopancreatography.
Laparoscopic versus small-incision cholecystectomy: Health status in a blind randomised trial 165
to 77.4% three months postoperatively. The nonresponders did not differ from those 
who remained in the study with regard to complications (16%), operative time (65 
minutes), hospital stay (1.5 days), return to work (3.2 weeks) or baseline scores.
When comparing LC with SIC (intention-to-treat), we found no differences in all SF-36
Preoperative Postoperative 
day 1 2 weeks 6 weeks 12 weeks
P value
SF-36
physical LC 77.0 (23.0) 57-1 (29.5) 67.5 (23.2) 83.2 (21.2) 87-8 (17-4) 0.413
SIC 83.0(18.3) 39-9(29-8) 63.0 (22.8) 83.1 (20.8) 87-5 09-3)
social LC 43-4 (14-2) 77-8 (19.9) 70.7 (23-9) 86.5 09.3) 91-9 05-9) 0.260
SIC 42.7 (17.1) 74-3 (22.6) 66.3 (25.8) 82.3(22.9) 90.4(19-0)
role physical LC 56 .4 (43'4) 52.6 (43-2) 26.7 (36.4) 67.4 (40.1) 81.1 (34-9) 0.667
SIC 60.8 (44.4) 53-0 (45-7) 29-5 (49-4) 54-8 (42.6) 79-2 (35-8)
role emotion LC 73-7 (3 9 4 ) 70.5 (38.8) 68.3 (41.7) 82.7 (33-6) 88.6 (27.8) 0.797
SIC 74-3 (39-7) 70.3 (40.7) 66.4 (54-9) 80.7 (36-5) 88.7 (29.4)
mental LC 6I.7 (11.8) 75-0 (17-1) 77-3 (18.3) 83-3 (16.2) 85.1 (16.6) 0-558
SIC 62.0 (l0.9) 72.1 (18.9) 74-5 (18.7) 81.2 (18.4) 83-4 (17-4 )
vitality LC 54.1 (11.0) 59.6 (22.4) 52.1 (21.1) 67.8 (20.1) 73-5 (20.4) 0.767
SIC 53.8 (12.2) 58.4(22.9) 51.8 (21.6) 66.9 (22.6) 72-7 (21.7)
pain LC 56.5 (19-5) 55.6 (22.5) 52.2 (21.7) 74-7 (20.2) 82.4(21.5) 0.429
SIC 54.6 (17.1) 55-9 (24-6) 46.4(21.9) 69.3 (23.8) 83-1 (21.4)
general health LC 56.1 (11.7) 69-7 (17-3) 71-8 (19.3) 74-9 (22.0) 76.3 (21.2) 0.457
SIC 5 7 4 (11-3) 65.1 (19.2) 70.1 (20.1) 72.5 (21.5) 76.4(19.2)
health change LC 57-7 (21-2) 57-7 (21.2) 62.0 (26.9) 76-7 (23-9) 77-1 (24.4) <0.001*
SIC 55-4 (20.4) 55-4(20.4) 53-5 (27-5) 64.6 (25.1) 71-5 (27-2)
GIOLI
physical LC 2.79 (0.76) 2.82 (0.73) 2-78 (0.75) 3.20 (0.62) 3-31 (o-59) 0.790
SIC 2-95 (o-74) 2.67 (0.83) 2.69 (0.75) 3-14(0-73) 3-30(0.63)
gastrointestinal LC 3-01 (0.59) 3-01 (0.54) 3-22 (0.48) 3.46 (0.41) 3-50 (0.42) 0.247
SIC 3-12(0.58) 3-13 (0-55) 3-22 (0.45) 3.46 (0.46) 3-52(0.40)
social LC 2.89 (O.48) 2.82 (0.42) 2.81 (0.52) 2-93 (0-37) 2-97(0.29) 0.056
SIC 2-90 (0.42) 2-82 (0.43) 2.76 (0.56) 2-85 (0.50) 2-85 (0.38)
mental LC 2-55 (o-55) 2-59 (0-45) 2.88 (0.41) 3-04(0-35) 3-07 (0 -37) 0.561
SIC 2.65 (0.49) 2-58 (0.55) 2.74(0.45) 2-99 (0.47) 3-0 4 (0 -44)
total LC 102.4(17.0) 102.6 (14.8) 108.5 (i5-o) 116.4(11.9) 118.3 (n-7) 0.607
SIC 106.7(14.9) 104.5 (16.0) 107.4(14.0) 116.7(13.2) 1l8.0 (ll.l)
BIO
body image LC 6.42 (1.98) - - 6.03 (1.90) - 0.530
SIC 6.26 (1.89) - - 5-85(1-35) -
cosmetic LC - - - 18.38(3.88) - 0.100
SIC - - - 17-52 (3-55) -
self-confidence LC 6.95 (1.27) - - 7.68 (1.21) - 0.647
SIC 7.02 (1.28) - - 7-49 0-15) _
Table 4: Comparison o f GIOLI, SF-36, and BIO scores in laparoscopic (LC) and small-incision cholecystectomy (SIC) according
to intention-to-treat (mean scores and SD).
* significant difference.
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subscales, except f o r ‘perceived health change’. There were significant differences 
favouring the laparoscopic technique (F = 16.054, df = 1; p < 0.001) (Table 4). Performing 
time-specific analyses, differences were identified at two weeks (p = 0.029) ar|d six 
weeks (p < 0.001) postoperatively.There were no differences between LC and SIC with 
regard to the four GIOLI subscales, the total GIOLI score, and the body image subscales.
Preoperative Postoperative 
day 1 2 weeks 6 weeks 12 weeks
P value
SF-36
physical min-inv 79-9 (21.3) 50.1 (30.9) 67-3 (22.1) 83-5 (21.1) 87-6 (18.9) 0.046*
conv 82.3 (17.5) 31.6 (24.9) 45-5 (22.6) 79-6(19.3) 87-8 (14-6)
social min-inv 43-2 (15-5) 76.7 (21.3) 69.9 (24.1) 85-1 (20.9) 90.9 (18.1) 0.214
conv 41.7(18.3) 70.1 (21.9) 55-1 (29.0) 76.1 (24.7) 93-2 (13-8)
role physical min-inv 60.2 (43.4) 54-0 (4 4 -5) 27-9 (36-3) 61.3 (41-7) 79-9 (35-2) 0.415
conv 46.9 (46.8) 43-1 (43-9 ) 31-0 (87.6) 55-0 (44-1) 81.8 (37.1)
role emotion min-inv 74-9 (39-o) 72.1 (38.8) 67-4(41-5) 82.1 (34-6) 89.3 (28.1) 0.373
conv 66.7 (42.8) 56.5 (45-4) 66.7 (93-7) 76.7 (40.6) 83-3 (32.1)
mental min-inv 61.8 (11.6) 73-8 (179) 76.6 (17.5) 82.7 (16.4) 84-9 (15-9) 0.413
conv 62.6 (9.l) 70.8 (19.5) 69.0 (25.5) 77-1 (24-4) 78.6 (23.8)
vitality min-inv 54.0 (11.9) 59.5 (22.8) 53-1 (21.1) 67-8 (21.4) 73-3 (20.6) 0.180
conv 53.2 (8.8) 55.0 (21.2) 41.6 (21.1) 63-3 (21.6) 71-1 (24-9)
pain min-inv 55.6 (18.4) 56.5 (23-7) 50.4(22.1) 72.5 (22.3) 82.9 (21.7) 0.038*
conv 55-2 (177) 49.6 (22.2) 37-1 (17-4) 65-4(22.4) 81.9 (18.5)
general health min-inv 56.8 (11.4) 68.2 (18.1) 72.0 (19.4) 74-2 (21.3) 76.9 (19.7) 0.136
conv 56.3 (12.4) 59-7 (19-6 ) 61.0 (20.2) 67-8 (25.1) 72.2 (23.3)
health change min-inv 56.8 (20.8) 56.8 (20.8) 58.8 (27.5) 71-7 (24-9) 74-9 (26.3) 0.066
conv 54.2 (20.4) 54-2 (20.4) 46.3 (24-7) 56-3 (24-2) 67-1 (23-6)
GIOLI
physical min-inv 2.90 (0.72) 2.78 (0.76) 2-79 (0.71) 3-19(0-65) 3-33(0-60) 0.007*
conv 2.67 (0.96) 2.4O (O.96) 2.20 (0.87) 2-96 (0.91) 3-10 (0.71)
gastrointestinal min-inv 3-09 (0.57) 3-10 (0.54) 3-23 (0-47) 3-47(0.43) 3-52(0.39) 0.052
conv 2.89 (O.68) 2-89 (0.56) 3-08 (0.37) 3-42 (0.50) 3-46 (0.50)
social min-inv 2.89 (O.46) 2-83 (0.42) 2-83 (0.51) 2-90 (0.43) 2-92(0.35) 0.003*
conv 2.90 (0.35) 2-75 (0 -45) 2-35 (0.62) 2-74 (0.58) 2-85 (0.35)
mental min-inv 2.60 (0.53) 2-58 (0.50) 2-84(0-41) 3-04(0-38) 3-06(0.38) 0.031*
conv 2.63 (0.45) 2.64(0.53) 2-48 (0.57) 2.81 (0.70) 2-96(0.63)
total min-inv 104.9 (l6.0) 104-3 (15-0) 108.9 (14-3) 117-1 (n-5) 118.4 O1-0 ) 0.020*
conv 101.4(17.0) 97-8 (17.8) 98-5 (13-3) 111-2(19-5) 115.8 (14.0)
BIO
body image min-inv 6.31 (i.8o) - - 5-75 0-27) - <0.001*
conv 6.60 (2.78) - - 7-55 (3-04) -
cosmetic min-inv - - - 18-27 (3-54) - <0.001*
conv - - - 14-86 (3.97) -
self-confidence min-inv 7.08 (1.16) - - 7-60 (1.13) - 0.064
conv 6.31 (1.83) _ - 7-38 (1.60) -
Table 5: Comparison o f GIOLI\ SF-36, and BIO scores in m inim al invasive laparoscopic (LC) and small-incision cholecystectomy (SIC) 
procedures versus converted (LC and SIC) procedures (mean scores and SD).
* significant difference; m in-inv: m in im a l invasive procedures (LC and SIC); conv: converted procedures (LC and SIC).
Laparoscopic versus small-incision cholecystectomy: Health status in a blind randomised trial 167
Subgroup analysis
In checking for differences in preoperative data in the minimal invasive procedures versus 
conversions comparison, we only found a significant difference in the self-confidence 
subscale of the body image questionnaire (t = 2.821, df = 207, p = 0.005) with higher 
self-confidence scores in the minimal invasive operated group (7.08 versus 6.31). No 
other differences were found in preoperative data.
In order to assess differences between minimal invasive procedures (both laparoscopic 
and small-incision) and procedures converted to the classical open cholecystectomy, 
we examined patients’ scores across the follow-up period (Table 5).
There were significant differences in the SF-36 subscales‘physical functioning’ (F = 4.057, 
df = i; p = 0.046) and ‘pain’ (F = 4.391, df = 1; p = 0.038). In the GIOLI questionnaire, there 
were significant differences in the total score (F = 5.593, df = 1; p = 0.020), and in the 
‘physical’ (p = 0.007),‘social’ (p = 0.003), ar|d ‘mental’ (p = 0.004) subscales. Also, in the 
BIO there were significant differences in the ‘body im age’ and ‘cosm etic’ subscales 
between both operative groups, favouring the minimal invasive procedures (F = 13.939, 
df = i; p < 0.001). No other differences were found.
DISCUSSION
We have used both generic and disease-specific health status questionnaires and 
a body image questionnaire to evaluate the effect of LC versus SIC in patients having 
cholecystectomy for symptomatic cholecystolithiasis. No differences were found 
between laparoscopic and sm all-incision cholecystectomies (applying intention-to- 
treat). However, with regard to minimal invasive or converted procedures, we found 
significant differences in the'physical’ subscales in both SF-36 and GIOLI as well as dif­
ferences in body image in favour of minimal invasive procedures.The fact that significant 
differences were found in the ‘physical’ subscales in both questionnaires illustrates 
construct validity between both health status instruments.
Literature
A few other studies have compared health status after LC and SIC [18-20].Two studies 
found that the laparoscopic technique was associated with a more rapid improvement 
in health status after cholecystectomy compared with the small-incision technique [18, 
19]. One study found no differences at all between both techniques [20]. However, it is 
difficult to draw conclusions from three studies that used different questionnaires and 
suffer several methodological flaws. None of the mentioned studies combined the SF- 
36 and GIOLI as advised by evidence-based guidelines [21].
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Barkun studied 35 and 23 patients in the LC and SIC groups, respectively, and used the 
same GIOLI as we did in addition to the Nottingham health profile (NHP) and a visual 
analogue scale (VAS) for health [18]. Allocation concealment was unclear, no blinding 
was used, and eight dropouts occurred in their rather small, preliminary stopped trial. 
They used cumulative totals of both GIOLI and NHP data instead of using subscales. 
Changes in one dimension might be offset by changes in other dimensions. Both ques­
tionnaires have more than onedimension (the cumulative total); subscales indeed pro­
vide the advantage of additional information on several dimensions. As a rather small 
number of patients were included (the trial was stopped preliminary), no subscales 
were assessed, and no considerations were given to the construct or divergent validity 
of both questionnaires, their conclusion that LC was associated with a significantly 
quicker return t o ‘good health’ seems inappropriate based on their results.
McMahon compared health status in 151 and 148 laparoscopic and small-incision 
cholecystectomy patients respectively using the SF-36 health survey questionnaire and 
the hospital anxiety and depression scale (HADS) [19]. Generation of the allocation 
sequence in theirtrial was unclearand no blinding was used.They found that patients 
recovering from LC enjoyed significantly better health 1 and 4 weeks after the operation 
compared with those recovering from SIC, but no significant difference was found at 12 
weeks.The absence of preoperatively baseline measurements and the absence of con­
siderations on the construct or divergent validity of the questionnaires make conclusions 
about postoperative data uncertain. Differences in SF-36 and HADS correlated with 
differences in return to domestic and leisure activities, but were not translated in 
differences in paid activity.
Squirrell used the NHP in 100 patients (50 in each group) preoperatively, and 3 weeks and
6 months postoperatively [20]. This was the only study that used blinding in their 
methods. Generation of the allocation sequence in theirtrial was unclear. At no time there 
was a significant difference between the two groups. The study used a rather small 
samplesize.and unfortunately they did not usea disease-specific questionnaire, but only 
one generic questionnaire.They concluded that it is necessary to take a broader view of 
health and not concentrate simply on pain when assessing postoperative recovery.
In our study, no significant differences were found between LC and SIC using both 
generic and disease-specific health status as well as body image with response in 
approximately 80% of patients.The response rate of 77.4% at 3 months follow-up may 
represent a possible source of bias. However, the non responders were comparable to those 
who remained in the study with regard to complications, operative time, hospital stay, 
return to work, and baseline scores of questionnaires. Moreover, our response rate is in 
line with the response rates in the studies of Barkun et al. (58%) and McMahon et al. (78%).
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We conclude that there are no differences between both operative techniques regarding 
health status.The only exception is that in the SF-36 subscale perceived health change 
we found a difference between LC and SIC, which appeared to be caused by the scores 
at 2 and 6 weeks postoperatively and disappeared at 3 months follow-up. LC patients 
reported a larger health change. However, in the evaluation of 17 aspects of health sta­
tus, only one difference was found. Moreover, this difference in perceived health change 
was not reflected in an earlier return to work in LC. In contrast, SIC patients returned to 
work quicker than LC patients, although this different was not significant. Therefore, 
our overall interpretation is that there are no differences between LC and SIC.
The com parable‘physical’ subscales in SF-36 and GIOLI, which are supposed to measure 
the same effect, are both significantly different in the minimal invasive versus conver­
sions comparison illustrating construct validity of both questionnaires. Subscales on 
different subjects in the questionnaires illustrate divergent validity.Significant differen­
ces between minimal invasive and converted procedures illustrate that the question­
naires used are able to measure what they are intended to do.
CONCLUSION
In our randomised trial with adequate generation of the allocation sequence, conceal­
ment of allocation, blinding, and follow-up we used both a generic and a disease-spe- 
cific questionnaire in addition to a body image questionnaire.There is no significant 
difference in health status measured with SF-36, GIOLI, and BIO between laparoscopic 
and small-incision cholecystectomy (applying the intention-to-treat principle). Addi­
tional calculations showed a significant difference between minimal invasive LC or SIC 
procedures and procedures converted to the classical open cholecystectomy.
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ABSTRACT
Background
After its introduction, laparoscopic cholecystectomy rapidly expanded around the world 
and was accepted the procedure of choice by consensus. However, analysis of evidence 
shows no difference regarding primary outcome measures between laparoscopic and 
small-incision cholecystectomy. In absence of clear clinical benefit it may be interes­
ting to focus on the resource use associated with the available techniques, a secondary 
outcome measure.This study focuses on a difference in costs between laparoscopic and 
small-incision cholecystectomy from a societal perspective with emphasis on internal 
validity and genera lisa bility
Methods
A blinded randomized single-centre trial was conducted in a general teaching hospital 
in The Netherlands. Patients with reasonable to good health diagnosed with sympto­
matic cholecystolithiasis scheduled for cholecystectomy were included. Patients were 
randomized between laparoscopic and small-incision cholecystectomy.Total costs were 
analyzed from a societal perspective.
Results
Operative costs were higher in the laparoscopic group using reusable laparoscopic in­
struments (difference 203 euro; 95% confidence interval 147 to 259 euro).There were no 
significant differences in the other direct cost categories (outpatient clinic and admit­
tance related costs), indirect costs, and total costs. More than 60% of costs in employed 
patients were caused by sick leave.
Conclusion
Based on differences in costs, small-incision cholecystectomy seems to be the preferred 
operative technique over the laparoscopic technique both from a hospital and societal 
cost perspective. Sick leave associated with convalescence after cholecystectomy in em­
ployed patients results in considerable costs to society.
Trial registration
ISRCTN Register, number ISRCTN67485658.
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BACKGROUND
Langenbuch's classical cholecystectomy has been the gold standard for over a century 
[i]. Since the mid 1970s surgeons began shortening their incisions because of a presumed 
quicker convalescence [2,3]. Soon thereafter, laparoscopic cholecystectomy (LC) was 
introduced, and rapidly expanded around the world [4]. The popularity of this proce­
dure was partly based on an appealing technological innovation as well as industry 
driven motives and not primarily a result of an evidence-based approach [5].
Analysis of evidence in Cochrane reviews shows no difference regarding primary out­
come measures (mortality and complications) between the three operative techniques 
of cholecystectomy (open, small-incision, and laparoscopic) [6-8]. In absence of clear 
clinical benefit based on these meta-analyses it may be interesting to focus on the 
resource use associated with the available techniques. We performed a single blind 
randomized clinical trial focusing on a secondary outcome: costs. In a previous paper we 
emphasized intrinsic validity of this trial, proved reproducibility of results from other 
trials, and showed genera lisa bility in a general teaching hospital [9].
The costs of LC and small-incision cholecystectomy (SIC) have been compared in six 
randomized trials [10-15].These available studies are inconsistent in outcome and con­
clusions, use different perspectives, and most of the trials suffer methodological short­
comings.
The research question is whetherthere is a difference in costs from a societal perspective 
between small-incision and laparoscopic cholecystectomy using a blind randomized 
approach. In a detailed cost analysis attention has to be paid to both direct and indirect 
costs as well as the perspective of the analysis. Furthermore, cost prices, budget prices, 
and tariffs have to be distinguished.
METHODS
In meta-analyses we found no major differences in clinical outcome measures (mortality, 
complications, conversions, hospital stay, and convalescence) between LC and SIC for 
patients with symptomatic cholecystolithiasis [8]. We also found no differences consi­
dering pulmonary function, health status, and cosmesis [16,17]. Costs are a secondary 
outcome measure and ultim ately may be a decisional factor. This paper focuses on 
cost-minimization analysis.
Medical Ethics Committee approval for this single-centre trial was obtained in September
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2000. Between January 2001 and January 2004, all patients referred to our surgical out­
patient's clinic with symptomatic cholecystolithiasis (confirmed by ultrasonography) 
were considered for inclusion in this study.
Inclusion- and exclusion criteria
Inclusion criteria were male or female patients with symptomatic cholecystolithiasis, 
aged 18 years or older at recruitment, reasonable to good health (ASA I or II), no known 
relevant allergies, and a signed informed consent letter.
Exclusion criteria were age younger than 18 years, choledocholithiasis (icterus, acholic 
faeces, and/or bilirubine of twice normal range), cholangitis, known pregnancy, mode­
rate to severe systemic disease (ASA III and higher), known cirrhosis of the liver, history 
ofabdominal malignancy, previous upperabdominal surgery (precluding a laparoscopic 
approach), psychiatric disease, or a reasons (e.g. lack of knowledge of the Dutch language) 
that might make follow-up or completion of questionnaires unreliable.
Obesity was not an exclusion criterion. Recovery after successful endoscopic treatment 
of choledocholithiasis was not a contra-indication. Acute cholecystitis was excluded.
Randomization
A random numbertable was used for generation of the allocation sequence [18] and the 
allocation concealment was guaranteed by using sealed envelopes. Patients were 
randomized after induction of anesthesia. An employee of the secretary office opened 
an envelope. Details were recorded in a case record form. Otherwise the procedure was 
recorded as 'trial cholecystectomy'.
Surgical procedures
All patients had a standard anesthesia regime. Premedication, medications for induction 
and continuation of anesthesia, as well as respiration during surgery were standardized. 
Residents (from 2nd year on) performed most of the operations. In case of technical dif­
ficulties either trial technique could be converted to open cholecystectomy (OC). 
Wounds were covered with standard wound dressings [19]. In this way blinding of 
patients, nurses, and ward physicians was achieved. Postoperative analgesics and 
medication for nausea were standardized.
Open introduction was performed in all laparoscopic cholecystectomies. Pneumoperi­
toneum was created with an intra-abdominal pressure up to 12 mmHg.Three trocars for 
instruments were inserted.The dissection of the cystic artery and cystic duct, identifying 
Calot's triangle, was performed using a three points 'flag' technique [20].The cystic duct 
and artery were clipped and transected. All instruments were reusable.
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In concordance with literature a cut-off point of 8 cm was used to differentiate between 
SIC and OC [14,19,21-26].The incision was placed over the musculus rectus abdominis. 
No special equipment was used. Access to the peritoneum was obtained by a 'muscle 
splitting' technique. The gallbladder was dissected by a 'fundus-first' technique. The 
cystic duct and artery were ligated and the gallbladder was removed. Posterior and 
anterior fascias were closed separately. If the length of the incision exceeded 8 cm, the 
operation was considered to be a conversion to OC.
Postoperative protocol
Early oral intake and mobilization were encouraged. Patients left the hospital as soon 
as they were able to do so. Incidental 'social' reasons for lengthening of hospital stay (by 
a few days) were accepted. Hospital stay was defined as the number of postoperative 
nights in hospital. For logistic reasons, we were not able to blind the surgeon during 
follow-up. Follow-up was standardized after 2 weeks, 6 weeks, and 3 months. Patients 
were encouraged to resume work as soon as possible.
Analysis and sample size
In meta-analyses no differences in patient-relevant outcomes appear to be present 
between these two techniques. Assuming no differences in primary outcome measures, 
sample size calculation was based on anticipated differences of costs. The direct costs 
of the first 50 patients in the trial were calculated so as to estimate the likely range of 
differences in costs and their standard deviations. On this basis, we estimated that 120 
patients per group would be needed to detect a difference of 10% in direct costs using 
a n a  of 0.05 and a 3 of 0.9.
Analyzing differences in costs due to complications between both techniques would 
require another sample size including thousands of patients in order to possibly find 
significant results. Consequently, differences in complication costs were therefore not 
statistically tested in our study. However, these costs were reported to illustrate their 
impact on total costs.
Statistics
All data were stored in a case record form (Access®) based on a patient-linked trial 
registration number. A double data entry was performed. Comparisons were made on 
an intention to treat basis. Calculations were made using SPSS 11.0®.
The chi-square test was used for dichotomous outcome. Normality of data was checked 
using the Kolmogorov-Smirnov test [27]. Levene's test was used for checking equality of 
variances. When the condition of normality and equal variances was met, the t-test for 
independent data was used; otherwise the nonparametric Mann-W hitney U test for
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independent data was used.
Methods of cost analysis
As cost items that are equally present in both groups do not contribute to differences, 
it can be argued that these can be left out of consideration.On the other hand all costs 
contribute to the total amount and the incremental value. Therefore, we strived for 
reporting costs in detail [28]. For each cost item, hospital costs, overhead costs, and 
consultants' costs were included if appropriate (Table 1).
All costs were calculated in euros (2004). All direct medical costs were summarized in 
different categories including costs due to complications (admittance, operative, out­
patients' clinic, and complications).
As there are no relevant or significant differences in clinical outcome [8,16] or quality- 
of-life [17], a cost-minimization analysis seems most appropriate. Afterwards, differences 
in costs can be balanced with other (thus far unknown) differences in outcome.
In evaluating costs, it is im portant to be complete in accounting for all items [29]. 
Therefore, in general a societal perspective is recommended [30-32]. In a societal perspec­
tive all costs are included in the analysis (patient, hospital, and losses in production), 
irrespective of the stakeholder incurring the costs or who benefits from treatment. 
Moreover, today's limited health care budgets warrant proper economic evaluation of 
treatments, especially when incidences and impact on economy are high (like in symp­
tomatic cholecystolithiasis).
Definitions of cost categories
Direct medical costs: costs resultingfrom outpatient clinic, hospital admittance, surgery, 
complications, etcetera.
Direct non-medical costs: costs arising from outside health care immediately related to 
treatment (e.g. traveling costs from patients).The problem is that it is very difficult to 
estimate these costs accurately in all patients. We assume that these costs are equal for 
both groups. Moreover, since the vast majority of patients have an uncomplicated 
recovery, these costs are assumed not to contribute importantly to total costs.
Indirect non-m edical costs: costs due to loss of productivity related to employment 
status of patients.These costs arise from loss of productivity caused by sick leave, dis­
abled for work, or mortality. We decided to use the friction cost method [31-36].
Tariffs, cost prices, budget prices and overhead costs
In cost assessments tariffs, cost prices, and budget prices have to be distinguished.
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Tariffs are costs that are calculated for insurance companies. Tariffs are nearly always 
different from real costs. Budget prices on the other hand are figures used for internal
Item
Preoperative General practioner
First visit to outpatient clinic (20min)
X-thorax*
ECG
Blood examinations 
Consultation pulmonologist (36min) 
Consultation cardiologist (22.65min) 
Consultation internist (30min)
ERCP (30min)
Ultrasound * (10min)
Operative Hospital operating room per minute 
Anaesthesiologist per minute* 
Surgeon per minute 
Surgical resident per minute 
Laparoscopic instruments - reusable 
Laparoscopic instruments - disposable
Admittance Ultrasound localization of gallbladder 
Blood gas analysis (Âstrup)
Spirometry analysis
One night hospital stay
One night medium care (including intensivist)
Intensive care (with mechanical breathing)
Intensive care (without mechanical breathing)
Pathology examination
Follow-up Outpatients visit (10min)
Complications Ultrasound drainage (10min)
Blood culture 
Blood transfusion 
Urologist outpatients visit (30min) 
Gastroscopy (30 min)
MRCP *
CTabdomen *
CT thorax*
CT angiography*
CT cerebrum *
MR cerebrum *
Re-laparotomy 
Emergency department visit 
Ultrasound duplex
Table v. List o f cost items used in calculations o f total costs. For each cost item hospital costs, 
overhead costs and consultants costs are included if  appropriate.
* Time spend by radiologists at diagnostic procedures was estimated at w  minutes,- #/n our hospital anaesthesiologists are 
responsible f o r  two operations at a time. Therefore, 140 euro (per hour) was calculated fo r  two operations resulting in 7.77 
euro per minute per operation. Time spend by consultants (for diagnostic procedures) in brackets.
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(hospital) calculations, and do not reflect real costs either. Cost prices are real costs for 
procedures and are usually not used in hospital administrations.These cost prices can 
be calculated but are sometimes difficult to retrieve.
Apart from these differences there are costs for depreciation and interest. Different me­
thods are used and no uniform guidelines exist how to estimate these overhead costs, 
neither do arguments exist that one method is superior over the other. In our hospital 
a percentage incremental value is added to every cost price. We applied this method in 
our study.
Figure i: Revised consort statement diagram showing the flo w  o f participants through each stage o f the randomized trial [37].
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Description of procedures and measurement of resources
In this cost-minimization analysis, all resources were prospectively recorded. A visit to 
the general practitioner, diagnostic examinations, and costs due to preoperative out­
patient clinic visits were counted. Hospital stay was counted as the number of over­
nights stay. Medication use is included in admittance cost prices. Operative costs and the 
costs of anesthesiologists were calculated according to operating room occupancy. Stan­
dard materials and equipment used in the operating room including costs associated 
with cleaning and sterilisation are included in hospital costs for surgery. The costs of 
the surgeon and resident were calculated from the time of incision to last suture. In 
laparoscopic instruments extra laparoscopy-specific materials like clips and endobags 
were calculated, but monitor, gass-insufflator, and camera were not calculated as these 
were considered present. In the small-incision procedure no extra equipment other than 
standard instruments is needed. In follow-up the time of the surgeon was calculated. 
Finally, if complications occurred, all extra costs were included. Costs of consultants 
were calculated using the national agreed honorarium (140 euro per hour) (Table 1).
Sensitivity analyses
Several sensitivity analyses were performed to yield an impression of the effect of 
changes on total costs. Variables were considered if the costs were appreciable and a 
change in the costs of the variable could be possible and clinically relevant:
1.The influence of the use of disposable instead of reusable laparoscopic instruments 
on total costs.
2. Influence of reduction of time back-to-work by one week on total costs.
3. Influence of the reduction of hospital stay by one night on total costs.
RESULTS
All trial patients were included and operated between January 2001 and March 2004. 
Leaving unwilling and excluded patients out of consideration, 366 patients visiting the 
outpatient clinic of the hospital for symptomatic cholecystolithiasis fulfilled the inclu­
sion criteria and were initially included in the trial. A total of 102 patients were not ran­
domized for a variety of reasons (Figure 1) [37]. After randomizing 264 patients, another 
7 patients were excluded for the following reasons: unwilling to continue in the trial 
(n = 2), intra-operative suspicion of malignancy (n = 2), transfer to a non-surgical ward 
(n = 1), inadvertent participation in multiple trials (n = 1), and inadequate Dutch language 
skills (n = 1). A total of 257 patients were left for analysis (LC:i20 and SIC:i37).
The two treatment groups did not differ regarding age, sex, body mass index (BMI), and 
American Society of Anesthesiologists (ASA) classification (Table 2). None of the 257
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patients were lost to follow-up and resources of all patients could be determined.
The numbers of converted procedures, hospital stay, the number of residents perfor­
ming the procedure, and the number of intra-operative and postoperative complications 
were not significantly different. Operative time was significantly shorter in the small- 
incision group (difference 11 minutes, 95% confidence interval (Cl) 6 to 17 minutes; 
p < 0.001) (Table 3).The total costs for both treatment groups including all 257 patients 
are summarized (Table 4).
There is an important difference in direct costs.The difference is caused by differences 
in costs due to complications and rendering total costs in favor of the laparoscopic 
procedure.
The difference in operation theatre cost is in favor of the SIC group however. Operation 
theatre costs are over 23% more expensive in the LC group compared to the SIC group 
(LC:m 2 euro compared to SIC: 901 euro; difference 211 euro, p < 0.001). Indirect costs are 
higher in the laparoscopic group.
Data of costs are non-Gaussian distributed, importantly influenced by one extreme out­
lier. Therefore, although intention-to-treat is violated, the results excluding one outlier 
in each group are also shown (Table 4). Results in the cost categories admittance and 
outpatients' clinic do not change.There still is a difference in operation theatre costs in 
favor of the SIC group (difference 203 euro; 95% Cl 147 to 259 euros). In the total costs, 
there is a difference in favor of the SIC group. All patients were operated using reusable
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision 
Cholecystectomy 
(n =137)
Statistical
analysis
Male /  Female 31/89 3O /IO 7 P=0-459
Age
mean (SD) 48.4(14.1) 48.5 (i4 -o) P=0-974
median (range) 49 (17-77) 48 (18-80)
BMI
mean (SD) 275 (4 -8) 27.9 (4.6) p=0.500
median (range) 26.8 (18.5-45.9) 27.2(18.0-43.3)
ASAclassiffication
1 82 (68.3%) 9I (66.4%) p=°.855
II 38 (31-7%) 46 (33.6%)
Table 2: Patient characteristics.
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laparoscopic instruments and costs were calculated accordingly.
In order to be able to compare uncomplicated LC and SIC procedures, costs were also 
calculated excluding all complicated cases.There still are differences present in the ope­
ration theatre related costs (difference 199 euro; 95% Cl 139 to 259 euro; p < 0.001) and 
in total direct costs (difference 139 euro; 95% Cl 42 to 237 euro; p = 0.006). No significant 
differences were observed in other direct cost categories, indirect costs, and total costs.
In order to estimate the influence of indirect costs on total costs we performed calcu­
lations only including employed patients (Table 5). Indirect costs appear to amount over 
60% of total costs in both groups.
Laparoscopic
Cholecystectomy
(n=i2o)
Small-lncision
Cholecystectomy
(n=i37)
Statistical
analysis
Mortality 0 0
Complications 21 16 p=o.ii9
intra-operative 5 3 p=°.363
postoperative 16 13 P=°-33i
Failed symptom relief 11 (9.2%) 14(10.2%) P=0-777
Operative time (min):
mean (SD) 71.9 (25.8) 60.4(18.3) p<o.ooi
median (range) 68.5 (26-215) 6O.O (29-IO5)
Conversion rate 14(11.7%) 22 (l6.1%) p=0.312
Operative team
surgeon-resident 15 (12.5%) 19 (13.9%) p=o.5i 5
resident-surgeon 84(70.0%) 100 (73.0%) p=o.596
resident-resident 21 (175%) 18 (13.1%) P=°-33i
Hospital stay*
mean (SD) 24(4.6) 3.1 (12.4) p=o.56o
median (range) 1 o - 36) 2 (1 - 4 4 )
Hospital stay* (without 1 extreme value)
mean (SD) 2-1 (3-4) 2.0 (2.4) P=o.877
Number of patients with:
1 night stay postoperative 67 (55.8%) 62 (45.3%) p=0.09i
2 nights stay postoperative 38 (31-7%) 56 (40.9%) p=o.i 27
Table 3: Comparison of clinical results.
* hospital stay: in postoperative nights.
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We performed a sensitivity analysis assuming the use of disposable instead of reusable 
laparoscopic instruments. Calculations show increase of operation costs resulting in
Laparoscopic
Cholecystectomy
Small-lncision
Cholecystectomy
Difference 
in costs 
(per patient)
Significance
All patients included
(i ntention-to-treat) (n=i2o) (n=i37)
Direct costs 305760 452654
(per patient) 2548 3304 -756 P=o,oo6*
Outpatients clinic related 54293 62627
(per patient) 452 457 -5 P=0.640
Operation theatre related 133406 123404
(per patient) 1112 901 211 P<0.001*
Admittance related 67972 81707
(per patient) 566 596 -30 P=o.342
Complications related 50089 184917
Indirect costs (n=5°) (n=5i)
172005 155024
(per patient) 3440 3040 400 P=°.315
Total costs 477765 6O7678
(per patient) 3981 4436 -454 P=0-737
Without one outlier in each group (n=ng) (n=i36)
Direct costs 272584 282683
(per patient) 2291 2079 212 P=o.oo6*
Outpatient clinic related 53980 62273
(per patient) 454 458 -4 P=o.669
Operation theatre related 130796 121856
(per patient) 1099 896 203 P<0.001*
Admittance related 67421 81131
(per patient) 567 597 -30 P=o.346
Complications related 20388 17423
Indirect costs (n=5°) (n=5i)
172005 155024
(per patient) 3440 3040 400 P=°.315
Total costs 444589 437706
(per patient) 3736 3218 518 P=0.034*
Table 4: Overview o f costs with all patients included and without one extreme value in each group (in euro).
*significant difference. Negative differences in costs favour the laparoscopic procedure and positive 
differences in costs favour the small-incision technique.
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differences of approximately 960 euro in favor of the SIC group (95% Cl 912 to 1024 euro; 
p < 0.001).
A sensitivity analysis assuming a decrease in work leave by 1 week for the employed 
patients (n = 101) in this trial results in savings of 82790 euro. In another sensitivity 
analysis assum ing a decrease in hospital stay by 1 night for the employed patients 
(n = 101) in this trial results in savings of 22980 euro.
DISCUSSION
When no differences in primary outcomes are found, consequently, several secondary 
outcome measures like operative time, hospital stay, and time to recovery as well as 
costs can be chosen as focus for a trial. Most of these secondary outcome measures are 
incorporated in a total cost assessment. Our cost analyses show that SIC is more 
expensive compared to LC when all patients are included (intention to treat, Table 4). 
Excluding one outlier from analyses in each group, total costs per patient are higher in
Laparoscopic
Cholecystectomy
(n=i2o)
Small-incision
Cholecystectomy
(n=i37)
Difference 
in costs 
(per patient)
Significance
60 and older 26 26
Employed 50 51
Unemployed /  unknown 44 60
Employed n=50 n=5i
Direct costs (37-7%) (38.4%)
104003 96454
(per patient) 2080 1891 189 P=o.o55
Indirect costs (62.3%) (61.6%)
172005 155024
(per patient) 3440 3040 400 P=°.315
Average period before return
to work (in weeks (SD): 4-2 (2-3) 3-7 (2.0) P=o.298
Total costs 276008 251477
(per patient) 5520 4931 589 P=o.i79
Table 5: Overview o f costs with employed patients only (in euro).
Total indirect costs:327029 euro (n=ioi). Average period before return to work:4.0 (SD:2.2) weeks. 
Average indirect costs per patient per week: 820 euro. Negative differences in costs favour the laparoscopic 
procedure and positive differences in costs favour the small-incision technique.
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the LC group (p = 0.034).This difference is caused by a difference in operative costs (dif­
ference 203 euro; 95% Cl 147 to 259 euro; p < 0.001) and a difference in indirect costs 
(p = 0.315). When all complicated cases are excluded, direct costs (p = 0.006) and ope­
rative costs (199 euro, p < 0.001) per patient remain higher in the LC group (using reusable 
laparoscopic instruments).
The problem in reporting costs are non-Gaussian distributions. Following intention-to- 
treat principles, complicated cases should be included to obtain an objective impression 
of absolute costs. Using means results in a biased impression of falsely increased 
measures as a consequence of skewed data, while using medians would ignore 
complicated cases since in cholecystectomy about 80% of operations are uneventful 
procedures (Table 4). In our trial one extreme outlier occurred. Differences in techni­
ques have to be distinguished from random variations. Meta-analyses demonstrate no 
differences in complications between laparoscopic and small-incision cholecystectomy. 
We therefore believe that differences in complication costs should be considered ran­
dom variations. Moreover, our trial was not powered to detect differences in complica­
tion costs and these results should be considered a spurious finding and should 
therefore not be statistically tested at all. Reporting costs excluding one outlier in each 
group might therefore be more correct as it incorporates complication costs but prohibits 
distortion of total costs by random extreme outliers.
There are several problems in analyzing and pooling cost results from different studies. 
First of all, costs are reported in different ways including different cost items. A second 
problem is that different points of views are taken. These different perspectives make 
comparison of studies difficult. A third problem is the difference in validity of the cost 
assessments, defined by the details in which costs are calculated. More detailed analyses 
are known for more reliable estimates, while less detailed studies cause severe bias 
[28,29]. A fourth problem in comparing studies is that there may be considerable 
differences in local costs. Specific items in cost analyses differ from one country or even 
setting to another. A fifth and probably most important problem are cultural differences. 
There are wide variations in convalescence (and return to work) between different 
cultures depending on a multitude of causes, like social security and cultural habits 
[38,39]. As multiple factors cause heterogeneity, pooling results seems inappropriate 
and one may only draw general conclusions from individual studies.
In literature six trials report costs and lack of methodological quality was present in 
several trials [10,12,14,40]. In some trials methodology of cost assessment was very 
limited described [12,40]. Outpatients' costs [11,12] and indirect costs [10-12,14] are 
excluded in several studies making overall (societal) comparison of techniques incom­
plete. Retrospective analyses [14] or expert settings [11,14] raise questions on reliability
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and generalisability. In our trial surgical residents performed 86% of the operations.
The trials byCalvertand Nilsson are high quality trials [11,13]. Unfortunately outpatients' 
clinic costs and indirect costs are not included in the trial by Calvert [11]. Additionally, 
median hospital stay and estimated operative time (instead of individual data) are used 
for calculations.They concluded that hospital costs using the laparoscopic technique 
were 29% higher [11].The trial by Nilsson is a high quality multi-centre trial. However, 
standardization of procedures is less biased and more uniform in a single-centre trial 
compared to a multi-centre trial. Costs are reported in medians (ignoring outliers and 
com plications). This study found lower direct costs and higher indirect costs for the SIC 
group [13].
Some conclusions of differences in costs were based on differences in hospital stay [10] 
or convalescence [13,14]. However, in meta-analysis no differences were found in hospi­
tal stay and convalescence between both techniques [8].The differences in indirect costs 
in our trial should be considered as random variations caused by random differences in 
age and sex between both groups in the employed patientsicalculated friction costs per 
hour per employee are higher for male and for higher aged employees.
Remarkably, the trials with lack in methodological or cost assessment quality [10,14,40] 
favor the laparoscopic technique, while the trials with high methodological quality or 
more detailed cost assessments [11,13] favor the small-incision technique.This linkage 
between unclear/inadequate methodological quality to significant overestimation of 
beneficial effects and underreporting of adverse effects is in concordance with other 
studies [8,41,42].
Different parties have different interests in cost analyses.Though, all perspectives belong 
to our society. Advantages of a certain therapy in a societal perspective should be given 
more importance compared to other perspectives not including all cost categories. It 
provides the most comprehensive assessment and is most relevant for national policy 
decisions. Implementation at a local level, however, may require to also taking into 
account a hospital perspective as financial consequences will become visible.
Feasibility of ambulatory cholecystectomy [43,44] and the wide range in return to work 
from a few days to 12 weeks raises questions on potential savings. Possibilities for future 
savings by reduction of hospital stay (direct costs), irrespective of the operating tech­
nique for cholecystectomy, were compared to savings by reduction of sick leave (indi­
rect costs). Assuming 21000 cholecystectomies in the Netherlands, reducing hospital 
stay by one night (50%) in every patient would result in potential savings of 4.8 million 
euro in the Netherlands annually. Assuming that 50% of the cholecystectomy patients
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are employed (Table 5), reducing sick leave by one week (25%) in every employed 
patient would lead to savings of 8.6 million euro on a national basis annually. Based on 
these hypothetical figures it seems easier to achieve savings by earlier return to work 
instead of reducing hospital stay. Moreover, as more than 60% of costs of employed 
patients are caused by sick leave it is more logical to focus on this cost category.
Assuming 21000 cholecystectomies in the Netherlands and an employment ratio of 
50%, calculations of sensitivity analyses on hypothetical savings were performed 
considering change in policy from disposable to reusable laparoscopic instruments, change 
from LC to SIC, or reducing sick leave by one week. As a result savings of approximately 
16 million, 4.2 million, and 8.6 million euro respectively are possible on a national basis 
annually. However, conclusions have to be careful since calculations are hypothetical.
CONCLUSION
In this single-centre trial with representative results and emphasis on methodological 
quality LC appears more costly: the procedural costs surpass those of SIC (and use of 
disposable instruments would only further increase this difference). Thus SIC is the 
preferred operative technique over LC both from a hospital and societal cost perspective.
Sick leave associated with convalescence after surgery results in considerable costs to 
society especially in the employed patient.
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ABSTRACT
Background
Cholecystectomy causes considerable financial burden on society with a major part 
caused by sick-leave.There are wide variations in duration of sick-leave. The aim of our 
study was to identify all aspects that influence the moment of return to work by using 
focus groups and to compare responses from patients and physicians.
Methods
A qualitative research design was planned using focus group discussions. Four focus 
group discussions were organized: two patient groups and two physician groups. 
Employed patients who had recovered after cholecystectomy were included in the 
patient groups.The physicians groups consisted of general practitioners, surgeons, and 
company physicians.Three investigators independently searched transcriptions of the 
sessions for all items relating to return to work.The importance of items and categories 
were assessed by determining frequencies.
Results
In the patients groups physical limitations (35.3%) and individual patient factors (17.5%) 
were important factors in the duration of sick-leave, while influence or advice comprised 
only 8.4% of the items. In the physicians groups influence or advice (21.8%) and infor- 
mation-related factors (21.4%) were thought to be important categories.
Conclusions
Physicians perceive their advices as an important factor in patients’ duration of sick-leave. 
In contrast, patients seldom mention this factor and experience physical complaints as 
the major reason influencing the moment of return to work.
Chapter 12
BACKGROUND
For about 100 years, open cholecystectomy (OC) was considered a safe standard [1]. 
Reduction in the length of the incision, known as small-incision cholecystectomy (SIC), 
with a concomitant reduction in postoperative morbidity, has been reported as early as 
the mid 1970’s [2,3]. However, before the SIC could find general acceptance, the lapa­
roscopic cholecystectomy (LC) was introduced in the late 1980’s [4_].This procedure gained 
rapid and immense popularity [5] and became the surgical treatment of choice even 
though its superiority was not in evidence [6].
Both minimal invasive techniques (SIC and LC) are preferred over the open technique 
because of a quicker convalescence (hospital stay and return to work) [7,8]. As no signi­
ficant differences between LC and SIC in primary outcome measures were found [9], 
secondary outcome measures should further decide on preferences.
The financial burden of cholecystectomy on society is considerable with over 60% of the 
total costs of employed patients caused by indirect costs related to sick-leave of 
employees [10]. As time before return to work ranges from 1 to 10 weeks, both in suc­
cessful LC and successful SIC [11], apparently other unknown factors are involved.The 
question arising is who or what influences the moment of return to work?
To answer this question, we have to know a wide range of factors that influence the 
absence from work. In the literature, patients’ expectations [12], low job satisfaction, 
physical effort at work, pain, patient’s expectation of slow recovery, expectation of no 
financial loss [13], a longer period of work incapacity before the intervention, older age, 
and longer hospital stay [14], are factors already identified in extending sick leave.The 
impact of cultural differences on the moment of return to work was shown as well [15]. 
These studies examined the influence of specific factors on the moment of return to 
work. However, as far as we know no attempt has been made to determine a wide range 
of factors that are involved.
Focus group discussions appeared to be a reliable method of gathering qualitative 
information on a subject [16,17]. A focus group is a type of group interview with the pri­
mary goal to generate ideas about a particular issue.The reliance in focus groups is on 
the interaction between the various participants [16].The dynamic interplay of partici­
pants replaces their interaction with the interviewer, leads to a greater emphasis on 
the participants’ point of view [18], generates additional ideas in the group, and is the 
additional value of focus group discussions compared to individual (patient) interviews.
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The aim of our study was to retrieve a wide range of aspects that influence the moment 
of return to work after cholecystectomy and to compare responses from patients and 
physicians.This was done usingfocus groups.We hypothesize that a physicians’ advice 
is important in the decision to return to work.
METHODS 
Participants
We organized four focus group discussions: two patient groups (seven patients each) 
and two physician groups (seven and eight physicians). Patients were randomly sampled 
from the patients included in our randomized clinical trial on outcome after laparoscopic 
and small-incision cholecystectomy [11]. Approval from the Medical Ethics Committee 
was obtained (ISRCTN67485658; http://isrctn.org). The indication for cholecystectomy 
in all patients was symptomatic cholecystolithiasis.The results and postoperative out­
come of the patients in our trial were in line with results in literature [11]. A paid job was 
an inclusion criterion in patient groups. A second inclusion criterion was that patients 
should have had their cholecystectomy at least six months earlier to guarantee full 
recovery. In both patient groups, there were patients operated on by three techniques: 
laparoscopic, small-incision, and procedures converted to conventional cholecystectomy.
Physicians who come in contact with this type of patients and, thus, can influence in 
some way the moment of return to work of patients are: general practitioners, surgeons, 
and company physicians. Company physicians are doctors who independently advice 
patients and employers when work should be restarted or which alternative work may 
be performed by the patient when unable to restart their usual activities. All three types 
of physicians were present in both physician groups. Physicians were randomly sam­
pled from a list representingthe hospitals’ affiliation area.They were invited to partici­
pate in the focus groups according to availability These physicians were not physicians 
for these particular patients.
In total four focus groups were run, two patients groups and two physicians groups. 
One patients’ focus group comprised of 4 men and 3 women and the other patients’ 
focus group consisted of 1 man and 6 women. All patients had their cholecystectomy at 
least six months earlier. Participants in the first physicians’ focus group were two com­
pany physicians, three general practitioners, and two surgeons. In the second physici­
ans focus group there were two company physicians, four general practitioners, and 
two surgeons. Informed consent was obtained from all participants.
Compared with the second patients’ focus group, in thefirst patients’ focus group more
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patients had remaining complaints and symptoms. However, the items mentioned in 
these two focus groups were the same.Therefore, the three investigators felt that satura­
tion was reached after only two sessions.The same occurred in the physicians focus groups.
Method of group discussion
The focus groups were run by the authors and all investigators were present in all four 
focus group sessions. In accordance with focus group methodology, the role of the 
investigator leading the focus group was restricted to procedural issues (e.g. making 
sure that every participant had the chance for expression of his/her opinion) and posing 
the two opening questions in order to let the interaction between participants domi­
nate the discussion.
The two opening questions in the patients’ focus groups were: (i) how did the patient 
experience his/her cholecystectomy, and (2) who or what factors did influence the 
moment of return to work.
The two opening questions in the physicians’ focus groups were: (1) how do the physi­
cians think that patients experienced their cholecystectomy, and (2) who or what do 
physicians think influences the moment of return to work in patients.
The patient group discussion was started by the opening question how patients had 
experienced and felt about their operation. At the end of a discussion around a question, 
the investigator summarized the items that were mentioned and asked patients if there 
were items they could think of that had not yet been mentioned. Consequently, the 
other opening question was posed.
Data recording
During the discussions, items were noted on a flip-over by one of the investigators. In 
addition, the sessions were audiotaped with permission from the patients.These tapes 
were subsequently verbatim transcribed.
Assessing the number of focus groups
The number offocus group sessions was determined by saturation, i.e., when in another 
group no new items are mentioned by the participants in comparison to a previous 
similar focus group. When saturation is reached, the number offocus groups is consi­
dered to be adequate.
Analysis
Analysis of results in qualitative research is completely different from classical statistical 
analysis of quantitative data. In our study, initially the transcriptions were searched for
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all possible items and factors and also items noted on the flip-over were added to the 
listed items from the transcriptions. Subsequently, by analyzing these items, main cate­
gories were determined and all items were classified into a main category indepen­
dently by three investigators. Disagreements were solved in consensus. In this way, bias 
caused by analyzing and interpreting data was minimized by comparing these inde­
pendently obtained results. Factors were clustered in subcategories after consensus. 
Then, the importance of the separate items was assessed by determining the frequency 
in which they were mentioned.The frequency of an item was used as a proxy for impor-
Physical factors 101
(353%)
Patients’ expectations or indi vidua 1 ly 
determined factors
50
(17.5%)
pain 15 consideration of being operated upon 7
open wound 11 fearof the operation 6
food related complaints 11 an individual's willingness to resume work 4
general physical complaints 11 a person's character 3
change for the better 9 individual differences 2
wound pain 7 recovery is disappointing compared to others 3
diarrhea 6 differences in experiencing pain 2
insomnia 6 experiences in the past 1
shoulder pain 5 other individual circumstances 3
lackof endurance 5 self determination 1
abdominal colic's 5 scar 4
gastrointestinal complaints 4 nervous disposition 2
infection 3 relaxed attitude 3
tiredness 3 disappointing
fear for resuming work activities 
other
3
1
5
Work-related factors 46
(16.1%)
Influence, expectations or advice by thirds 24
(8.4%)
type of work 11 discouraged by others 5
adapted work activities 8 pressure by employer 2
work with lifting activities 6 expectation of company physician 1
part-time work 3 advice of company physician 1
discouraged by employer 3 other factors related to company physician
work atmosphere 2 pressure by company physician 1
influence of temperature on wound 2 advice of surgeon
possibility to return home early 2 advice of any other physician 1
company physician related 1 financial pressure 1
autonomy 1 structure of health care 1
being in contact with the company 1 society's expectations 1
continuity at work 1 people's expectations
no use of a partly recovered colleague 1 advise of others 1
independent (own store) 1 taking others into consideration 1
relation with employer 
other
1
3
expectations of children 2
Table i: Score of items relating to return to work in patients focus groups.
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tance. After assessing the frequencies of each item, the importance of an individual 
item as well as the importance of a main group could be determined.
RESULTS
After transcription ofthe tapes and checking 
defined:‘physical’, ‘ hospital stay related’, ‘h
Hospital related factors 47
(16.4%)
good follow-up care 9
earlier discharge 5
delayed discharge 5
operative technique 5
operation delay 4
postoperative information 3
physicians with limited time 3
ga 1 Ibladder cond it ion 3
visit to outpatients'clinic 3
anesthesia 3
operating surgeon dependent 2
waiting list 1
changing physicians 1
Home factors 12
(4 .2%)
children 8
housekeeping 2
getting bored at home 1
gender differences 1
Information related factors 6
(2.1%)
Other 0
the flip-overs, eight main categories were 
ome’, ‘work-related’, ‘influence or advice 
(including expectations) of others’, 
‘patients’ expectations or individually 
determined factors’/inform ation’, and 
‘other’. Consequently, items relating 
to the same subject were summed, 
leading to subcategories.
Patients’ focus groups
Results o fth e  patients’ focus groups 
are shown in table i. All items of the 
two groups were combined and led to 
309 items. A total of 23 items were 
irrelevant to return to work (e.g. a pa­
tient mentioning that it took a long 
time before the diagnosis was set), 
resulting in the 286 items that are lis­
ted (Table 1). Physical limitations (35.3%), 
individual patient factors (17.5%), hos­
pita l-related factors (16.4%), and work- 
related factors (16.1%) were important 
factors in time to return to the job. 
Influence or advice comprised only 
8.4% o fth e  items mentioned in the 
decision to resume the job. Home fac­
tors (4.2%) or information related fac­
tors (2.1%) were not experienced by 
patients to be important reasons for 
delaying or resuming work activities.
Within the physical factor, pain (14.9%), 
an open wound (10.9%), food-related
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complaints (10.9%), wound complaints (10.9%), and general health related complaints 
(10.9%) were mentioned most frequently. A reduction in physical complaints after 
cholecystectomy was mentioned by 8.9% as a positive factor for return to work. Other 
factors were: wound pain (6.9%), diarrhea (5.9%), and insomnia (5.9%).
In the individual patient factor, patients mentioned that they had to be careful to 
resume their work as a simple consequence of having surgery (14%). Differences in the 
type of person (6%) and having fear for the operation (12%) were important reasons as 
well.
In hospital related factors, patients mentioned a positive follow-up care after the ope­
ration (19.1%), earlier (10.6%) or delayed (10.6%) discharge and the type of surgery (10.6%) 
to be important reasons.
Influence or advice (including 55 Information related factors 54
expectations) by thirds (21.8%) (21.4 %)
society's expectations 10 lack of information 13
structure of health care 8 lackof guidelines 10
advise of others 7* a structure for communication 9
influences of cultural differences 7 pamphlet information 6
people's expectations 6* lackof advice 4
advice of general practitioner 6* positive attitude 3
advice of company physician 4* differences in interpretation of information 2
advice of surgeon 3* other 7
employer's expectations 2
other 2
Patients’ expectations or individually 35 Hospital related factors 31
determined factors (13.9%) (12.3%)
individual differences 8 information about the operation 8*
a person's character 7 type of operation 7
motivation 5 visit to outpatients'clinic 7*
personal circumstances 5 information on recovery 4*
differences in experiencing pain 3 hospital stay 2
an individual's interpretation waiting list 2
of information 2 good follow-up care 1
other 5
Home factors 4
(1.6%)
Table 2: Score o f items relating to return to work in physiciansfocus groups. * items somehow relating to information,
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In the work related factors, the type of work (23.9%), adapted work (17.4%) and work 
requiring weight lifting (13%) were most important.
"... initially I assisted in administrative activities, which is completely different 
fro m  my usual activities on the j o b ...”
The main category ‘influence or advice’ was mentioned in 8.4% to be important and 
within this main category, the influence or advice of a physician was the reason in 33.3%. 
Sometimes patients wanted to work, but others advised them not to (20.8%).
"... the company physician advised not to resume work and to take it easy, 
ju s t  because I had abdom inal surgery...”
Work-related factors 41
(16.3%)
type of work 7
initiatives of the employer 6
possibility to return home early 6
work atmosphere 4
motivation 4
adapted work activities 4
financial aspects employer 3
relation with employer 2
commitment 2
independent (own store) 2
other 1
Physical factors 20
(7-9%)
pain 8
tiredness 6
diarrhea 2
endurance 2
wound healing 2
Other 12
(4.8%)
legal aspects 4
analgesics 4
other 4
not scored in the information category.
Physicians focus groups
Results of the physicians’ focus groups 
are shown in table 2. All items of 
these two groups were combined and 
led to 280 items. A total of 28 items 
were irrelevant to return to work (e.g. 
someone describing situations in 
other countries), resulting in the 252 
items that are listed (Table 2). Influ­
ence or advice by others (21.8%) and 
information-related factors (21.4%) 
were the two most im portant cate­
gories in time to return to the job in 
the physicians’ groups. Work-related 
factors (16.3%), individual patient 
factors (13.9%) and hospital-related 
factors (12.3%) were assessed less im ­
portant in the decision to return to 
work. Physical factors (7.9%) and home 
factors (1.6%) were not experienced 
by physicians to be important reasons 
for patients in delaying or resuming 
their work activities.
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W ithin the ‘influence or advice by others’ category physicians assessed that society 
expectations were the most important subcategory (18.2%).The structure of health care 
and financial arguments was thought to be important as well (14.5%). Other factors 
that were revealed: advices in general (12.7%),the role of the general practitioner (10.9%) 
and advices by societal contacts of patients (like neighbors) (10.9%). Cultural factors 
were thought to be important as well (12.7%).
In the (secondly most important) ‘information-related item s’ category physicians 
thought that lack of information (on expectations) to the patient is mainly responsible 
for delay in return to work (24.1%). Additionally supplying information to patients by a 
pamphlet (11.1%) and a lack of guidelines (18.5%) were thought to be important as well.
"... do company physicians have guidelines on what to advice to patients considering 
the m om ent to return to work? No. And do general practitioners have guidelines?
No. In the surgical world there are no guidelines or evidence on when to return to 
work e ith e r... Actually, nobody knows what should be advised to patients...”
Another important and time consuming issue in the discussions (and all physicians 
agreed on being important) was the lack of a structure to communicate between sur­
geons, general practitioners and company physicians (16.7%).
"... There is no contact and communication between surgeons, general practitioners and 
company physicians on what to advice to a patient on return to work. A structure f o r  
communication is necessary and currently missing, especially quick com m unication...”
In the work-related category, the type of work (17.1%), initiative by the employer to con­
tact the employee (14.6%), and flexibility (24.4%) (including adaptive activities (9.8%) 
and possibilities to return home at all times (14.6%)) were assessed important in the 
decision of patients to resume activities. Additionally the atmosphere at the job (9.8%) 
and an individual’s motivation (9.8%) were assessed by physicians to play a role.
In the individual patient factors category, individual factors (22.9%), personality (20%), 
an individual’s motivation (14.3%) and specific individual circumstances (14.3%) were 
the main subcategories.
In the hospital related category, physicians assessed that patients being informed by 
surgeons about operative findings (25.8%) and the process at the outpatients’ clinic 
(22.6%) were the main subcategories. The type of operative technique (22.6%) was 
thought to be important as well.
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Summarizing all items somehow relating to information or advice (including lack of 
information, lack of advice and incorrect advice), lead to a total of 99 items (39.3%).
DISCUSSION
The aim of our study was to retrieve a wide range of aspects that influence the moment 
of return to work after cholecystectomy and we hypothesized that a physicians’ advice 
would be important in the decision when to return to the job.This qualitative research 
showed that physicians believe that their advices are most important. In contrast, 
patients mentioned this factor seldom and experience physical complaints as the major 
reason influencing their return to work.The hypothesis was rejected that a physicians’ 
advice was important in a patients’ decision to return to work. Our study showed that 
we need to pay more attention to the physical complaints after cholecystectomy. 
Surprisingly, guidelines concerning advice when to resume work activities and commu­
nication between physicians appearto be missing.Structured communication between 
physicians may supply the patient with an individual appropriate advice.
It has to be emphasized that we used a qualitative design and results should therefore 
be considered in an explorative perspective. Drawing quantitative conclusions from this 
study is inappropriate.
The inclusion criterion that patients had their cholecystectomy at least six months ear­
lier may very well have resulted in recall bias. However, it was considered that a shorter 
period might have distorted results by information bias as a consequence of differences 
in the state of recovery in the participating patients. Patients might very well have 
overestimated the importance of current factors compared to factors that played a role 
in the past. Overall, we had the impression that patients remembered their recovery 
and sick-leave very well.
As far as we know, in literature only the influence of specific factors on the moment of 
return to the job was evaluated [12-15]. N° attempt has been made thus far to identify 
a wide range of factors that influence the moment back to work.Thefactor‘an older age’ 
was not identified, but all other factors mentioned in literature were included in our 
results. Work incapacity before the intervention was not the focus of this study.
We found several discordant findings between the patients and physicians focus groups. 
The first most striking difference between patients and physicians was that physicians 
thinktheiradvice is most important.Most ofthe items in the physicians group concerned
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advices to a patient to resume work.These physician advices were not mentioned in the 
patient group and, thus, time back to work is not related to this.There were some other 
items concerning possibilities of physicians believing that in some way the recovery of 
patients after surgery could be influenced (e.g. by preoperative expectations). Obviously, 
patients would not mention these items while they were not aware of the possibilities 
how their recovery could be influenced.This partly explained the difference between the 
two types of groups. It was also remarkable that some patients wanted to resume work, 
but they were advised by company physicians not to do so. Apparently, physicians were 
sometimes too careful.
Another major discordance was found in physical factors. Patients experienced physi­
cal complaints as the most important reason causing delay in return to work, while 
physicians did not assess the physical factors to be important. One could expect that 
pain in some way inhibits patients’ return to work, but more surprising was the large 
number of gastro-intestinal complaints. Inability to eat, intestinal colic’s and a disturbed 
defecation (i.e. diarrhea) were frequently mentioned reasons not to return to work. 
Being tired, inability to sleep and lack of general fitness were also frequently mentioned. 
A reduction in physical complaints after cholecystectomy was mentioned seldom by pa­
tients as a positive factor, while one would expect that disappearance of symptomatic 
cholecystolithiasis would be an important positive reason for resuming work activities.
Another problem that became obvious in the physicians groups concerned communi­
cation between various types of physicians.There appeared to be no communication 
between surgeons, general practitioners and company physicians relating to the moment 
of return to work of a patient. Company physicians sometimes wanted to ask a surgeon 
for advice, but writing, sending, answering, and returning a letter takes up too long 
(several weeks) and was, therefore, impractical. Making a phone call often was a problem 
as well (e.g. because of performing surgery). In future, communication between surgeons 
and company physicians could combine technical information of the operation with 
the specific work-related knowledge of company physicians and might result in an 
appropriate advice for the individual patient.
One of the most surprising remarks in the physicians’ groups came up when the exis­
tence of protocols was discussed. Each type of physician thought that the others had 
some kind of protocol about a standard period of sick leave and expected that their col­
leagues advised patients on when to return to work. However, no protocol or guidelines 
existed and no concrete advice was given to the patient.The main thing physicians told 
their patients in relation to time back to work was to listen to their body and to return 
to the job as soon as they felt well enough to do so. Advices varied and it seemed that 
every physician generates his or herown advice independent from each other. Company
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physicians and general practitioners gave advices w ithout asking a surgeon for his 
opinion and a surgeon usually did not give any advice or simply referred to the company 
physician.
Since we included patients with a paid job in ourfocus group discussions it is not pos­
sible to conclude from our study on convalescence in patients w ithout a paid job, 
although some factors might very well apply to these patient categories as well. We 
focused on individual aspects using a qualitative study design. The influence of other, 
non individual, more general factors like differences in social class and education level 
should be addressed by a quantitative study design.
This raises the question whether our results are generalisable to other general surgical 
procedures such as inguinal hernias, appendectomies and varicose surgery. We feel that 
many factors may very well be generalisable. Alternatively, other factors and especially 
incentives in the health care system may vary considerably from one place to another. 
The results may be different in countries without a Western European social security 
system where patients suffer financial loss during sick leave. Financial situations are 
different and the factors influencing return to work may therefore differ as well. How­
ever, future research is necessary to examine this.
CONCLUSION
Physicians perceive of their advices as an important factor in patients’ duration of sick 
leave. In contrast, patients seldom mention this factor and experience physical com­
plaints as the major reason influencing the moment of return to work.
Attention has to be paid to patients’ physical complaints after cholecystectomy as well 
as to the way information is supplied to the patient. More adequate information, 
generating guidelines on time back to work in general and improving communication 
between types of physicians, might result in an appropriate advice for every individual 
patient. Knowledge of factors influencing the moment of return to work may result in 
improvements of patients’ recovery. Additionally, reductions in sick-leave and subse­
quently substantial savings in indirect costs may be reached.
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ABSTRACT
Background
Patients with symptomatic cholecystolithiasis are treated by three different techniques 
of cholecystectomy: open, small-incision, or laparoscopic.There is no overview on Cochrane 
systematic reviews on these three interventions.
Objectives
To sum marise Cochrane reviews that assess the effects of different techniques of 
cholecystectomy for patients with symptomatic cholecystolithiasis.
Methods
The Cochrane Database o f  Systematic Reviews (CDSR) was searched for all systematic 
reviews evaluating any interventions for the treatment of symptomatic cholecystoli­
thiasis (Issue 4, 2009).
M ain results
Three systematic reviews that included a total of 56 randomised trials with 5246 patients 
are included in this overview of reviews. All three reviews used identical inclusion cri­
teria for trials and participants, and identical methodological assessments.
Laparoscopic versus small-incision cholecystectomy
Thirteen trials with 2337 patients randomised studied this comparison. Bias risk was 
relatively low.There was no significant difference regarding mortality or complications. 
Total complications of laparoscopic and small-incision cholecystectomy were high, i.e., 
17.0% and 17.5%.Total complications (risk difference, random-effects model -0.01 (95% 
confidence interval (Cl) -0.07 to 0.05)), hospital stay (mean difference (MD), random- 
effects -0.72 days (95% Cl -1.48 to 0.04)), and convalescence were not significantly 
different.Trials with low risk of bias showed a quicker operative time for small-incision 
cholecystectomy (MD, low risk of bias considering’blinding’, random-effects model 16.4 
minutes (95% Cl 8.9 to 23.8)) while trials with high risk of bias showed no statistically 
significant difference.
Laparoscopic versus open cholecystectomy
Thirty-eight trials with 2338 patients randomised studied this comparison. Bias risk was 
high. Laparoscopic cholecystectomy patients had a shorter hospital stay (MD, random- 
effects model -3 days (95% Cl -3.9 to -2.3)) and convalescence (MD, random-effects model 
-22.5 days (95% Cl -36.9 to -8.1)) compared with open cholecystectomy but did not 
differ significantly regarding mortality, complications, and operative time.
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Small-incision versus open cholecystectomy
Seven trials with 571 patients randomised studied this comparison. Bias risk was high. 
Small-incision cholecystectomy had a shorter hospital stay (MD, random-effects model 
-2.8 days (95% Cl -4.9 to -0.6)) compared with open cholecystectomy but did not differ 
significantly regarding complications and operative time.
Authors’ conclusions
No statistically significant differences in the outcome measures of mortality and com­
plications have been found among open, small-incision, and laparoscopic cholecystec­
tomy. There were no data on symptom relief. Complications in elective cholecystectomy 
are high.The quicker recovery of both laparoscopic and small-incision cholecystectomy 
patients compared with patients on open cholecystectomyjustifies the existing prefe­
rences for both minimal invasive techniques over open cholecystectomy. Laparoscopic 
and sm all-incision cholecystectomies seem to be comparable, but the latter has a 
significantly shorter operative time, and seems to be less costly.
PLAIN LANGUAGE SUMMARY
Open, small-incision, and laparoscopic cholecystectomy seem comparable with regard 
to mortality and complications
Gallstones are one of the major causes of morbidity in western society. Prevalence of 
persons with asymptomatic and symptomatic gallstones varies between 5% and 22%. 
There is consensus that only patients with symptomatic gallstones need treatment. 
Three different operation techniques for removal of the gallbladder exist: the classical 
open operation technique and two minimally invasive procedures, the laparoscopic and 
the small-incision technique.This overview evaluates the three surgical procedures and 
comprises fifty-six trials with 5246 patients randomised.
Complication proportions in all three techniques are high, but there seem to be no 
significant differences in mortality and complications between the three operation 
techniques. Both minimally invasive techniques have advantages overthe open opera­
tion considering postoperative recovery.This overview of three Cochrane Hepato-Biliary 
Group systematic reviews shows that the laparoscopic and the small-incision opera­
tion should be considered equal regarding patient-relevant outcomes (mortality, com­
plications, hospital stay, and convalescence). Operative time seems to be quicker and 
costs seem to be lower using the small-incision technique.
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The question today is why the laparoscopic cholecystectomy has become the standard 
treatm ent of cholecystectomy for patients with symptomatic cholecystolithiasis 
without the evidence being present. We were unable to find any arguments suppor­
ting the ’gold standard’ status of laparoscopic cholecystectomy.
In future trials, research should concentrate more on outcomes that are relevant to 
patients (e.g., complications and symptom relief). Furthermore, the execution of the 
trials should comply with CONSORT requirements (www.consort-statement.org).
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BACKGROUND
Gallstones are one of the major causes of morbidity in western society. In many persons gall­
stones remain asymptomatic.Treatment is required only in persons with symptomatic 
gallstones [NIH Consensus conference 1993]. Prevalence of persons with asymptomatic 
and symptomatic gallstones varies between 5% and 22% in the USA, and the total esti­
mated number of people with gallstones is 20 million (based on 290 million inhabi­
tants) [Legorreta 1993; Everhart 1999]. Prevalence of persons with asymptomatic and 
symptomatic gallstones in Europe shows similar distributions varying between 25 and 
50 million persons (based on 500 million inhabitants in 32 countries) [Jensen 1991; 
Attili 1995]. It is estimated that theyearly incidence of symptomatic cholecystolithiasis 
is up to 2.2 per thousand inhabitants [Steiner 1994].
Description of the condition
There is general agreement supported by limited evidence that gallstone carriers with 
vague symptoms should not undergo cholecystectomy, whereas gallstone carriers with 
one or more biliary colic should be offered operation [Scott 1992; NIH Consensus con­
ference 1993; Neugebaueri995].A biliary colic is typically defined by severe pain in the 
epigastrium or the right hypochondrium, eventually radiating to the back, persisting 
for one to five hours, often waking the patient during the night, and sometimes provoked 
by meals. Classically, patients experience the need to move around, and there is no 
typical sign at physical examination.The presence of gallstones is usually confirmed by 
ultrasound examination [Johnston 1993].
Description of the interventions
Cholecystectomy is the preferred treatment in symptomatic cholecystolithiasis and is 
one of the most frequently performed operations. The annual number of cholecystec­
tomies in the USA exceeds 500,000 patients [Olsen 1991; NIH Consensus conference 
1993; Roslyn 1993]. Until the late 1980s, the classical open cholecystectomy was the gold 
standard for treatment of symptomatic cholecystolithiasis [Traverso 1976]. In the early 
1970s, small-incision cholecystectomy was introduced as a minimal invasive procedure 
[Dubois 1982; Goco 1983]. As incisions for cholecystectomy were shortened, morbidity 
and complications seemed to decline [Dubois 1982; Goco 1983] and patients recovered 
faster. Laparoscopic cholecystectomy was first performed in 1985 [Mühe 1986] and 
rapidly became the method of choice for surgical removal of the gallbladder [NIH 
Consensus conference 1993], although the evidence of superiority over small-incision 
cholecystectomy was absent.This rising popularity was based on assumed lower mor­
bidity and complication proportions, and a quicker postoperative recovery compared to 
open cholecystectomy. Laparoscopic cholecystectomy seemed superiorto open cholecys­
tectomy [Deziel 1993; Downs 1996; Shea 1996] and to small-incision cholecystectomy
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[Ledet igg ojO ’Dwyer 1990; Olsen 1993;Tyagi 1994; Seale 1999]. However, the mentioned 
studies are non-randomised trials, and accordingly they may not provide a fair assessment 
of the effects of the interventions.
How the intervention might work
Removal of the gallbladder including its content prevents recurrence of colics caused by 
gallbladder stones. However, patients often do not present with the classical symptoms 
of biliary colics.Therefore, patients with non-classical symptoms or asymptomatic gall­
stones may be offered gallbladder removal in the presence of symptoms originating 
from other abdominal organs. In fact, abdominal complaints wrongly attributed to co­
existent gallstones could explain the relatively high proportions of failures in symptom 
relief by cholecystectomy.
W hy it is important to do this overview
Laparoscopic cholecystectomy is the treatment of choice by consensus in patients with 
symptomatic cholecystolithiasis [NIH Consensus conference 1993], while high level 
evidence for this consensus is lacking. Recently, three Cochrane Hepato-Biliary Group 
systematic reviews have been conducted comparing different surgical techniques for 
gallbladder removal in these patients [Keus 2006a; Keus 2006b; Keus 2006c]. An over­
view of the reviews considering the surgical treatment of symptomatic cholecystoli- 
thiasis is lacking.This was the reason for preparing this overview of systematic reviews.
OBJECTIVES
The objective was to evaluate the beneficial and harmful effects of different types of 
cholecystectomy for patients with symptomatic cholecystolithiasis. We wanted to 
assess whether laparoscopic, small-incision, or open cholecystectomy are different in 
terms of primary outcomes (mortality, complications, and relief of symptoms) or 
secondary outcomes (conversions to open cholecystectomy, operative time, hospital 
stay, and convalescence). When data were available, differences in other secondary 
outcomes like analgesic use, postoperative pain, pulmonary function, and costs were 
also compared.
METHODS
The overview was conducted according to the recommendations by The Cochrane 
Handbook f o r  Systematic Reviews o f  Interventions [Higgins 2008] and the Cochrane 
Hepato-Biliary Group M odule [Gluud 2009].
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Criteria for considering reviews for inclusion
Only Cochrane reviews were considered for inclusion in this overview. Non-Cochrane 
reviews were not planned to be included in this overview.
Participants
Participants in the included reviews were patients suffering from symptomatic chole- 
cystolithiasis. Reviews on participants with acute cholecystitis were excluded from this 
overview for reasons of heterogeneity in patient populations.
Interventions
Only surgical treatments for symptomatic cholecystolithiasis were considered.Three 
different techniques for cholecystectomy were recognised: open, small-incision, and 
laparoscopic cholecystectomy. The following classifications of the surgical procedures 
(based on intention-to-treat) were used:
Laparoscopic cholecystectomy includes those procedures that are started as a lapa­
roscopic procedure; i.e., any kind of laparoscopic cholecystectomy with creation of a 
pneumoperitoneum (by Veress needle or open introduction) or mechanical abdominal 
wall lift, irrespective of the number of trocars used.
Only i f ’small-incision’, ’minimal access’, ’minilaparotomy’, or similar terms as intended 
terms were mentioned in the primary classification of the procedure, then the surgical 
intervention was classified as a ’small-incision’ cholecystectomy (i.e., length of incision 
less than 8 cm).The incision length of up to 8 cm was chosen arbitrarily as most authors 
had used this length as a cut-off point between small-incision and (conversion to) open 
cholecystectomy.
All other surgical interventions for gallbladder removal were classified as ’open chole­
cystectomy’; this traditional procedure can be carried out through a larger, i.e., > 8 cm, 
subcostal incision or median laparotomy.
Outcomes o f interest
Both primary and secondary outcome measures were considered. Primary outcome 
measures were mortality, complications (including subcategories), and symptom relief. 
Secondary outcome measures were all other, less important, outcome measures evalua­
ted, if any. All outcomes reported in the three systematic reviews were included.
Search methods for identification of reviews
As only Cochrane reviews were considered for inclusion in this overview of reviews, 
The Cochrane Database o f  Systematic Reviews (CDSR), Issue 4, 2009, was searched
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(Table i).The systematic reviews had to evaluate any surgical interventions for the tre­
atment of symptomatic cholecystolithiasis. The term ’cholecystectomy’ was entered 
and restricted to title, abstract, or keywords. As describing an operation of the gall­
bladder in medical terms without the word cholecystectomy is impossible, a maximal 
sensitive search with the term cholecystectomy was achieved. No other databases were 
searched. No restrictions in the inclusion criteria of the identified reviews were applied 
regarding participants, details of the interventions, or outcomes of interest.
Data collection and analysis
The following methods on data collection and data analyses were used in the overview 
of reviews.
Selection of reviews
The selection process of Cochrane reviews was performed based on the criteria for con­
sidering reviews for inclusion. Cochrane reviews were included when comparisons were 
made between any kind of surgery in patients suffering from symptomatic cholecys- 
tolithiasis.
Data extraction and management
Data from the Cochrane reviews were extracted independently by two authors and re­
garding outcomes not reported in the reviews by one author (FK). Disagreements were 
resolved by consensus. In case of missing data, all original reports of included trials were 
assessed and additional analyses of missing data were performed if appropriate.
Assessment of methodological quality of included reviews 
Quality o f included reviews
The quality of the included reviews was taken into account. We described the quality of 
the reviews in a narrative way.The risk of systematic errors (bias) in systematic reviews 
is influenced by the risks of systematic errors (bias) in the primary trials included in the 
systematic review.
Quality o f evidence in included reviews
Only recently, methodological quality assessment is recommended according to the
Database Search performed in Search strategy
The Cochrane Database o f  Systematic Reviews (CDSR) Issue 4,2009 'cholecystectomy'
Table i: Search strategy
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GRADE recommendations [Atkins 2004; Atkins 2005; Guyatt 2008; Guyatt 2008a]. 
However, the quality of evidence of the included trials in the reviews, prior to this new 
assessment tool, was assessed according to four components assessing risk of bias: 
generation of the allocation sequence, allocation concealment, blinding, and follow- 
up. We described the bias risk of the included trials as they were assessed in the included 
reviews.
Data synthesis
Data were extracted from the underlying systematic reviews, and the sum mary fin ­
dings were presented in tables (Table 2;Table 3 ;Table 4 ;Table 5; Table 6 ;Table 7). Data 
were extracted from direct comparisons, and no indirect comparisons were made since 
evidence from indirect comparisons may be less reliable than evidence from direct 
(head-to-head) comparisons. All data rest on intention-to-treat analyses.
RESULTS
A total of 14 systematic reviews were identified by the search strategy in the Cochrane 
Database of Systematic Reviews.Three of these systematic reviews could be included 
(Table 2) [Keus 2006a; Keus 2006b; Keus 2006c]. For detailed descriptions of all results, 
we refer to the three individual Cochrane Hepato-Biliary Group reviews [Keus 2006a; 
Keus 2006b; Keus 2006c] and a paper publication in which all the three reviews were 
updated [Keus 2008a].
Description of included reviews
The included three reviews contain a total of 56 randomised trials with 5246 patients 
randomised. One of the randomised trials [Coelho 1993] was included in all the three 
systematic reviews because it had three parallel-group comparisons [Keus 2006a; Keus 
2006b; Keus 2006c].
The Cochrane Database o f  Systematic Reviews in The Cochrane Library (Issue 4, 2009) 
was searched to identify reviews for this overview of reviews. The three systematic 
reviews used identical inclusion criteria for inclusion of trials.Only randomised trials were 
included. Identical criteria for types of participants were used.Three reviews were inclu­
ded which compared open, small-incision, and laparoscopic cholecystectomy (Table 2).
Identical outcome measures were considered in the three systematic reviews [Keus 
2006a; Keus 2006b; Keus 2006c]. Primary outcomes were distinguished from secon­
dary outcome measures (Table 3; Table 4). Primary outcomes were mortality and com­
plications. Complications were subcategorised into four subcategories (intra-operative,
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bile duct injuries, minor complications, and severe complications) apart from total 
complication proportions. Secondary outcomes were convalescence (including return to 
normal activity and return to work), operative time, and hospital stay. No data were 
available considering symptom relief.
Methodological quality of included reviews
The methodological quality of the randomised clinical trials in the included reviews 
was evaluated by assessing the following risk of bias components: generation of the 
allocation sequence, allocation concealment, blinding, and follow-up [Higgins 2006; 
Gluud 2009]. Each component was assessed adequate, unknown (’not performed’ for 
blinding), or inadequate. Subgroup analyses were performed based on these assess­
ments.The risk of bias of the included trials was considered high both in the small-in- 
cision versus open cholecystectomy and in the laparoscopicversus open cholecystectomy 
comparisons, while it was considered relatively low in the laparoscopic versus small- 
incision cholecystectomy comparison.
Effect of interventions - Outcomes reported in the systematic reviews
Summary of findings were reported in Table 5,Table 6, and Table 7.
Mortality
Mortality was not reported in all seven trials in the small-incision versus open chole­
cystectomy comparison. Mortality was reported in 14 trials in the laparoscopic versus 
open cholecystectomy comparison and in seven trials in the laparoscopicversus small- 
incision cholecystectomy comparison.
We found no significant differences in mortality between the three techniques. 
Mortality rates were low (up to 0.09%) in the different comparisons.
Complications
Complications were categorised into intra-operative, minor, severe, bile duct injury com­
plications, and total complication proportions.There were no significant differences in 
any of the complication categories.
Intra-operative complications
There were zero intra-operative complications in the small-incision versus open chole­
cystectomy comparison. In the laparoscopicversus open cholecystectomy comparison, 
the intra-operative complication proportions were 0.9% and 0.1%, respectively, and in 
the laparoscopicversus small-incision cholecystectomy comparison, the intra-operative 
complications were 13.1% and 7.6%, respectively.
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M inor complications
In the small-incision versus open cholecystectomy comparison, the minorcomplication 
proportions were 8.6% and 6.8%, respectively. In the laparoscopic versus open chole­
cystectomy comparison, the minor complication proportions were 2.1% and 3.1%, 
respectively, and in the laparoscopic versus small-incision cholecystectomy comparison, 
the minor complications were 8.3% and 9.2%, respectively.
We found no significant differences in the minor complications between the three tech­
niques.
Severe complications
In the small-incision versus open cholecystectomy comparison, the severe complication 
proportions were 1.4% and 2.5%, respectively. In the laparoscopic versus open cholecys­
tectomy comparison, severe complication proportions were 2.2% and 6.8%, respectively, 
and in the laparoscopic versus small-incision cholecystectomy comparison, the severe 
complications were 4.0% and 4.2%, respectively.
We found no significant differences in the intra-operative complications between the
three techniques.
Quality assessment
Outcomes Limitations Inconsistency Indirectness Imprecision
Intra operative 
complications
All trials very serious no serious 
inconsistency
no serious 
indirectness
serious
Minor
complications
All trials very serious no serious 
inconsistency
no serious 
indirectness
serious
Severe
complications
All trials very serious no serious 
inconsistency
no serious 
indirectness
serious
Bile duct 
injuries
All trials very serious serious no serious 
indirectness
serious
Total
complications
All trials very serious no serious 
inconsistency
no serious 
indirectness
serious
Table 5: Summary o f  Findings table: OC vs SIC.
Modified table using GRADE pro software. OC-.open cholecystectomy; SIC: small-incision cholecystectomy;
RR: relative risk. GRADE Working Group grades o f  evidence: High quality: Further research is very unlikely to change 
our confidence in the estimate o f  effect. Moderate quality: Further research is likely to have an important impact on 
our confidence in the estimate o f  effect and may change the estimate.
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Bile duct injury
In the small-incision versus open cholecystectomy comparison, zero bile duct injuries 
were reported. In the laparoscopic versus open cholecystectomy comparison, the pro­
portion of bile duct injuries was 0.2% in both groups. In the laparoscopic versus small- 
incision cholecystectomy comparison, the bile duct injury proportions were 1.2% and 
1.9%, respectively (risk difference, fixed-effect model -0.01, 95% Cl -0.02 to 0.00). The 
difference is mainly caused by eight patients with bile leakage with unknown origin 
and conservative treatment in the small-incision group (five patients from one trial).
We found no significant differences in the bile duct injuries between the three tech­
niques.
Total complications
In the small-incision versus open cholecystectomy comparison, no significant differences 
were found; the total complication proportions were 9.9% and 9.3%, respectively (risk 
difference 0.00,95% Cl -0.06 to 0.07).
We found no significant differences in the severe complications between the three
techniques.
Summary of findings
Other Risk OC 
(control)
Risk SIC 
(comparator)
Relative effect 
SIC vs OC
Absolute effect 
SIC vs OC
Quality of
the evidence (GRADE)
none 0 per 279 
(0%)
0 per 292 
(0%)
not estimable 0 more 
per 1000
VERY LOW
none 19 per 279 
(6.8%)
25 per 292 
(8.6%)
1.26 18 more 
per 1000
VERY LOW
none 7 per 279 
(2.5%)
4 per 292 
(1.4%)
0.56 11 fewer 
per 1000
VERY LOW
none 0 per 279 
(0%)
0 per 292 
(0%)
not estimable 0 fewer 
per 1000
VERY LOW
none 26 per 279
(9 -3%)
29 per 292
(9.9%)
1.06 6 more 
per 1000
VERY LOW
Low quality: Further research is very likely to have an important impact on our confidence in the estimate o f  
effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.
The downgrading in the grades o f  evidence (decrease quality o f  evidence) is based on the assessment o f  five factors: 
limitations in design, inconsistency in results, indirectness o f  evidence, imprecision o f  results, and publication bias. 
Upgrading o f  evidence (increase quality o f  evidence) may occur based on the assessment o f  three factors: the magnitude 
o f  effect, influence o f  all residual confounding, and the dose-response gradient.
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In the laparoscopic versus open cholecystectomy comparison, the total complication 
proportions were 5.4% and 10.1%, respectively Although significant differences were 
found including all trials and in the trials with high risk of bias (risk difference -0.04,95% 
Cl -0.07 to -0.01), no significant difference was found in the trials with low risk of bias 
(risk difference -0.01,95% Cl -0.05 to 0.02).
No significant differences were observed in the total complication proportions in the
Quality assessment
Outcomes Limitations Inconsistency Indirectness Imprecision
Mortality All trials very serious no serious 
inconsistency
no serious 
indirectness
serious
Intra operative 
complications
All trials very serious serious no serious 
indirectness
no serious 
imprecision
Trials with 
low risk of bias
serious no serious 
inconsistency
no serious 
indirectness
serious
Minor
complications
All trials very serious serious no serious 
indirectness
no serious 
imprecision
Trials with 
low risk of bias
serious no serious 
inconsistency
no serious 
indirectness
serious
Severe
complications
All trials very serious serious no serious 
indirectness
serious
Trials with 
low risk of bias
serious no serious 
inconsistency
no serious 
indirectness
serious
Bile duct 
injuries
All trials very serious serious no serious 
indirectness
serious
Trials with 
low risk of bias
serious no serious 
inconsistency
no serious 
indirectness
very serious
Total
complications
All trials very serious serious no serious 
indirectness
no serious 
imprecision
Trials with 
low risk of bias
serious no serious 
inconsistency
no serious 
indirectness
serious
Table 6: Summary o f Findings table: OC vs LC
Modified table using GRADE pro software. OC: open cholecystectomy; LC: laparoscopic cholecystectomy; RR: relative risk 
GRADE Working Group grades o f  evidence: High quality: Further research is very unlikely to change our confidence in the 
estimate o f  effect. Moderate quality: Further research is likely to have an important impact on our confidence in the 
estimate o f  effect and may change the estimate.
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laparoscopic versus sm all-in cisio n cholecystectom y com parison (26.6% and 22.9%, 
respectively) (risk difference -0.01,95%  Cl -0.07 to 0.05) w ith 1.6% re-operations in both 
groups. We also sum m arised the com plications in trials, in w hich three or more bias 
com ponents w ere considered adequate. There w as no sig n ifican t difference in the 
proportions o f total com plications between laparoscopic and sm all-incision cholecys­
tectom y w hen only trials with low risk of bias were included. However, in the trials with 
low risk of bias the com plication proportions in both groups w ere h igher than the
Summary of findings
Other Risk OC Risk LC Relative effect Absolute effect Quality of
(control) (comparator) LC vs OC LC vs OC the evidence (GRADE)
none 1 per 485 0 per502 not estimable 2 fewer VERY LOW
(0.2%) (0%) per 1000
none 1 per 939 9 per 975 9.0 8 more VERY LOW
(0.1%) (0.9%) per 1000
none 0 per 32 0 per 31 not estimable 0 more LOW
(0%) (0%) per 1000
none 35 per 9 39 23 per 975 0.65 13 fewer VERY LOW
(3-7%) (2.4%) per 1000
none 1 per 32 0 per 31 not estimable 31 fewer LOW
(3.1%) (0%) per 1000
none 72 per 939 25 per 975 0.34 51 fewer VERY LOW
(7-7%) (2.6%) per 1000
none 1 per 32 0 per 31 not estimable 31 fewer LOW
(3.1%) (0%) per 1000
none 2 per 939 2 per 975 1.0 0 fewer VERY LOW
(0.2%) (0.2%) per 1000
none 0 per 32 0 per 31 not estimable 0 fewer VERY LOW
(0%) (0%) per 1000
none 110 per 939 59 per 975 0.52 56 fewer VERY LOW
(n.7%) (6.1%) per 1000
none 2 per 32 0 per 31 not estimable 63 fewer LOW
(6.3%) (0%) per 1000
Low quality: Further research is very likely to have an important impact on our confidence in the estimate o f  effect 
and is likely to change the estimate. Very low  quality: We are very uncertain about the estimate.
The downgrading in the grades o f  evidence (decrease quality o f  evidence) is based on the assessment o f  5 factors: 
limitations in design, inconsistency in results, indirectness o f  evidence, imprecision o f  results, and publication bias. 
Upgrading o f  evidence (increase quality o f  evidence) may occur based on the assessment o f  3 factors: the magnitude 
o f  effect, influence o f  all residual confounding, and the dose-response gradient.
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Quality assessment
Outcomes Limitations Inconsistency Indirectness Imprecision
Mortality All trials serious no serious 
inconsistency
no serious 
indirectness
serious
Trials with 
low risk of bias
no serious 
limitations
no serious 
inconsistency
no serious 
indirectness
serious
Intra operative 
complications
All trials very serious very serious no serious 
indirectness
serious
Trials with 
low risk of bias
no serious 
limitations
serious no serious 
indirectness
no serious 
imprecision
Minor
complications
All trials serious serious no serious 
indirectness
serious
Trials with 
low risk of bias
no serious 
limitations
no serious 
inconsistency
no serious 
indirectness
no serious 
imprecision
Severe
complications
All trials serious serious no serious 
indirectness
no serious 
imprecision
Trials with 
low risk of bias
no serious 
limitations
no serious 
inconsistency
no serious 
indirectness
no serious 
imprecision
Bile duct 
injuries
All trials serious serious no serious 
indirectness
serious
Trials with 
low risk of bias
no serious 
limitations
no serious 
inconsistency
no serious 
indirectness
serious
Total
complications
All trials serious very serious no serious 
indirectness
no serious 
imprecision
Trials with 
low risk of bias
no serious 
limitations
no serious 
inconsistency
no serious 
indirectness
no serious 
imprecision
Table j:  Summary o f Findings table: LC vs SIC
Modified table using GRADE pro software. LC: laparoscopic cholecystectomy; SlC.-small-incision cholecystectomy; 
RR: relative risk. GRADE Working Group grades o f  evidence: High quality: Further research is very unlikely to change 
our confidence in the estimate o f  effect. Moderate quality: Further research is likely to have an important impact 
on our confidence in the estimate o f  effect and may change the estimate.
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Summary of findings
Other Risk SIC 
(control)
Risk LC 
(comparator)
Relative effect 
LC vs SIC
Absolute effect 
LC vs SIC
Quality of
the evidence (GRADE)
none 1 per 977 
(0.1%)
1 per 975 
(0.1%)
1.00 0 fewer 
per 1000
LOW
none 0 per 599 
(0%)
0 per 582 
(0%)
not estimable 0 fewer 
per 1000
MODERATE
none 88 per 1151 
(7-6%)
153 per 1164
03.1%)
1.72 55 more 
per 1000
VERY LOW
none 87 per 599
(14-5%)
153 per 582 
(26.3%)
1.81 118 more 
per 1000
MODERATE
none 106 per 1151 
(9.2%)
97 per 1164
(8.3%)
0.90 9 fewer 
per 1000
VERY LOW
none 58 per 599
(9.7%)
57 per 582 
(9.8%)
1.01 1 more 
per 1000
HIGH
none 48 per 1151
(4.2%)
46 per 1164 
(4.0%)
0.95 2 fewer 
per 1000
LOW
none 34 per 599 
(5-7%)
27 per 582
(4.6%)
0.81 11 fewer 
per 1000
HIGH
none 22 per 1151 
(1.9%)
14 per 1164 
(1.2%)
0.63 6 fewer 
per 1000
VERY LOW
none 10 per 599 
(i-7%)
8 per 582
(1.4%)
0.82 3 fewer 
per 1000
MODERATE
none 264 per 1151
(22.9%)
310 per 1164 
(26.6%)
1.16 37 more 
per 1000
VERY LOW
none 189 per 599 
(31.6%)
245 per 582 
(42.1%)
1-33 105 more 
per 1000
HIGH
Low quality: Further research is very likely to have an important impact on our confidence in the estimate o f  effect 
and is likely to change the estimate. Very low  quality: We are very uncertain about the estimate.
The downgrading in the grades o f  evidence (decrease quality o f  evidence) is based on the assessment o f  5 factors: 
limitations in design, inconsistency in results, indirectness o f  evidence, imprecision o f  results, and publication bias. 
Upgrading o f  evidence (increase quality o f  evidence) may occur based on the assessment o f  3 factors: the magnitude 
o f  effect, influence o f  all residual confounding, and the dose-response gradient.
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com plication proportions in the trials w ith high risk of bias.
W e found no sig n ifican t differences in the total com plications between the three 
techniques.
Conversions
Conversion proportions in the sm all-incision versus open cholecystectom y com parison 
and in the laparoscopicversus open cholecystectomy comparison have not been reported. 
No sig n ifican t differences in conversion proportions w ere found in the laparoscopic 
versus sm all-incision cholecystectom y com parison (13.4% and 16.1%, respectively; risk 
difference 0.00 ,9 5%  Cl -0.05 to 0.04).
Operative time
We did not observe significant differences considering operative tim e in the sm all-in- 
cision versus open cholecystectom y com parison (MD 1.94 minutes, 95% Cl -1.37 to 5.25).
W e found no sig n ifican t differences consid erin g  operative tim e in the laparoscopic 
versus open cholecystectom y com parison (MD 3.79 minutes, 95% Cl -4.88 to 12.46).
There is a sig n ifican t difference in operative tim e in the laparoscopic versus sm all- 
incision cholecystectom y com parison. Sm all-incision cholecystectom y is significantly 
faster to perform (MD 9.20 minutes, 95% Cl 2.06 to 16.35). Trials w ith low risk of bias 
showed significant differences (MD, trials w ith low risk of bias considering ’b linding’, 
random -effects model 16.4 m inutes (95% Cl 8.9 to 23.8)), w hile  trials w ith high risk of 
bias showed no significant difference.
Hospital stay
In the sm all-incision versus open cholecystectom y comparison, hospital stay was signi­
ficantly shorter using the sm all-incision technique (MD -2.78 days, 95% Cl -4.94 t o -0.62).
In the laparoscopic versus open cholecystectom y com parison, hospital stay was sign i­
ficantly shorter using the laparoscopic operation (MD -3.07 days, 95% Cl -3.89 to -2.26).
In the laparoscopic versus sm all-incision cholecystectom y com parison, no significant 
difference regarding hospital stay w as present in the trials w ith low risk of bias (MD, 
trials w ith low risk of bias co n sid erin g ’blinding’, random -effects model -0.56 days (95% 
Cl -1.24 to 0.11)), but a significant difference was present in the trials with high risk of bias 
(MD, trials w ith high risk of bias considering ’blinding’, random-effects model -1.08 days 
(95% Cl -1.88 to -0.28)).
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Convalescence
As convalescence can also be measured according to return to work and return to normal 
activity (at home), different analyses were conducted.
In the sm all-incision versus open cholecystectom y com parison, no data were available 
considering w ork leave. In the laparoscopic versus open cholecystectom y comparison, 
a significant difference was found w ith the laparoscopic cholecystectom y show ing a 
shorter w ork leave (MD -22.51 days, 95% Cl -36.89 to -8.13). In the laparoscopic versus 
sm all-in cision  cholecystectom y com parison, no sig n ifican t difference betw een the 
techniques regarding work leave was found (MD, random-effects model -0.43 days (95% 
Cl -4.37 to 3.51)).
No results were reported in the sm all-incision versus open cholecystectom y comparison 
and in the laparoscopic versus open cholecystectom y com parison. Data on convale­
scence to norm al activity w ere available in the laparoscopic versus sm all-incision 
cholecystectom y com parison only: no sig n ifican t difference w as found considering 
convalescence to norm al activity (at home) (MD, trials w ith low risk o f bias considering 
’ blinding’, random -effects model 0.79 days (95% Cl -5.96 to 7.55)).
DISCUSSION
Summary of main results
The present overview  of three Cochrane Hepato-Biliary Group system atic reviews con­
tains at least nine m ajorfinding s. First, the com parison of the clinical outcom e o f open, 
sm all-incision, or laparoscopic cholecystectom y has been well tested in 56 randomised 
clinical trials, and the risk of bias has been relatively low in laparoscopic versus sm all- 
incision cholecystectom y trials, but generally high in laparoscopic versus open chole­
cystectom y trials and in the sm all-incision versus open cholecystectom y trials. Trials 
w ith inadequate m ethodological com ponents carry a higher risk o f bias [Schulz 1995; 
M oher 1998; Juni 2001; Kjaergard 2001; Egger 2003; W ood 2008]. Second, laparoscopic 
cholecystectom y does not seem to carry more bile duct injuries than sm all-incision or 
open cholecystectomy. In this com parison one has to assum e that especially interested 
and skilled surgeons conducted the trials and carried out the interventions.Therefore, 
everyday clinical practice and com plication rates ought to be followed through clinical 
databases and compared to benchm ark values [Winkel 200 7].Third, the total num bers 
of patients with com plications are high and not significantly different for the three pro­
cedures. Fourth, sm all-incision cholecystectom y takes significantly less tim e to perform 
than laparoscopic cholecystectom y. Fifth, both o f the m inim ally invasive techniques 
have a shorter hospital stay compared w ith open cholecystectomy. Hospital stay after
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laparoscopic and sm all-incision cholecystectom y w as not significantly different. Sixth, 
convalescence after laparoscopic and sm all-in cisio n cholecystectom y m easured by 
return to work and return to normal activity was not significantly different. Laparoscopic 
cholecystectom y shows a shorter convalescence compared with open cholecystectomy. 
Seventh, there seem to be no significant differences in pulm onary function and an al­
gesic use for laparoscopic and sm all-incision cholecystectom y (see below). Eighth, there 
seem to be no significant differences in health status am ong laparoscopic and sm all- 
incision cholecystectom y (see below). Ninth, costs appear to be low er from different 
perspectives w hen using the sm all-incision technique (see below).
Overall, both laparoscopic and sm all-incision cholecystectom y show  quicker convale­
scence compared with open cholecystectom y.Sm all-incision cholecystectom y is quicker 
to perform and associated w ith lower costs from different perspectives compared with 
laparoscopic cholecystectomy.
Overall completeness and applicability of evidence
After having conducted the three Cochrane Hepato-Biliary Group reviews, it appeared 
that both of the m inim al-invasive techniques were advantageous compared w ith the 
open cholecystectom y. Both m inim al-invasive techniques seemed to be com parable. 
Therefore, w e questioned the reliability of our findings of the laparoscopic versus sm all- 
incision cholecystectom y review w ith respect to the prim ary outcom e m easures. We 
perform ed tw o ad ditional studies; one assessing  the robustness of fin din g s using 
different pooling methods [Keus 2009a], and the other evaluating the risk o f random 
error [Keus 2009b] by using trial sequential analysis [Brok 2008; W etterslev 2008; Brok 
20og;T horlund 2009].
From previous studies including sim ulation studies, it is known that zero event trials 
may introduce analytical problems [Sweeting 2004; Bradburn 2007]. In our system atic 
review there w ere many zero-event trials. Therefore, w e evaluated the role of different 
continuity corrections, sum m ary effect measures, and statistical methods for pooling 
data consid ering  outcom es on rare events, in clu ding  zero event trials. In num erous 
robustness assessm ents w e found im portant inconsistencies in inferences, confidence 
intervals, and pooled intervention effect estim ates [Keus 2009a]. An inconsistency in 
co nclusions w as found w ith respect to intra-operative com plications. Robustness 
assessm ents showed more intraoperative com plications in the laparoscopic cholecys­
tectom y group. However, detailed evaluation of the types of intra-operative com plica­
tion causin g  this statistical difference show ed th at intraoperative gallb ladder 
perforations were responsible for this. M any surgeons w ill not regard gallbladder per­
forations to be a com plication.Therefore, overall, these robustness assessm ents agreed 
that no significant difference was found in prim ary outcom es (m ortality and com pli-
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cations) between laparoscopic and small-incision cholecystectomy.
In another stu d y w e applied trial sequential analysis to our laparoscopic versus sm all- 
incision cholecystectom y review [Keus 2009b].This technique has been developed for 
the evaluation of the risk o f random  error due to the play of chance and m ultiple 
testing in cum ulative m eta-analysis in order to prevent prem ature conclusions due to 
spurious findings. Analyses were restricted to the prim ary outcom e m easures. Additio­
nally w e constructed a com posite outcom e m easure ’serious adverse events’ including 
all im portant com plications. Analyses were based on low bias risk estim ates o f control 
event rates and intervention effects. Furthermore, adjustm ents were made for the bias 
risks of trials as well as heterogeneity. It appeared that the inform ation size needed for 
strong conclusions is not reached for mortality, bile duct injuries, and severe com plica­
tions. Considering intra-operative and total com plication proportions, it appeared that 
intraoperative gallbladder perforations influenced the results importantly. After excluding 
g allb ladder perforations from  the analyses (for th eir lack o f clinical relevance) the 
inform ation size needed for strong conclusions was reached. No significant differences 
w ere found betw een laparoscopic and sm all-incision  cholecystectom y considering 
intraoperative and total com plications. Since the more clinical relevant question of 
potential differences between laparoscopic and sm all-incision cholecystectom y with 
respect to serious com plications w as not answered, we considered the com posite out­
come m easure ’serious adverse events’.The inform ation size needed to draw  strong 
conclusions w ith respect to serious adverse events is w ithin  reach w ith one additional 
m ulticentre trial w ith low  risk o f bias. W hen ign orin g  intraoperative gallb ladder 
perforations as a com plication, all trial sequential analyses agree that so far there is no 
argum ent to support either laparoscopic or sm all-incision cholecystectomy.
Our tw o additional studies on assessm ents on robustness of evidence and trial sequen­
tial analyses confirm the review conclusions of no significant differences between lapa­
roscopic and sm all-incision cholecystectom y considering prim ary outcome measures.
An issue in applicability is the question w h ether selection for random ised trials intro­
duces bias so that participation is associated w ith greater risks and that outcom es are 
w orse than expected in daily life practice. Differences in outcom es caused by a different 
(better or worse) treatm ent have to be distinguished from  a better recording of out- 
comes.There is em pirical evidence that participation in randomised trials does not lead 
to w orse outcom es and that results are applicable to usual practice [Vist 2005; Vist 
2008], so there seem s to be no difference in treatm ent outcom es [W inkel 2007]. Yet 
one could expect that through a more careful follow-up, outcom es are better recorded 
leading to more objective results.
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The three system atic reviews report different com plication proportions in both the tot­
als and the complication categories. Complications are higher in the laparoscopic versus 
sm all-incision cholecystectom y review compared to the other tw o reviews. We believe 
that differences in m ethodological quality may explain these differences in data: the 
overall risk o f bias in the laparoscopic versus sm all-incision cholecystectom y review was 
considered relatively low compared to the other tw o reviews.These observations are in 
accordance w ith  other studies sh o w in g  linkage betw een unclear and inadequate 
m ethodological quality to significant overestim ation o f beneficial effects and under­
reporting o f adverse effects. High quality trials are more likely to estim ate the 'tru e ' 
effects o f the interventions [Schulz 1995; M oher 1998; Juni 2001; Kjaergard 2001; Egger 
2003; Wood 2008]. The differences in the design o f the trials may also explain diffe­
rences in com plications. M any trials in the laparoscopic versus open cholecystectom y 
review  focus on haem odynam ics, acute phase reactants, oxidative stress factor, or 
endocrine functioning etcetera.These outcom es are short-term results, implying limited 
follow-up. Moreover, these trials have probably not focused on com plications, m aking 
registration probably less accurate.Therefore, underreporting may very well explain the 
low er com plication proportions in the laparoscopic versus open cholecystectom y 
review. However, heterogeneity may be another factor exp lain in g  the differences in 
com plication proportions. Other factors like changing practices over the years, changes 
in surgical techniques, or improvements in anaesthesia cannot be ruled out to play a role 
as well.
Based on 6 billion people in the world, an occurrence of gallstones of 5%, assum ing that 
10% of these people become sym ptom atic, and th at roughly 50% o f sym ptom atic 
patients may undergo cholecystectomy, it can be calculated that 15 m illion cholecys­
tectom ies could be perform ed w o rld w id e  annually. The assum p tion s are all chosen 
towards the lower boundaries, so that these calculations probably underestimate the true 
figure. We showed in the review an average quicker operative tim e of 16 m inutes using 
the sm all-incision approach com pared w ith the laparoscopic operation. Accordingly, 
w orldw ide, 4 m illion hours operative tim e could potentially be saved w hen changing 
from laparoscopic to sm all-incision cholecystectom y annually. Now that resources are 
becomingscarcer.this may offer additional opportunities and solutions for other problems.
There w as no significant difference in hospital stay between laparoscopic and sm all- 
incision cholecystectomy, but hospital stay w as shorter in both m inim ally invasive tech­
niques com pared w ith the open cholecystectom y. One m ight find hospital stay long 
compared to daily life practice. Probably, study conditions and different practice over 
tim e are responsible. Apart from these reasons, there m ight be other reasons for diffe­
rences in hospital stay, including cultural differences [Vitale 1991]. However, we have to 
rem em ber that hospital stay is only a surrogate marker for convalescence and because
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of num erous factors influencing its length, it does not necessary reflect objective dif­
ferences between tw o operative procedures. Differences in hospital stay in open studies 
may represent bias, unless the type of surgery is blinded. Therefore, differences in hos­
pital stay have to be interpreted w ith care. We feel that the im portance o f hospital stay 
is overrated in surgical literature, probably due to the fact that it can be m easured so 
easily. The GRADE categorisation o f outcom es places hospital stay in perspective to 
other outcom es like m ortality and grades hospital stay as being ’not im portan t for 
decision m aking - of lower im portance to patients’ [Guyatt 2008a]. In case tw o inter­
ventions do not have sim ilar effect on patient im portant outcomes, length o f hospital 
stay may, however, become im portant to patients and tax or insurance payers.
Outcomes not reported in the systematic reviews
A dditional data are available on other outcom es in clu d ing  pulm onary function and 
analgesic use, health status, and costs.The conclusions in the individual random ised 
trials on these outcom es are contrasting. These outcom es w ere not reported in the 
system atic reviews and the overview  o f reviews due to statistical problems in meta- 
analysing these data as w ell as a lack of uniform ity in the way som e o f these outcom es 
w ere measured. Therefore, w e have sum m arised qualitatively the available data from 
the randomised trials on these outcomes.
Pulmonary function and analgesic use
Pulm onary function differences between laparoscopic and sm all-incision cholecystec­
tom y have been studied in seven random ised trials [Kunz 1992; Coelho 1993;M cM ahon 
1993; M cM ahon 1994; Squirrel 11998; Bruce 1999; Harju 2006; Keus 2007]. Since different 
variables and different tim es o f m easurem ent were chosen, outcom es w ere reported 
inconsistently [Kunz ig92;C oelh o 1993; M cM ahon 1993; M cM ahon 1994; Squirrel 11998; 
Bruce 1999; Harju 2006; Keus 2007], involved sm all num bers of patients [Coelho 1993; 
Squirrell 1998; Bruce 1999] as w ell as seemed to incorporate som e im portant m etho­
dological shortcom ings [Kunz 1992; Coelho 1993; Harju 2006]. Three trials suggested 
superiority of a procedure, based upon a difference in one [Kunz 1992; Coelho 1993] or 
tw o [Bruce 1999] pulm onary function variables.Three trials incorporated sam ple sizes 
of 15 patients or less per intervention group [Coelho 1993; Squirrell 1998; Bruce 1999]. 
Two trials used a blind approach [Squirrell 1998; Keus 2007]. Details on peri-operative 
anaesthesia m anagem ent were not provided in five of these trials [Kunz 1992; Coelho 
1993; M cM ahon 1993; M cM ahon 1994; Squirrell 1998; Bruce 1999]. One larger trial with 
64 patients in each group, found th at the laparoscopic tech n iq ue w as superior and 
reported both pulm onary function testingand analgesic use [McMahon ig93;M cM ahon 
1994]. However, this m ulti-centre trial did not attem pt to either blind patients or phy­
sicians, details on anaesthesia m anagem ent were not provided, and an incision of 10 cm 
w as considered small, ignoring the more com m only used 8 cm lim itation [M cM ahon
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1 9 9 3 ; M cM ahon 1994]. Harju et al evaluated p ulm onary fun ctio n  in som e o f their 
patients (w ithout explaining how these were selected) and found no significant diffe­
rence between both techniques [Harju 2006]. Our trial including 257 patients showed 
no significant differences evaluating eight pulmonary function variables and analgesic use 
[Keus 2007]. Overall, qualitatively sum m arising the results of these seven randomised 
trials, w e conclude that no differences in pulm onary function and analgesic use have 
been shown between laparoscopic and sm all-incision cholecystectom y
Health status
Differences in health status between laparoscopic and sm all-incision cholecystectom y 
were examined in fo u rtria ls  [Barkun 1992;M cM ahon 1994a;Squirrell 1998; Keus 2008b]. 
Recently, evidence-based g uidelines advise to use the g astrointestinal quality o f life 
index (GIOLI) and the short form  (SF-36) for evaluating health status in cholecystec­
tom y [Korolija 2004]. Retrospectively, three [Barkun 1992; M cM ahon 1994a; Squirrell 
1998] of the fo ur trials did not use the appropriate questionnaires and one trial did 
[Keus 2008 b]. These questionnaires appear to be valid for evaluating patients’ functional 
recovery after cholecystectom y [Korolija 2004]. One trial w ith low risk of bias including 
257 patients and using the appropriate questionnaires found no significant differences 
between laparoscopic and sm all-incision cholecystectom y [Keus 2008b].
Cosmetic results of both m inim al-invasive results were evaluated in one trial com paring 
laparoscopic versus sm all-incision cholecystectom y [Keus 2008b]. The cosm etic effect 
of both techniques was evaluated using the validated body image questionnaire [Dunker 
1998].This low bias risk trial did not find any significant difference between laparoscopic 
and sm all-incision cholecystectom y in the 257 patients [Keus 2008b].
Costs
Differences in costs between laparoscopic and sm all-incision cholecystectom y were 
considered in seven trials [M cM ahon 1994a; Barkun 1995;Calvert 2000;Srivastava 2001; 
Secco 2002; Nilsson 2004; Keus 2009c]. There are several problem s in analysing and 
pooling cost results from different studies. First, costs are reported in different ways 
including different cost items. Second, different points o f view s are taken m aking com ­
parison o f studies difficult. Generally, a societal perspective is recom m ended [Siegel 
1 9 9 7 ; O ostenbrink 2002]. Third, there is a difference in valid ity  of cost assessm ents, 
defined by the details in w hich costs are calculated. M ore detailed analyses provide 
more reliable estim ates [Graves 2002]. Fourth, there may be considerable differences 
in local costs. Specific items in cost analyses differ from  one country or even setting to 
another. Fifth, cultural differences are probably the most im portant problem .There are 
w ide variations in convalescence (and return to w ork) between different cultures 
dependingon a m ultitude of causes, like social securityand cultural habits [Vitale 1991].
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These m ultiple factors cause heterogeneity, and pooling results seems, therefore, inap ­
propriate. So far, seven trials measured costs, and several o f these trials had high risk of 
bias [M cM ahon 1994a; Barkun 1995; Srivastava 2001; Secco 2002]. In some trials m etho­
dology of cost assessm ent w as very lim ited described [M cM ahon 1994a; Srivastava
2001]. O utpatients’ costs [Calvert 2000; M cM ahon 1994a] and indirect costs [M cM ahon 
1994a; Barkun 1995; Calvert 2000; Secco 2002] were excluded in several studies m aking 
overall (societal) com parison of techniques incomplete. Retrospective analyses [Secco
2002] or expert settings [Calvert 2000; Secco 2002] raise questions on reliability and 
genera Usability. In one trial, a significant advantage was found favouring sm all-incision 
cholecystectom y w ith  surgical residents perform ing 86% o f the operations [Keus 
2008c]. Overall, the trials showed a neutral or beneficial effect favouring the sm all-in- 
cision technique [M cM ahon 1994a; Barkun 1995; Calvert 2000; Srivastava 2001; Secco 
2002; Nilsson 2004], and especially, the trials w ith low risk of bias favoured the sm all- 
incision technique [Calvert 2000; Nilsson 2004; Keus 2008c]. Qualitatively sum m arising 
cost results from  the random ised trials we conclude that costs seem to be low er using 
sm all-incision cholecystectomy. Moreover, taking into account that our review did not 
find any significant differences between laparoscopic and sm all-incision cholecystec­
tom y w ith respect to hospital stay and convalescence, it is even more likely that costs 
are lower using the sm all-incision approach.
Today with increasing budget restrictions we have to focus on the resource use associa­
ted w ith the available techniques. Savings, from an operation theatre perspective, have 
been reported as high as 23% when usingthesm all-incision cholecystectomy technique. 
Rem inding that cholecystectom y is one of the m ost frequen tly  perform ed surgical 
procedures, saving resources by sw itch in g  the tech n iq ue of cholecystectom y offers 
opportunities for a re-allocation of these saved resources.
Symptom relief
Remarkably, very little to no inform ation was available w ith respect to sym ptom  relief. 
It seems logical that no recurrences of sym ptom s o f gallbladder colic are to be expected 
w hen the gallbladder is removed. Especially w hen tw o different techniques for chole­
cystectom y are being compared, no differences in sym ptom  relief are to be expected. 
However, data from lower level of evidence suggest that in up to 40%  of patients, sym p­
tom s recur after cholecystectomy. Since this lower level of evidence is the best we have, 
the true figure rem ains unknow n. Retrospectively, the diagnosis sym ptom atic chole- 
cystolithiasis and the indication for cholecystectomy may not have been correct in these 
patients. Therefore, sym ptom  relief should become the focus o f research. Moreover, 
remembering the high complication proportions, it is very hard to justify the risks patients 
w ith incorrect diagnosis of sym ptom atic cholecystolithiasis and patients exposed to 
cholecystectomy with its unacceptable high complication rates are facing. Future research
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urgently needs to refocus on outcom es critical for decision making, i.e., low ering the 
num bers of com plications as w ell as achieving im provem ents in the accuracy of the 
diagnosis of sym ptom atic cholecystolithiasis.
Quality of the evidence
Trials w ith low risks o f bias seem more likely to show  no effect or a negative effect of 
laparoscopic surgery, whereas trials w ith high risk o f bias seem more likely to show  a 
positive effect or no effect of laparoscopic surgery.These observations are in accordance 
w ith other studies show ing linkage between high risk of bias to significant overesti­
mation of beneficial effects and underreporting of adverse effects. Trials w ith low risk 
o f bias are more likely to estim ate the 't ru e ' effects of the interventions [Schulz 1995; 
M o h e ri9 9 8 ;Ju m  2001; Kjaergard 2001; Egger 2003; Wood 2 00 8].This overestim ation of 
beneficial effects associated w ith laparoscopic surgery in trials w ith unclear or inade­
quate m ethodology may be an illustration of personal preferences of surgeons. Lack of 
objectivity biases results.Therefore, overall im provem ent o f m ethodological quality of 
trials, and hence risk o f bias, especially in surgery, is needed to obtain valid and reliable 
results.
We only based our assessm ent of bias on generation o f the allocation sequence, alloca­
tion concealment, blinding, and follow-up. It is a weakness that we have not assessed bias 
due to selective outcom e reporting, baseline differences, early stopping, and vested 
interests [Higgins 2008;G luud 2009]. We plan to address these issues in future updates 
o f the reviews.
Potential biases in the overview process
The first and most im portant potential source of bias relates to us, being the authors 
o f all the three included Cochrane reviews. Additionally, w e performed one o f the trials 
w ith low risk o f bias. We m ight not have recognised the potential mistakes conducted 
in the review process, neither may we be aware of any other potential sources o f bias 
present in the three included reviews. In contrast, having critically appraised all individual 
trials, w e are in detail informed on their weaknesses and strengths on which the reviews 
build.This may be an advantage.
A second issue are the risks of bias in the included trials. A systematic review sum m arises 
results of individual trials and collects their data into pooled effect estim ates.The risks 
o f bias are assessed to evaluate the valid ity of the intervention effects. Obviously, a 
review depends on the methodological quality of the individual trials and is never capa­
ble o f increasing the strength of the trials with high risks of bias. In the third comparison, 
laparoscopic versus sm all-incision cholecystectomy, the overall risk o f bias w as consi­
dered relatively low, w hile  in the other tw o com parisons the overall risk of bias in the
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included trials w as considered high.Therefore, the estim ates of both m inim al invasive 
techniques compared w ith the open technique may not be reliable estim ates of the 
true intervention effects.
Agreements and disagreements with other studies or reviews
The total com plication proportions w e found in the laparoscopic versus the sm all-inci- 
sion cholecystectom y com parison are 26.6% and 22.9%, respectively. These figures 
include gallbladder perforations. As som e surgeons may not regard gallbladder perfo­
ration as a complication, our figures decrease to 17.0% and 17.5% if gallbladder perforation 
is excluded from our figures. However, these figures are still much higher than total 
com plication figures up to 5% reported in other series and reviews including non-ran- 
dom ised series. Such studies represent low er levels o f evidence [Southern Surgeons 
Club 1991; Litwin 1992; Deveney 1993; Deziel 1994; Downs 1996]. We are not aware of 
the exact reasons for the three tim es higher proportion of com plications reported in 
random ised trials as compared to that originating from observational studies, but our 
fin d in g s are in accordance w ith previous observations [Papanikolaou 2006]. These 
observations point collectively to the fact that observational studies are more conser­
vative than the random ised trial w hen reporting harm.
In the laparoscopic versus open cholecystectom y review, we found total com plication 
proportions of 5.4% and 10.1%, respectively, w ith no significant difference applying the 
random -effects m odel.These figures differfrom  the laparoscopic versus sm all-incision 
cholecystectom y review (17.0% versus 17.5%). Probably differences in m ethodological 
quality of the trials may play a role. As results from high quality trials are more reliable 
[Schulz i995;W ood 2008], we believe that the 17% is closer to the truth, p articularly 
because the proportion o f trials w ith low risk of bias in the laparoscopic versus sm all- 
incision cholecystectom y review outw eighs the proportion of trials with low risk of bias 
in the laparoscopic versus open cholecystectom y review. The sam e argum ents hold 
regarding the 17.5% com plication proportion in sm all-incision cholecystectom y w hen 
compared to com plication proportions in the sm all-incision versus open cholecystec­
tom y review.
AUTHORS’ CONCLUSIONS 
Implications for practice
Both sm all-incision and laparoscopic cholecystectom y seem superior to open cholecys­
tectomy. The question today is w hy the laparoscopic cholecystectom y has become the 
standard treatm ent of cholecystectom y for patients w ith sym ptom atic cholecystoli- 
thiasis w ithout strong evidence show ing it is superior to sm all-incision cholecystectomy.
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W e w ere unable to identify any outcom e m easure, significan tly and convincingly in 
favour o f the laparoscopic approach. There are no significant differences in mortality, 
com plications, conversions, hospital stay, and convalescence on the low  risk o f bias 
evidence level. Other outcomes not suitable for pooling in meta-analyses, like pulm onary 
function, pain and analgesic use, and health status w ere not sig n ifican tly  different 
either. Operative tim e and costs were significantly different, both favouring the sm all- 
incision technique. From a patient-relevant outcomes perspective, both techniques may 
be considered equally effective. However, from a society perspective there seem to be 
advantages using the sm all-incision technique.
The high complication proportions observed in all three techniques in trials with low risk 
of bias raise questions and demand for 'best practice' standardised technical guidelines 
for safer cholecystectom y procedures.
Implications for research
Research should concentrate on outcom es th at are relevant to patients instead of 
focusing on outcom es that are of interest m ainly to the surgeons. The causes of the 
high com plication proportions need to be addressed. Furthermore, one additional trial 
w ith low risk of bias on a com posite outcom e m easure ’serious adverse events’ seems 
to be able to reach the cum ulative inform ation size needed for firm  conclusions regar­
ding the com parison sm all-incision versus laparoscopic cholecystectom y. Instead of 
considering total complications, w hich is a composite outcome measure, it may be more 
relevant to consider the individual com plication categories since they may differ regar­
ding their consequences to the patients. A num ber of the included trials did not report 
the specific subgroup o f com plications and their severity. Adverse event reporting is an 
issue that needs urgent attention in surgical trials. M ore elaborate cost evaluations, 
especially on a m acro-econom ic level may provide additional argum ents to decide on 
preferences for either one o f both these techniques.
Reports on postoperative sym ptom  relief are highly needed. The high failure rates of 
symptom relief suggested by lower level evidence raise questions on our quality of care. 
The lack of high quality evidence considering this patient relevant outcom e is remar­
kable. We need a higher level of evidence to confirm  or reject these failure rates. We 
urge trialists to conduct long-term  follow -up to assess patient-relevant outcom es. If 
the figures originating from lower level of evidence appear to be true, then research 
should focus on im provem ents in the diagnostic process.
The high com plication proportions in elective m inim al invasive cholecystectom y should 
be our m ajor concern.Today, research in surgery focuses on the widespread im plem en­
tation o f laparoscopy rather than im proving critical patient relevant outcom es. We
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ought to w orry about the patients’ interests and take their perspective w hen conside­
ring a hierarchy o f relevance o f outcom es as recom m ended by the GRADE W orking 
Group [Guyatt 2008a]. It is w orrying that w e focus on reducing hospital stay by im ple­
m enting laparoscopic surgery rather than focusing on critical patient relevant outcomes. 
The overall quality o f the included random ised trials varied w ith the m ajority o f trials 
having several m ethodological deficiencies. The quality of trials needs to improve by 
adopting the CONSORT Statem ent (w w w .consort-statem ent.org).
There are several questions th at still rem ain unansw ered, like questions regarding 
pulm onary consequences after surgery, cost aspects, and more detailed questions on 
convalescence.
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Chapter i is the introduction of this thesis and presents a brief historical overview  of 
cholecystectom y and the developm ent of m inim al invasive techniques.
Chapter 2 describes the method o f evaluating clinical intervention research along the 
three most im portant dim ensions in which a risk of error may be committed: systematic 
error (m ethodological quality), random error (the play of chance), and design errors (e.g. 
outcom e m easures). U sing an exam ple it is show n how available evidence may be 
analysed and eventually conclusions may be drawn from the evidence using a three- 
dim ensional m atrix approach.
The chapters 3 until 12 present the results of this thesis.
Chapter 3 describes a system atic review com paring conventional open cholecystectom y 
w ith sm all-incision cholecystectomy. No significant differences were found considering 
com plications between both techniques, but the sm all-incision technique has a shorter 
hospital stay.
Chapter 4 describes a system atic review com paring conventional open cholecystectom y 
w ith laparoscopic cholecystectomy. No significant differences were found considering 
com plications and operative tim e between both techniques, but the laparoscopic tech­
nique has a quicker convalescence.
Chapter 5 describes a system atic review com paring laparoscopic cholecystectom y with 
sm all-in cision  cholecystectom y. No sig n ifican t differences w ere found considering 
com plications and convalescence betw een both techniques, but the sm all-incision  
technique has a shorter operative time.
Chapters 3, 4, and 5 sh ow  that both m inim al invasive tech n iq ues (laparoscopic and 
sm all-incision cholecystectom y) have a quicker recovery compared w ith conventional 
open cholecystectomy, w hich ju stifies that both m inim al invasive techniques are pre­
ferred over the conventional open cholecystectomy. Based on these findings both m i­
nimal invasive techniques should be furth er evaluated and balanced.
Chapter 6 evaluates w hether the conclusions in chapter 5 are influenced by the chosen 
statistical pooling method. M ultiple choices have to be made in m eta-analysis consi­
dering the statistical pooling method, especially w hen no events occur in one or both 
groups o f a trial (zero-event trials). The analyses show  that choices o f the statistical 
pooling method may very w ell influence the conclusions drawn from m eta-analysis. 
M u ltip le  analyses are therefore needed to evaluate the robustness o f conclusions. 
Detailed analyses of both m inim al invasive techniques for cholecystectom y show  that
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In chapter 7 a new statistical technique for m eta-analyses, called trial sequential ana­
lysis, is used for the assessm ent o f the risk of random error. This technique evaluates 
w h eth er definitive evidence has been reached or w h ether significant findings may be 
caused by spurious fin d in g s.T h is technique may also estim ate how many additional 
random ized patients are needed before firm  evidence may be reached to accept or 
reject potential differences between tw o interventions.The results show  that there are 
no sign ifican t differences between laparoscopic and sm all-incision cholecystectomy. 
Moreover, it is highly unlikely that a difference in com plications between laparoscopic 
and sm all-incision cholecystectom y w ill ever be show n in the future.
The results in chapters, 6 and 7 show  that there are no significant differences in primary 
outcom e m easures (m ortality and com plications) between laparoscopic and sm all-in- 
cision cholecystectomy, accounting for risks of system atic and random error.Therefore, 
it seem s ju stified  to prefer laparoscopic or sm all-incision cholecystectom y based on 
secondary outcom e m easures (chapters 8 until 11).
Chapter 8 shows the results of a randomized trial between laparoscopic and sm all-in- 
cision cholecystectom y in a Dutch general teaching hospital focusing on a difference in 
costs.The num bers o f com plications in the trial are in line w ith the results in chapter 5. 
The large majority of the operations were performed by surgical residents.The numbers 
of procedures converted to conventional open cholecystectomy, hospital stay, and return 
back to w ork were also not significantly different between both m inim al invasive tech­
niques. Operative tim e was significantly shorter using the sm all-incision approach.
Chapter 9 shows the results of pulm onary function and blood gas analyses of the patients 
in the trial. Anaesthesia techniques, analgesic use, and peri-operative care in the trial 
w ere standardized by protocol. No sig n ifican t differences w ere found in pulm onary 
function and blood gas analyses between laparoscopic and small-incision cholecystectomy.
Chapter 10 describes the results of health status and cosm esis evaluated by question ­
naires o f all patients in the trial. The SF-36 and G astrointestinal Q uality of Life Index 
(GIOLI) were used to evaluate health status and the Body Image Questionnaire was used 
to evaluate cosmesis. No significant differences considering health status and cosmesis 
w ere found between the laparoscopic and the sm all-incision technique.
Chapter 11 shows the results of the cost analysis o f the trial com paring laparoscopic 
and sm all-incision cholecystectomy. A cost-m inim isation analysis w as conducted from
there are no significant differences considering complications between laparoscopic
and small-incision cholecystectomy.
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a societal perspective including direct and indirect costs.The results of the cost analysis 
show  that the sm all-incision technique is preferred, both from a hospital and from a 
societal perspective. From a societal perspective the costs caused by work-leave appear 
to contribute the largest part of all costs irrespective the operative technique used.
In chapter 12 the results of a qualitative research study are described. The aim was to 
identify all aspects and factors that influence the m om ent of return to w ork by using 
focus groups and to com pare responses from patients and physicians. It appears that 
physicians perceive their advices as an im portant factor in patients’ duration of sick- 
leave. In contrast, patients seldom m ention this factor and experience physical com ­
plaints as the m ajor reason influencing the m om ent of return to work.
Chapter 13 is the discussion of this thesis. The available evidence considering cholecys­
tectom y for sym ptom atic cholecystolithiasis is sum m arized in an o verview  review 
o f Cochrane H epato-Biliary G roup reviews along the perspective o f the three most 
im portant dim ensions o f the risks of error: system atic error (m ethodological quality), 
random error (the play of chance), and design error (e.g. outcom e measures). Laparos­
copic and sm all-incision cholecystectom y are both preferred over conventional open 
cholecystectom y based on a quicker recovery. No sig n ifican t differences are found 
between laparoscopic and small-incision cholecystectomy considering complications and 
analysis of the risk o f random error usin gtrial sequential analysis shows that it is highly 
unlikely that a difference in com plications w ill ever be found in the future. There are 
also no significant differences in num bers of conversions, hospital stay, convalescence, 
pulm onary function, analgesic use, health status, and cosm esis between laparoscopic 
and sm all-incision cholecystectomy.The sm all-incision technique has a shorter operative 
tim e and is associated w ith lower costs, both from a hospital and a societal perspec­
tive. Both techniques appear applicable in a teaching hospital. Both m inim al-invasive 
techniques may be considered equally effective from  a patient perspective, however, 
the sm all-incision technique is preferred from a societal perspective based on a quicker 
operative tim e and lower costs.
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Hoofdstuk i vorm t de in leiding van dit proefschrift en geeft een kort historisch over­
zicht van de cholecystectom ie en de ontw ikkeling van m inim aal-invasieve technieken.
Hoofdstuk 2 beschrijft de methode van interventie onderzoek w aarin de drie belang­
rijkste dim ensies van mogelijke fouten in onderzoek worden beschreven: system atische 
fouten (m ethodologische kwaliteit), toevallige fouten en uitkom stm aten. Aan de hand 
van een voorbeeld w ordt getoond hoe bestaand onderzoek met elkaar vergeleken kan 
w orden en uiteindelijk een conclusie getrokken kan w orden uit het aanw ezige bewijs 
met behulp van een drie-dim ensionele m atrix benadering.
De hoofdstukken 3 t/m  12 tonen de resultaten van dit proefschrift.
H oofdstuk3 beschrijft een system atische review w aarin de conventionele open chole­
cystectom ie w ordt vergeleken met d e 'sm all-ind sio n ’ cholecystectom ie. Er worden geen 
verschillen in com plicaties gevonden, m aard e 'sm all-in cisio n ’ techniek kent een kortere 
opnam eduur.
Hoofdstuk 4 beschrijft een system atische review w aarin de laparoscopische cholecys­
tectom ie w ordt vergeleken met de conventionele open cholecystectom ie. Er w orden 
geen verschillen in com plicaties en in operatieduur gevonden, m aar de laparoscopische 
techniek kent een sneller herstel.
Hoofdstuk 5 beschrijft een system atische review w aarin de laparoscopische cholecys­
tectom ie w ordt vergeleken met de ‘sm all-incision’ cholecystectom ie. Er w orden geen 
verschillen in com plicaties gevonden en ook niet in duur van herstel, m aar de ‘sm all- 
incision’ techniek kent een kortere operatieduur.
In de hoofdstukken 3,4 en 5 w ordt gevonden dat beide m inim aal-invasieve technieken 
(laparoscopische en ‘sm all-incision’ cholecystectom ie) een sneller herstel kennen dan 
de conventionele open cholecystectom ie, w aardo or het gerechtvaardigd is beide 
m inim aal-invasieve technieken de voorkeur te geven boven de conventionele open 
cholecystectom ie. Op basis van deze bevindingen moeten beide m inim aal-invasieve 
technieken verder geevalueerd en tegen elkaar afgew ogen worden.
In hoofdstuk 6 w ordt nagegaan in hoeverre de conclusies in hoofdstuk 5 w orden beïn­
vloed door de gekozen statistiche analyse methode. Bij het verrichten van een meta- 
analyse moeten er verschillende keuzes w orden gem aakt w at betreft de te gebruiken 
statistische technieken, met name als er onderzoeken zijn w aarin geen gebeurtenissen 
voorkomen in een of beide groepen (‘zero-event trials’). Het blijkt dat de gekozen statis-
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tische analyse techniek voor het ‘ poolen’ van de data de conclusie kan beinvloeden. 
Hierdoor lijkt het verstandig om meerdere analyses te verrichten om de robuustheid 
van de conclusies te ondersteunen. Bij gedetailleerde analyse van beide m inim aal-in- 
vasieve technieken voor cholecystectom ie blijken er geen verschillen te bestaan wat 
betreft com plicaties tussen beide technieken.
In hoofdstuk 7 w ordt met behulp van een nieuw e statistische analyse techniek voor 
m eta-analyses ‘trial sequential analysis’, geevalueerd of er sprake is van toevallige fo u­
ten. Deze techniek analyseert of er voldoende zekerheid is o f een verschil tussen beide 
m inim aal-invasieve technieken aanw ezig is o f hoeveel patienten nog nodig zijn om een 
zeker verschil tussen beide technieken aan te kunnen tonen. Er blijken geen verschillen 
in com plicaties te bestaan tussen laparoscopische en ‘sm all-incision’ cholecystectom ie 
en het is hoogst onw aarschijnlijk  dat er ooit nog een verschil in com plicaties tussen 
beide technieken aangetoond gaat worden.
Op basis van de resultaten in de hoofdstukken 5, 6 en 7 blijken er geen verschillen in 
primaire uitkomstm aten (m ortaliteit en complicaties) te bestaan tussen laparoscopische 
en'sm all-incision’ cholecystectomie, rekening houdend met mogelijke fouten in m etho­
dologische kwaliteit en toevallige fouten. Derhalve lijkt het gerechtvaardigd om op basis 
van secundaire uitkom stm aten een keuze te maken voor een van beide technieken 
(hoofdstukken 8 tot en met 11).
In hoofdstuk 8 worden de resultaten beschreven van een gerandom iseerde trial gericht 
op een verschil in kosten tussen laparoscopische en ‘sm all-incision’ cholecystectom ie 
in een Nederlands opleidingsziekenhuis. De aantallen com plicaties komen overeen met 
de gevonden resultaten in hoofdstuk 5. Het overgrote deel van de operaties werden 
door chirurgen in opleiding uitgevoerd. Aantallen conversies naar conventionele open 
cholecystectom ie, o p nam ed uur en d u u r van herstel zijn eveneens niet sig n ifican t 
verschillend. De operatieduur was significant korter voor d e ‘sm all-incision’ techniek.
In hoofdstuk 9 w orden de resultaten beschreven van de longfunctie onderzoeken en 
bloedgas analyses van de patienten in de trial. Anaesthesie technieken, analgetica en 
perioperatieve zorg waren in de trial gestandaardiseerd voor alle patienten. Er werden 
geen verschillen gevonden in lo ngfunctie  onderzoek en bloedgas analyses tussen 
laparoscopische en ‘sm all-incision’ cholecystectom ie.
In hoofdstuk 10 w orden de resultaten beschreven van de vragenlijsten die voorgelegd 
zijn aan alle patienten in de trial om de gezondheidstoestand (‘ health statu s’) en de 
cosm etiek te evalueren. Hiertoe w erden de SF-36 en de GIOU vragenlijsten gebruikt
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voor de gezondheidstoestand en de Body Image Q uestionnaire voor de cosmetiek. Er 
w erden geen verschillen in gezondheidstoestand en cosm etiek gevonden tussen de 
laparoscopische en ‘sm all-incision’ techniek.
In hoofdstuk 11 worden de resultaten beschreven van de kosten analyse van de trial 
w aarin de laparoscopische en ‘sm all-incision’ cholecystectom ie w orden vergeleken. Er 
werd een kosten-m inim alisatie analyse verricht vanuit een m aatschappij perspectief 
w aarin  alle directe m edische kosten en indirecte niet-m edische kosten w erden 
m eegenom en. Zowel van uit een ziekenhuis perspectief als van u it een m aatschappij 
perspectief heeft de ‘sm all-incision’ techniek de voorkeur. Ongeacht de operatietech­
niek zijn vanuit een m aatschappij perspectief de kosten als gevolg van ziekteverlof de 
belangrijkste kostenpost.
In hoofdstuk 12 w orden de resultaten van een kw alitatief onderzoek beschreven. M et 
behulp van focus groepen werden discussies gevoerd met zowel patienten als artsen om 
een inzicht te verkrijgen in de redenen waarom  patient ju ist snel het w erk hervatten en 
w aarom  w erkhervatting som s lang duurt. Het blijkt dat artsen verw achten dat hun 
advies de belangrijkste factor is in de duur van het ziekteverlof terw ijl patienten aan ­
geven dat licham elijke klachten de belangrijkste redenen zijn.
Hoofdstuk 13 vorm t de discussie van dit proefschrift. In een ‘overview  review’ w ordt het 
beschikbare bewijs beschreven voor cholecystectom ie vanw ege sym ptom atische cho- 
lecystolithiasis in het perspectief van m ethodologische kwaliteit, toevallige fouten en 
uitkom stm aten. Op basis van een sneller herstel hebben laparoscopische en ‘sm all-in- 
cision’ cholecystectom ie de voorkeur boven conventionele open cholecystectom ie. Er 
zijn geen verschillen in complicaties gevonden tussen laparoscopische e n ‘sm all-incision’ 
cholecystectom ie en analyse van de kans op toevallige fouten toont dat het hoogst 
onw aarschijnlijk is dat er ooit nog een verschil in deze uitkom stm aat tussen beide tech­
nieken aangetoond zal w orden. Er zijn ook geen verschillen in aantallen conversies, 
opnameduur, duur van herstel, longfunctie, analgetica gebruik, gezondheidstoestand en 
cosmetiek tussen laparoscopische e n ‘sm all-incision’ cholecystectomie. D e‘sm all-incision’ 
techniek heeft een kortere operatieduur en kent lagere kosten, zowel van uit een zie­
kenhuis als een m aatschappij perspectief. Beide technieken blijken goed toepasbaar in 
een o p leidin gssituatie. Vanuit een patienten p erspectief kunnen beide m inim aal- 
invasieve technieken gelijkw aardig worden beschouwd, m aar vanuit een m aatschappij 
p erspectief heeft de ‘sm all-in cisio n ’ techniek de voorkeur op basis van een kortere 
operatieduur en lagere kosten.
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Promoveren doe je  niet alleen. Velen hebben op welke m anier dan ook een bijdrage gele­
verd aan het tot stand komen van dit proefschrift. Zonder hun hulp was dit proefschrift 
onm ogelijk geweest, ik wil iedereen bedanken, m aar enkelen wil ik graag in het bijzonder 
noemen.
Professor dr.C.J. H .M .van Laarhoven, beste Kees. Deze odyssee heeft langer geduurd dan 
gepland, maar het heeft ons zeer veel geleerd en nog meer gebracht dan alleen vandaag. 
Ik ben je  erg dankbaar voor het vertrouw en d a tje  altijd in me hebt gehad. Je hebt me 
op vele momenten gecoacht en soms had dat iets met het proefschrift te maken. Ik ben 
je  zeer dankbaar voor je  vriendschap.
Professor dr. H. G. Gooszen. Ik ben u zeer dankbaar, niet alleen voor uw  bijdrage bij het 
tot stand komen van dit proefschrift, m aar vooral ookvoor het vertrouw en dat u vanaf 
het begin in me hebt gehad.
Christian Gluud. Dear C hristian, th an k you for all yo ur tim e, your patience, all w ise 
lessons, and your friendship. I have learnt a lot, especially your clear view  on issues and 
yo ur ab ility  to take a bird’s eye view  to see the figures like in Nasca. It is much too 
sim ple to ju st sa y 'th a n ky o u  for everything’. It is a real honor to have you here today.
Jorn W etterslev. Dear Jorn, thank you for all the tim e w e have worked together. Your 
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to thank you for all reconsiderations, concluding in the m ornings upon your arrival in 
CTU that all calculation of the previous day were not correct in the end (not always nice 
to hear, but always for the better). It was always a pleasure to return to Copenhagen.
The Copenhagen Trial Unit and The Cochrane H epato-Biliary Group, Copenhagen, 
Denmark: Dima, Sarah, Kate, and all others, thanks for all your excellent support.
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Verder wil ik graag alle onderstaande personen hartelijk danken voor hun bijdrage, zonder 
de illusie te hebben compleet te zijn:
De leden van de m anuscriptcom m issie: prof. G.J. van derW ilt, prof dr.J. Drenth en prof. 
dr. D. Lege mate.
De raad van bestuur (prof. dr. H.J.J. M. Berden) van het St. Elisabeth ziekenhuis in Tilburg 
voor de ondersteuning van onderzoek op vele fronten.
M aatschap chirurgie van het St. Elisabeth ziekenhuis in Tilburg voor de ondersteuning 
van de trial.
Prof. dr. I. H. M. Borei Rinkes en alle stafleden van de afdeling Heelkunde, UMC Utrecht 
en dr. G.J. Clevers en de m aatschap chirurgie, Diakonessenhuis Utrecht voor de onder­
steuning tijdens de opleiding.
Alle stafleden van de afdeling Heelkunde, UMC St Radboud, Nijmegen.
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het UMC Utrecht, het Diakonessenhuis in Utrecht en het UMC St Radboud, Nijmegen.
Annelies W erner voor de betrouwbare data verzam eling van het laatste deel van de trial.
Alle m edeauteurs: Usama Ahmed Ali, Jeroen de Jong, Trudy de Jonge, Jolanda de Vries, 
Anne Roukema, Gerrit-Jan Noordergraaf, Erik Buskens.
Het secretariaat en vooral ook de polikliniek van de afdeling chirurgie van het St. Elisabeth 
ziekenhuis in Tilburg.
De afdeling Anaesthesie, OK en verkoeverkamervan het St. Elisabeth ziekenhuis in Tilburg.
Alle verpleegkundigen van afdeling B3 van het St. Elisabeth ziekenhuis in Tilburg en 
toenm alig hoofd van de afdeling Anneke Collet.
De polikliniek longziekten van het St. Elisabeth ziekenhuis in Tilburg voor alle long- 
functieonderzoeken.
Alle huisartsen en arbo artsen die hebben deelgenom en aan de focus groep discussies. 
Alle patienten die hebben deelgenom en aan de trial.
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